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RÉSUMÉ 
L'utilisation d’échafaudages tridimensionnels poreux ensemencés avec des cellules 
ostéoprogénitrices, telles que les cellules souches mésenchymateuses humaines (CSM) pour la 
régénération des os, est devenue un outil prometteur pour l’ingénierie tissulaire osseuse. Les 
échafaudages dans l’ingénierie tissulaire osseuse agissent à titre de structure facilitant 
l'attachement, la migration, et la distribution des cellules hôtes impliquées dans le processus de 
réparation osseuse. Ces structures poreuses doivent être biocompatibles, biodégradables et 
doivent idéalement avoir une chimie de surface favorable, un niveau élevé d’interconnectivité des 
pores, des pores au diamètre favorable et finalement une distribution étroite de la taille des pores. 
Parmi une panoplie de matériaux synthétiques et naturels proposés pour l’ingénierie tissulaire 
osseuse, le poly(ε-caprolactone) (PCL) a été largement utilisé à cette fin grâce à sa 
biocompatibilité, sa basse immunogénicité, sa lente biodégradation et sa stabilité mécanique 
allant jusqu'à trois ans in vivo. Différentes techniques de fabrication ont été utilisées afin de 
produire des échafaudages pour l’ingénierie tissulaire osseuse, telles que le frittage, la coulée 
avec un solvant suivi du lessivage des particules, le moussage, et le prototypage rapide. Ces 
méthodes présentent habituellement de nombreux inconvénients comme l'utilisation de solvants 
toxiques, les limitations imposées par la forme de la phase de l’agent porogène, le niveau faible 
d'interconnectivité des pores, la température élevée du procédé, la large distribution de la taille 
des pores et les coûts élevés du traitement. Jusqu’à présent, une recherche complète sur les 
échafaudages utilisés en génie tissulaire ayant des pores de taille significativement différente et 
contrôlée de manière précise au niveau microscopique tout en considérant l'infiltration de 
l'échafaudage comme un paramètre déterminant n'a pas encore été faite. 
Des échafaudages en PCL ayant les propriétés mentionnées précédemment ont été fabriqués par 
un mélange à l'état fondu avec du poly(oxyde d'éthylène) (PEO) choisi comme phase porogène. 
La composition du mélange a été choisie pour avoir une morphologie co-continue. Un recuit 
statique et une extraction sélective du PEO, qui est hydrosoluble, ont été effectués sur les 
mélanges ainsi obtenus. Les pores générés par cette méthode se sont avérés être entièrement 
interconnectés une propriété qui n'a pas été perturbée par le recuit. Le niveau d'interconnectivité 
des pores a été mesuré indirectement en déterminant le pourcentage de continuité de la phase 
porogène suite à l’extraction. Afin d'étudier l'effet de la taille des pores sur l'infiltration dans 
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l'échafaudage, des structures en PCL ayant des diamètres moyens de pores de 84, 116, 141, et 
162 micromètres ont été produits en faisant varier la durée du recuit. Pour cela, une nouvelle 
analyse in vitro a été utilisée pour comparer l'infiltration à travers l'échafaudage par des billes de 
polystyrène de 10 micromètres de diamètre ayant la même taille que les cellules souches 
mésenchymateuses (CSM) humaines et celle par des CSMs humaines. Le niveau de pénétration 
des billes à travers l’échafaudage a montré une augmentation linéaire avec la hausse de la taille 
de pores, tandis que les CSMs ne se sont infiltrées que dans les pores ayant une taille de 141 et 
162  micromètres. Pour les tailles de pores inférieures, les cellules se sont agrégées et ont adhéré 
près de la zone d’ensemencement avec une basse infiltration dans la structure poreuse. Utiliser 
des billes sphériques non réactives a permis d’obtenir un point de référence pour les systèmes 
non-agrégés qui pourraient être considérés comme le scénario idéal pour l'infiltration. Ces 
résultats ont indiqué que les billes imitent étroitement les cellules pour des tailles de pores égales 
ou supérieures à 141 micromètres. Les tests de cytotoxicité utilisant des fibroblastes de souris 
L929 ont démontré que les échafaudages ne sont pas cytotoxiques et qu’ils n’induisent pas de 
nécrose lors du contact avec les cellules. Cependant, une légère diminution de l'activité 
métabolique des cellules a été observée, elle peut être attribuée à la surface hydrophobe du PCL. 
Par conséquent, la modification de la surface des échafaudages en PCL avec un agent 
cytocompatible et hydrophile peut fortement augmenter l’adhésion, la propagation et la 
différenciation des CSMs en ostéoblastes. 
Le chitosane, un composant important de la famille de polysaccharides, a été utilisé pour 
modifier la chimie des échafaudages de PCL en apportant l’hydrophilicité sur la surface. Le dépôt 
d'une couche homogène de chitosane sur la surface des échafaudages de PCL a été effectué à 
l'aide d'un autoassemblage couche-par-couche (LbL) de poly(chlorure de 
dialyldemethylammunium) (PDADMAC) comme polyélectrolyte cationique et de 
poly(styrenesulfonate de sodium 4) (PSS) comme polyélectrolyte anionique. La dernière couche 
de PSS négativement chargée permet l'addition du chitosane positivement chargé comme couche 
externe. Les mesures gravimétriques ont indiqué qu’une addition allant jusqu'à 3 couches a abouti 
à la formation de chaînes interpénétrées de polyélectrolyte qui ne permettent pas la formation de 
couches distinctes de charges positives ou négatives clairement définies. En augmentant le 
nombre de couches de polyélectrolytes chargés alternativement, des couches distinctes et mieux 
définies ont été formées. Les analyses détaillées des rapports d'O/C, de N/C et de S/C par la 
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spectroscopie de photoélectrons induits par rayons X (XPS), ont confirmé la présence dominante 
de la molécule de PSS à la surface, étant la dernière couche de polyélectrolyte déposée et en plus 
grand nombre de dépôts (n=8), qui pourra être plus tard la surface de déposition du chitosane. Il a 
alors été montré que la méthode de dépôt LbL a conduit à l’obtention d’une couche homogène de 
chitosane pour toutes les profondeurs de cavités dans les échafaudages. Cela confirme que la 
méthode de dépôt LbL est une meilleure stratégie que la méthode de revêtement par immersion. 
L'analyse au microscope électronique à balayage (MEB) a montré une surface rugueuse de 
chitosane sur les substrats 2D de PCL, dont l'épaisseur totale s'étend de 550-700 nanomètres. Ces 
résultats ont permis de vérifier que l'utilisation de l’autoassemblage couche-par-couche de 
polyélectrolytes suivie de l'addition de chitosane comme couche externe, a conduit à une 
modification stable et bien homogène de la surface. De plus, cette méthode a le potentiel de 
transformer un matériel classique en polymère synthétique avec des pores complètement 
interconnectés en un matériel ayant des caractéristiques de surface identiques à celles du 
chitosane. 
Le potentiel ostéogénique des échafaudages de PCL avec un traitement de surface par chitosane 
utilisant la méthode de dépôt LbL n'a jamais été évalué. Cette partie de la thèse considère 
l’hypothèse que l’ostéogenèse in vitro pourrait être réalisée dans les échafaudages 3D de PCL 
avec des pores interconnectés ayant un diamètre moyen de 84 et 141 micromètres, et que la 
biominéralisation pourrait être améliorée quand les pores sont revêtus avec du chitosane par 
l’approche LbL. Afin de réduire au minimum les erreurs provenant des inefficacités de 
l’infiltration cellulaire, le protocole le plus performant d’ensemencement des cellules a du être 
établi. Parmi l’ensemencement classique des cellules à 37 °C, l’ensemencement en deux étapes à 
37°C, et l'ensemencement à froid à 4°C, dans un milieu contenant 2% de FBS (Fetal Bovine 
Serum), le dernier a montré la plus grande population de CSMs fraîchement trypsinisées dans 
toutes les profondeurs des échafaudages de 1 mm d’épaisseur. Les CSMs ensemencées dans des 
échafaudages de PCL, avec ou sans revêtement de chitosane par LbL, ont tout d’abord été mis en 
culture dans un milieu de prolifération pendant 10 jours, puis cultivées 21 jours dans un milieu 
ostéogénique. Au jour 2, les CSMs ont formé des monocouches creuses avec des morphologies 
cellulaires arrondies ayant de minces filopodes ancrés à la surface non modifiée du PCL, 
contrairement aux cellules étalées sur la surface des pores de PCL revêtue avec le chitosane. Au 
jour 10, les cellules ont proliféré formant une couche externe sur PCL et ont migré sur les réseaux 
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de collagène sécrétés qui remplissent les espaces entre les pores dans tous les échafaudages, par 
contre, elles n’adhèrent qu’à des surfaces de pores revêtues par le chitosane. Au jour 31, des 
quantités équivalentes de tissu ont été observées dans les échafaudages avec et sans chitosane, 
cependant les dépôts de tissu ont été plus importants dans les pores externes que dans les pores 
internes. En outre, une plus grande quantité de matrice biominéralisée a été observée dans les 
pores internes des échantillons de 84 micromètres ayant un revêtement de chitosane. Dans les 
échantillons de PCL pur, le dépôt de minéraux a été observé de façon aléatoire dans les sections 
supérieures très colonisées et dans les pores internes de 141 micromètres de diamètre. Les CSMs 
cultivées sur la surface de contrôle 2D avec un revêtement de chitosane ont montré une coloration 
plus prononcée de la phosphatase alcaline, demeurant une minéralisation négligeable. Cette étude 
prouve que les CSMs survivent, se prolifèrent, et adhérent plutôt à la matrice fibreuse qu’à la 
surface non-modifiée des pores du PCL. De plus, les échafaudages revêtus par LbL-chitosane 
présentent plus de biominéralisation en 3D dans les pores internes de 84 micromètres; une 
réponse cellulaire qui peut être liée à la courbure de la surface ainsi qu’à l’amélioration de 
l'hydrophilicité de la surface. 
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ABSTRACT 
The application of porous three-dimensional scaffolds seeded with osteoprogenitor cells such as 
human mesenchymal stem cells (hBMSC) for bone regeneration has become a promising tool for 
in vitro bone tissue engineering. Scaffolds in bone tissue engineering act as a supportive bridge 
that facilitates the migration, attachment and distribution of the host cells involved in bone 
ingrowth. These porous structures should be biocompatible, biodegradable and ideally exhibit a 
favorable surface chemistry, controlled interconnected pores, pore sizes and narrow pore size 
distributions. Among a variety of synthetic and natural materials suggested for bone tissue 
engineering, poly(ε-caprolactone) (PCL) has been widely used for this purpose, owing to its 
biocompatibility, low immunogenicity, slow biodegradation and mechanical stability for up to 
three years in vivo. Various fabrication techniques have been used for the production of bone 
tissue engineering scaffolds, such as sintering, solvent casting and particulate leaching, gas 
foaming and rapid prototyping. These methods are normally associated with numerous 
drawbacks such as the use of toxic solvents, limitations imposed by the shape of the porogen 
phase, low levels of pore interconnectivity, high processing temperatures, large pore size 
distributions and high processing costs. To date, a thorough investigation of tissue engineering 
scaffolds of significantly different and highly controlled pore sizes at the microscopic level 
including scaffold infiltration as a crucial parameter has not been done. 
PCL scaffolds with the features mentioned above have been fabricated by melt blending of PCL 
with poly(ethylene oxide) (PEO) at co-continuous composition followed by static annealing of 
the blends and selective extraction of water soluble PEO as the porogen phase. The pores 
generated by this method were proved to be fully interconnected- a property which was not 
disrupted by annealing. The level of pore interconnectivity was measured indirectly by 
determining the continuity % of the porogen phase post-extraction. PCL scaffolds with 84, 116, 
141, and 162 μm average diameter pore sizes have been generated by varying the annealing time 
to investigate the effect of pore size on the scaffold infiltration. For this purpose, a novel in vitro 
assay was used to compare scaffold infiltration by 10-micron diameter polystyrene beads and 
trypsinized human bone marrow stromal cells (hBMSCs). Beads showed a linear increase in the 
extent of scaffold infiltration with increasing pore size. BMSCs infiltrated the 162 and 141 μm 
pore samples, below which the cells aggregated and adhered near the seeding area with low 
xi 
 
infiltration into the porous device. Using non-interacting spherical beads provides a base-line for 
non-aggregated systems which could be considered as the ideal infiltration scenario. These results 
revealed that the beads closely mimic the cells at pore sizes equal and higher than 141 μm. 
Cytotoxicity studies using L929 mouse fibroblasts demonstrated that the scaffolds are not 
cytotoxic and do not induce necrosis upon contact with the cells. However, a slight decrease in 
the metabolic activity of the cells was observed which was attributed to the hydrophobic surface 
of PCL. Hence, the surface modification of PCL scaffolds with a hydrophilic cytocompatible 
agent could potentially enhance cell attachment, spreading and differentiation of hBMSCs into 
osteoblasts. 
Chitosan, an important member of the polysaccharide family was used to alter the chemistry of 
PCL scaffolds and bring hydrophilicity to the surface. The deposition of a homogeneous chitosan 
layer on the surface of the PCL scaffolds was carried out using a Layer-by-Layer (LbL) self-
assembly of poly(dialyldemethylammunium chloride) (PDADMAC) as cationic and poly(sodium 
4-styrenesulfonate) (PSS) as anionic polyelectrolytes. The final negatively charged PSS layer 
allows for the addition of the positively charged chitosan as the outermost layer. Gravimetric 
measurements revealed that the addition of up to 3 layers leads to the formation of interdiffusing 
polyelectrolyte layers which do not allow for the formation of defined positive or negative 
charges. By increasing the number of polyelectrolyte layers with alternating charges, more well-
defined layers are formed. Detailed analyses of O/C, N/C and S/C ratios by X-ray photoelectron 
spectroscopy (XPS) show that the PSS molecule dominates the surface as the last deposited 
polyelectrolyte layer at higher number of depositions (n=8), which can later be the surface for the 
deposition of chitosan. The LbL deposition of the chitosan layer on the LbL coating was then 
shown to be locally homogeneous at different depths within the scaffolds which also clarified that 
the LbL method is superior to the dip coating strategy. SEM analysis showed that there is a rough 
chitosan surface on the 2D solid PCL constructs whose thickness ranges from 550-700 
nanometers. These results demonstrate that the application of LbL self-assembly of 
polyelectrolytes followed by the addition of chitosan as the outermost layer provides a route 
towards stable and homogeneous surface modification and has the potential to transform a classic 
fully interconnected porous synthetic polymer material to one with essentially complete chitosan-
like surface characteristics. 
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The osteogenic potential of PCL scaffolds with a chitosan coating using Layer-by-Layer (LbL) 
surface modification has never been evaluated before. This part of the study tests the hypothesis 
that in vitro osteogenesis can be achieved in 3D PCL scaffolds with fully interconnected pores of 
84 μm or 141 μm average diameter and biomineralization can be enhanced when pore surfaces 
are coated with chitosan adsorbed to LbL deposited polyelectrolytes. In order to reduce the errors 
originating from cell infiltration inefficiencies, the most competent cell seeding protocol has to be 
defined. Among classical cell seeding at 37°C, 2-step seeding at 37°C and cold seeding at 4°C in 
a medium containing 2% FBS, the last strategy proved to yield the best population of  freshly 
trypsinized hBMSCs at all depths of the 1mm-thick scaffolds. hBMSCs cold-seeded in PCL 
scaffolds with or without an LbL-chitosan coating were cultured for 10 days in proliferation 
medium, followed by 21 days in osteogenic medium. At day 2, MSCs formed sparse monolayers 
with rounded cell morphologies with thin filopodia anchored to the unmodified PCL, as 
compared to more spread cells on chitosan-coated pore surfaces. At day 10, cells proliferated as 
an external layer, and migrated onto secreted collagen networks that filled the interpore spaces of 
all scaffolds, but only adhered to chitosan-coated pore surfaces. At day 31, similar levels of tissue 
formed in scaffolds with and without chitosan, but more tissue was deposited in the outer pores 
than the inner pores. Furthermore, more biomineralized matrix was observed in the inner 84 μm 
chitosan-coated pores (p<0.05). In the PCL-only samples, haphazard mineral deposits were 
observed in highly colonized outer layers and in the inner 141 μm pores. MSCs cultured on 
chitosan-coated 2D control surfaces show higher alkaline phosphatase staining but negligible 
mineralization. This study showed that hBMSCs survive, proliferate, and attach to fibrotic matrix 
rather than the PCL-only scaffold pore surfaces. LbL-chitosan-coated scaffolds showed more 
biomineralization in 3D inner 84 μm pores, a cell response that may be related to surface 
curvature in addition to improved surface hydrophilicity.  
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CHAPTER 1 INTRODUCTION AND OBJECTIVES 
1.1 Introduction 
Broken bone is one of the most painful medical conditions that people are commonly suffering 
from every day. Even the seemingly simple bone fractures could potentially cause recurring pain 
through a lifetime and may eventually require physical therapy or surgery as the last measure. 
According to the most recent data, over 717,000 Canadians aged 12 or older suffered from 
broken or fractured bones in the years 2009 and 2010, which is approximately 2% of the whole 
population (Canadian Community Health Survey, 2009-2010). Although sport accidents seem to 
be the most common cause for fractured bones, an average Canadian suffers from a broken bone 
triggered by road accidents, falls and animal attacks. Among all mentioned causes, fall accidents 
are the main unintentional reason for the initiation of a fracture or eventually breaking a bone. 
Only in the years 2009 and 2010, over 1,714,000 fall accidents were reported which mostly led to 
injuries in the hands and the spine (Canadian Community Health Survey, 2009-2010).  
Most of the bone fractures heal naturally through a cascade of overlapping events comprised of 
three major phases: inflammation, repair and remodeling (Remedios, 1999). However, depending 
on the type of the fracture, fracture stability, and fracture gap some variations in these healing 
phases might occur, which are not the focus of this thesis study. Although most fractures heal 
naturally through all or a portion of the aforementioned classical bone healing steps, certain 
complications do exist.  
Delayed and nonunion fracture healings across species are defined as follows. By definition, 
when a bone fracture is not repaired in an expected time frame, yet signs of healing still exist, a 
delayed fracture healing is occurring (Taylor, 1992). On the other hand, when the normal healing 
process is permanently ceased without attaining completion, it is perceived that a nonunion 
fracture healing has taken place (Taylor, 1992). A considerable percentage of 5-10% of bone 
fractures end up as delayed or nonunion fractures, which accounts for 35,850-71,700 Canadians 
in 2009-2010 (Canadian Community Health Survey, 2009-2010). Figure 1.1 illustrates a 
nonunion fracture at the proximal fifth metatarsal bone. 
There are two main factors that contribute to the formation of delayed and nonunion fractures: 
insufficient fracture stability and inadequate biologic environment. The existence of either or the 
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combination of both these adverse parameters increases the chance of such bone healing 
abnormalities. Other factors include inadequate vascularity, lack of nutrition, large fracture gaps, 
interposition of soft tissue between the fracture gaps, unfavorable metabolism, patient’s age, 
infection and administration of drugs that can interfere with the healing process (such as 
anticoagulants) (Bartels, 1987; DeAngelis, 1975; Hoefle, 1993).   
 
Figure  1.1: Radiograph of a patient with a nonunion stress fracture of the proximal fifth 
metatarsal (demonstrated by an arrow) (Rosenberg & Sferra, 2000) 
In some cases, these complications occur because of the excessive extraction of bone during 
surgery, which leads to degenerative abnormalities with very little bone mineralization at the site 
of the injury. Figure 1.2 demonstrates the posteroanterior skull radiograph of a young female with 
microsomia (i.e. abnormal smallness of body parts) who had undergone distraction of the 
mandible.      
 
Figure  1.2: Microsomia due to a distraction of the mandible, leading to nonunion bone defect 
(Agarwal, 2013) 
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The exact approach taken to treat fracture nonunion depends on many parameters such as 
existence of infection, surrounding tissue damage, and the fracture condition (Chao & Inoue, 
2003). However, a long and complicated orthopedic surgery is usually needed to repair the 
nonunion site. Additionally, although a variety of biological, mechanical and physical approaches 
have been investigated, there is still a need for a treatment that will consistently assist in the 
repair of non-healing or delayed healing of bone fractures and also provide convincing evidence 
that the healing of a fracture can be enhanced (Einhorn, 1995). One promising approach is the use 
of bone tissue engineering scaffolds to guide local bone regeneration and repair.  
Bone tissue engineering also has the potential to be used in order to avoid delayed or nonunion 
fracture healing for the bones that are more susceptible to poor healing conditions. These sites 
include upper thigh bone (femur head and neck) and small wrist bones (scaphoid) which have 
limited vascularity and therefore are more prone to destruction, should an impact occur. Also, 
moderate blood supply exists in some bones like tibia and might be sufficient for fracture repair, 
but a severe trauma or injury can destroy internal or external vascular network and therefore 
natural healing would be compromised. Another example is the fifth metatarsal fractures (i.e., 
Jones fracture) which usually end up in delayed and nonunion healings despite surgical 
treatments (Nunley, 2001). Should there be a fracture in the mentioned sites, tissue engineering 
approaches could be applied to repair the bone and further avoid surgical complications. 
Furthermore, large defects in load bearing bones with the aforementioned limitations always need 
graft interventions for providing the best healing conditions (Banes et al., 2001; Khan et al., 
2008). 
 
1.2 Research Hypothesis 
We hypothesize that PCL scaffolds with controlled pore sizes, fabricated by the melt blending of 
co-continuous immiscible polymers and surface modified by chitosan, can enhance 3D in vitro 
osteogenesis of hBMSCs and lead to biomineralization.   
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1.3 Objectives 
The main objective of this thesis is to fabricate a fully functional porous polymeric poly(ε-
caprolactone) (PCL) scaffold which can satisfy all features required for in vitro bone tissue 
engineering (discussed in Section 2.2.3), in order for it to be clinically used as grafts to repair 
bone fracture nonunions. There are an important number of parameters that have to be considered 
simultaneously for the design and application of these scaffolds as bone grafts, such as scaffold 
infiltration behavior, porous microstructure and surface chemistry. The specific objectives of this 
thesis are thus defined as the following: 
1. To fabricate and thoroughly characterize (pore size, pore size distribution, pore 
interconnectivity, surface chemistry) PCL scaffolds derived by a melt blending approach 
of PCL/Poly(ethylene oxide) (PEO) followed by static annealing and selective extraction  
2. To examine the scaffold infiltration by human bone mesenchymal stem cells (hBMSCs) 
by establishing the pore size and cell seeding protocol requirements that yield the most 
homogeneous cell distribution inside the 3D constructs 
3. To systematically modify the hydrophobic surface of PCL by chitosan as a hydrophilic 
compound and evaluate the uniformity of such surface treatment at all positions inside the 
3D scaffolds with considerable and comparable spatial dimensions  
4. To determine the effect of pore size and chitosan coating on the in vitro matrix 
mineralization behaviour of human bone mesenchymal stem cells (hBMSCs) seeded 
inside 3D porous scaffolds, and elicit matrix calcification through cell-biomaterial 
interactions   
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CHAPTER 2 LITERATURE REVIEW 
What is tissue engineering and why is it needed? What are the strategies in tissue engineering in 
general and how do they relate to bone tissue engineering? What are the roles and requirements 
for bone tissue engineering scaffolds? How are they produced and how can melt blending of 
polymer blends serve bone tissue engineering? This chapter seeks help from the existing 
scientific works in literature to answer these questions along with many others. 
 
2.1 Tissue engineering overview 
The research into tissues and organs dates back to 3000 B.C. The most ancient and well-known 
example of creating living creatures from living or non-living specimens is the biblical tale of the 
creation of Eve from Adam’s rib which triggered the curiosity of men of ancient ages to strive to 
discover such concepts according to social, cultural and scientific backgrounds of the people in 
those times. As a result of such curiosities, Theophrastus von Hohenheinm (Paracelsus) tried to 
find a recipe to create human life by mixing chemical substances in a confined environment, 
whose efforts of course failed.  
Although similar research activities went on for centuries in ancient history, the term “Tissue 
Engineering” was coined for the first time by Skalak and Fox in 1988 and defined as follows: 
“Tissue engineering is the application of principles and methods of engineering and life sciences 
toward the fundamental understanding of structure-function relationships in normal and 
pathological mammalian tissues and the development of biological substitutes to restore, 
maintain, or improve tissue functions” (Skalak & Fox, 1988). Therefore, the concept of tissue 
engineering can be considered mostly as a therapeutic action whose aim is to replace, remove, 
repair or reconstruct a lost or damaged tissue. 
In general, two main parameters are required for tissue engineering: cells and matrix also known 
as scaffold. These two fundamental elements will be discussed further in detail in this chapter. 
There are several strategies in tissue regeneration: first strategy involves the implantation of a 
biomaterial matrix inside the injured region, in order to fill the gaps produced by the defect and 
let the body repair the defect by growing tissue on the implanted matrix. However, a typical in-
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vitro tissue regeneration process involves the incorporation of cells into the matrix followed by in 
vitro cultivation and maturation over a certain period of time, and eventually its implantation into 
the target body (Figure 2.1). The advantage of this technique is that less cellular migration from 
the host body to the damaged region is needed, since the already present cells in the scaffold have 
initiated the deposition of extracellular matrix which accelerates the healing process (Mano et al., 
2002). Bone tissue engineering strategies will be discussed in further detail in section 2.2.1. 
 
Figure  2.1: Representative tissue engineering process involving in vitro expansion of healthy 
autologous cells (Bartis, 2011) 
 
2.2 Bone tissue engineering 
Even though an estimation on total bone grafting procedures performed in Canada does not yet 
exist, this value for the United States is predicted to be approximately half a million per year 
(AATB, September 2010). It is a known fact that there is a critical shortage of musculoskeletal 
tissue donors who are crucial to these procedures. Figure 2.2 depicts the evolution of the number 
of musculoskeletal tissue donors before the year 2007 (AATB, September 2010). The number of 
donors of these types of tissues account for only 5% of the total required grafting procedures. As 
a result of such shortage in donor supplies, the sales for bone grafts and graft substitutes have 
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increased substantially from $300 million in 1999 and reached a value of $1.5 billion over a 
period of 10 years (Orthopedics Network News, 2011). 
 
Figure  2.2: Musculoskeletal tissue donors over the years in the US (AATB, September 2010) 
 
2.2.1 Bone tissue engineering strategies 
2.2.1.1 Osteoconduction 
In the Osteoconduction strategy, as the oldest approach used in bone regeneration (Keating & 
McQueen, 2001), bone graft (scaffold) acts as a supportive “bridge” which due to its specific 
microstructure facilitates the migration, attachment and distribution of the host cells involved in 
vascular bone ingrowth and healing (Bauer & Muschler, 2000; Fleming et al., 2000; Keating & 
McQueen, 2001). For instance, hydroxyapatite (HA) grafts have proved to possess 
osteoconductive properties as new bone was shown to form around and inside the implant (Figure 
2.3) (Scaglione et al., 2012). Since the scaffolds are not pre-seeded with cells in the 
osteoconductive approach, the efficiency of bone formation in the healing process is mostly 
dependent upon the three-dimensional (3D) micro-architecture, porosity, surface chemistry and in 
vivo degradation time of the scaffold. After implantation, the surrounding soft tissue of the host 
migrates through the porous network and into the voids of the scaffold, which gives a rise to the 
formation of new fibrovascular tissue and new blood vessels. These newly formed blood vessels 
could again drive more bone-forming cells to the damage site and accelerate the healing process 
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(Fleming et al., 2000). Although bone itself is the most osteoconductive material, other synthetic 
biomaterials such as HA whose properties mimic those of the mineral phase of the bone have 
been extensively studied. As another option, bioactive proteins can be impregnated inside the 
scaffolds and be delivered to the grafted site in order to enhance bone regeneration (Fleming et 
al., 2000).   
 
Figure  2.3: (a) the interface between the new bone and HA scaffolds, 2 months post-implantation. 
(b) and (c) are high magnifications of (a) (adapted from (Scaglione et al., 2012)) 
 
2.2.1.2 Osteoinduction 
Osteoinduction is the ability of a biomaterial scaffold to induce migration and differentiation of 
osteogenic precursor cells in the surrounding host tissue (Ladd & Pliam, 1999; Weigel, 1993). 
Although by definition osteoinductivity is an intrinsic behaviour of the graft material, synthetic 
biomaterials are not capable of such feature without the incorporation of functional bioactive 
molecules. These biomolecules include epidermal growth factor (EGF), platelet-derived growth 
factors (PDGFs), fibroblast growth factor (FGF), transforming growth factor beta (TGF-β) 
superfamily, and parathyroid hormone (PTH) (Muschler & Midura, 2002). Among these bio-
agents, bone morphogenetic proteins (BMPs) are the most investigated osteoinductive stimuli 
(Klokkevold 2003).  
HA  
New Bone 
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2.2.1.3 Osteogenesis 
Osteogenesis as a strategy is the process of bone formation by pre-seeded cells in the presence or 
absence of growth factors inside the scaffold. In this approach, all the effort is focused on the 
maintenance of cells such as multipotent precursor cells (such as BMSCs), osteocytes and 
osteoblasts, together with matrix proteins which are synthesized during the osteogenesis period. 
These cells are accompanied by other diffusing cells from the tissue fluids in the vicinity of the 
graft and are therefore maintained or compensated via further vascularisation inside the graft 
(Attawia, 2003). For instance, new bone was formed within porous bioglass scaffolds pre-seeded 
with primary rat BMSCs after 4 weeks post-implantation in rat cortical bone defects  (Livingston 
et al., 2002) (Figure 2.4). Also, when poly(lactic-co-glycolic acid) (PLGA) scaffolds were seeded 
with rabbit BMSCs and implanted into rabbit mandible defect models, considerable amount of 
new bone was detected at the defect at 4 and 8 weeks post-implantation (Liu et al., 2014). 
 
Figure  2.4: Histological micrograph of a bioglass scaffolds pre-seeded and cultured in alpha 
essential medium (αMEM) with primary rat bone marrow stromal cells, and implanted in rat 
cortical bone defects for 4 weeks. Stevenel's Blue as the stain and Van Gieson's Picro-Fuchsin 
was used as counterstain (SVG stain). S, B and CB are scaffold, new bone and host cortical bone 
(adapted from (Livingston et al., 2002)) 
 
These strategies have been separately exercised in the past. Yet, in order to achieve the most 
successful integration of the bone implant and the surrounding tissue at the damaged site, a 
combination of osteoconduction, osteoinduction and/or osteogenesis should be used (Betz, 2002; 
Fox, 1984; Keating & McQueen, 2001).  
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In this thesis, we aim to generate bone tissue engineering scaffolds that are presumed to satisfy a 
combination of osteoconductive and osteogenic strategies for potential future in vivo applications. 
Since this study does not include the use of bioactive agents, osteoinductive strategy is not 
considered. Moreover, since we only evaluate the in vitro osteogenesis, the term “scaffold” has 
been mostly used instead of “bone graft”. 
 
2.2.2 Cells used in bone tissue engineering 
Several cell types have been commonly used in bone tissue engineering such as mesenchymal 
stem cells isolated from various tissues (bone marrow, periosteum, human umbilical cord blood) 
and mature osteoblasts including primary cells from trabecular bone derived during iliac crest 
biopsies (Barralet et al., 2005; Batorsky et al., 2005; Chiu et al., 2006; Hattori et al., 2005; 
Hillsley & Frangos, 1994; Jayakumar & Di Silvio, 2010; Khan et al., 2008; Pietrzak & Woodell-
May, 2005). Among the aforementioned cells, bone mesenchymal stem cells mainly derived from 
bone marrow and periosteum are the most frequent cell type used in bone tissue engineering 
(Seong et al., 2010). As their name implies, mesenchymal stem cells are progenitor cells that 
contribute to the generation or regeneration of mesenchymal tissues such as bone, cartilage, 
muscle, tendons, ligaments, and other connective tissues as shown in Figure 2.5 (Caplan, 2005). 
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Figure  2.5: Differentiation strategies of BMSCs (adapted from (Seong et al., 2010)) 
 
2.2.2.1 Bone marrow-derived mesenchymal stem cells (BMSCs) 
Mesenchymal stem cells derived from bone marrow have been extensively cultured in vitro and 
shown to be able to differentiate into multiple cell lineages depending on the culture conditions. 
Upon addition of certain exogenous supplements such as β-glycerophosphate (GP), ascorbic acid 
(ASC) and dexamethasone (Dex) or their derivatives, these cells differentiate into colonies 
composed of cuboidal osteoblastic cells which can finally form mineralized bone nodules (Costa-
Pinto et al., 2009). Table 2.1 summarizes the most common culture conditions (cell culture media 
and supplements) for the osteogenesis of BMSCs.  
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Table  2-1: Cell culture supplements for the osteogenesis of BMSCs. Abbreviations used are 
Dulbecco’s modiﬁed Eagle’s medium (DMEM), alpha-modiﬁed minimum essential Eagle’s 
medium (αMEM), fetal bovine serum (FBS) and fetal calf serum (FCS)  
Media Serum 
Ascorbic Acid 
or Derivative 
Dexamethasone 
or Derivative 
β-glycerophosphate 
or Derivative 
Reference 
DMEM 
10% 
FBS 
50 μmol/L 10−7  mol/L 10 mmol/L 
(Bosnakovski et 
al., 2005) 
10% 
FBS 
50 μmol/L 10−8  mol/L 10 mmol/L 
(Costa-Pinto et al., 
2009) 
αMEM 
10% 
FBS 
200 μmol/L 10−8  mol/L 10 mmol/L 
(Sugiura et al., 
2004) 
10% 
FCS 
100 μmol/L 10−8  mol/L 10 mmol/L 
(Gronthos et al., 
1994) 
 
Apart from the supplements added to the culture, other exogenous osteoinductive factors (as 
mentioned in section 2.2.1.2) such as recombinant human BMP-2 (rhBMP-2) and parathyroid 
hormone (PTH)-related peptide have been reported to accelerate osteogenesis of BMSCs in in 
vitro and in vivo investigations (Miao et al., 2001; Yamagiwa et al., 2001). Also, it has been 
shown that low passage number as opposed to high passage number cells and culture in alpha-
modiﬁed minimum essential Eagle’s medium (αMEM) as opposed to Dulbecco’s modiﬁed 
Eagle’s medium (DMEM) lead to higher expression of osteogenic markers and mineralization 
(Coelho et al., 2000; Sugiura et al., 2004). 
 
2.2.2.2 Osteogenesis of BMSCs and marker expressions   
The bone tissue currently produced by today’s osteogenic strategies is not sufficiently stiff to 
endure high load-bearing functions (Dawson & Oreffo, 2008). Therefore, bone tissue engineering 
scientists are now facing specific challenges for the development of new bone regeneration 
approaches to produce fully functional bone constructs in clinical applications. These challenges 
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could not be tackled without a proper knowledge about the molecular and cellular mechanisms 
involved in the process of osteogenesis. Insights into specific mechanisms controlling 
osteogenesis are made possible by in vitro cell culture assays, and the ability to detect various 
components or “markers” of different stages of osteogenesis. Some bone tissue engineering 
approaches analyze the interaction between a new material and primary osteoblasts or osteoblast 
cell lines that are already committed to forming a mineralized matrix. It could be said that to 
better reflect processes occurring in clinical bone repair, a scaffold should be seeded with primary 
cells that normally participate in bone repair, with human cells, and primary cells as opposed to 
immortalized cells that require artificial conditions to arrest proliferation and differentiate. Bone 
marrow stromal cells (BMSCs) from adult bone marrow aspirates are such a cell source. 
BMSCs are multipotent adult progenitors capable of differentiating into osteoblasts, 
chondrocytes, adipocytes, or fibroblasts depending on the culture medium (Yoo & Johnstone, 
1998). In the osteogenesis assay, BMSCs are seeded at low density as monolayers, allowed to 
become confluent, then a medium containing osteogenic factors is added. In osteogenic medium, 
dexamethasone is an additive that suppresses inflammatory factor secretion by BMSCs, which 
allows cells to stop proliferating and differentiate to osteoblasts (Guzmán-Morales et al., 2009). 
Other factors including beta-glycerol phosphate and ascorbate are added to supply phosphate for 
hydroxyapatite mineral formation and for appropriate collagen type I fibril assembly. With the 
addition of the osteogenic medium to a culture of BMSCs, these cells increase expression of 
alkaline phosphatase, a marker expressed by the osteoblasts or bone making cells and the 
initiation of osteogenesis is hence confirmed. Other markers such as osteonectin, osteopontin, 
and osteocalcin may also be induced. According to Huang et al. the osteogenic differentiation of 
BMSCs to osteoblasts occurs in three principal stages (Huang et al., 2007). The first stage takes 
place in the first four days and it denotes a peak in the number of cells. The early osteogenic 
marker alkaline phosphatase (ALP) protein is transcribed and expressed in the days 5 to 14 
whose expression is known to decline afterwards (Aubin, 2001). The expression of collagen type 
I could also be detected in these early stages of osteogenesis (Quarles et al., 1992). The final 
stage of the osteogenesis occurs from the days 14 to 28 when high levels of osteocalcin and 
osteopontin marker expression are observed, especially in rodent cultures, together with the 
deposition of calcium and phosphate minerals in the assembled collagen type I matrix (Hoemann 
et al., 2009). As also explained in the previous section, the existence of osteogenic factors such as 
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dexamethasone, ascorbic acid and β-glycerol phosphate is known to stimulate the osteogenesis of 
BMSCs (Vater et al., 2011). 
When differentiating into osteoblasts, the morphology of the BMSCs transforms from a 
fibroblastic to a cuboidal shape (Vater et al., 2011). Also, an extracellular matrix mainly 
composed of collagen type I is secreted from the cells at this and later stages of the osteogenesis 
which can ultimately form mineral nodules in rodent cultures that can be detected by alizarin red 
(AR) and/or Von Kossa (VK) staining (Vater et al., 2011). In osteogenic cultures of human 
primary BMSCs that have been amplified by 3 to 6 passages, a more diffuse mineral stain is 
normally observed (Guzmán-Morales et al., 2009). It should be noted that both fibroblasts and 
osteoblasts express collagen type I, and that undifferentiated BMSCs can sporadically express 
alkaline phosphatase (Hoemann et al., 2009). Therefore, more than 1 marker is usually needed to 
convincingly demonstrate successful osteoblast differentiation and end-stage functional bone 
deposition. The two most frequently employed markers of osteogenesis are alkaline phosphatase 
(an enzyme reflecting osteoblast commitment and competence to hydrolyze β-glycerol phosphate 
to free phosphate), and a histological stain for hydroxyapatite mineral deposition. Alizarin red 
stain for calcium is often used because the dye can be further extracted from monolayer cultures 
and quantified using standard spectroscopic absorbance for statistical hypothesis testing. 
 
2.2.2.3 In vitro osteogenesis of BMSCs in 3D constructs   
Whether the in vitro system is two or three-dimensional can be very determining for the 
osteogenic outcome from the cells. As an example, higher levels of osteogenic differentiation of 
rat BMSCs were observed in 3D as compared to 2D systems (Hosseinkhani et al., 2006). Also, 
increased absolute expression of osteogenic markers such as alkaline phosphatase, osteonectin, 
osteopontin and Collagen type I of human adipose-derived stem cells was observed in 3D as 
opposed to 2D substrates (Gabbay et al., 2006). Moreover, in 3D culture, an increase was 
observed in the differentiation of primary human osteoblasts (bone-forming cells) into osteocytes 
(bone cells) as compared to the classic 2D-culture (Boukhechba et al., 2009). Therefore, 
obtaining fully functional mineralizing matrix in a 3D environment becomes crucial as bone 
tissue regeneration almost never occurs on a 2D substrate. 
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Fischer et al. demonstrated that hybrid injectable microparticles of HA impregnated with BMSCs 
could exhibit osteogenic potential in a 3D environment (Fischer et al., 2003). In another work, 
BMP-2 Gene transfection (process of introducing genes into a cell) performed on BMSCs led to 
the endogenous secretion of BMP-2 which highly improved osteogenic differentiation of the cells 
seeded in 3D porous silk ﬁbroin sponge-like scaffolds (Meinel et al., 2006). Moreover, following 
the procedure scheme in Figure 2.1, BMSCs harvested from a patient’s body, cultured in vitro 
and directed toward differentiation and mineralization inside three-dimensional HA ceramic 
scaffolds, were implanted back into the original patient and proved to have osteogenic potential 
with no side effects (Morishita et al., 2006). Table 2.2 summarizes some of the recent works that 
investigated 3D osteogenesis involving BMSCs. In this table, abbreviations GP, ASC and Dex, 
represent pure or chemical derivatives of β-glycerophosphate, ascorbic acid and dexamethasone. 
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Table  2-2: Recent developments in 3D-osteogenesis by BMSCs 
BMSC 
source 
Osteogenic media/culture time 3D scaffold (details) 
Seeding 
density 
Reference 
Rat 
α MEM, 10% FBS, 10 mM b-
GP, 50 μg/ml ASC, (No Dex) 
PCL and HA composite 
scaffold by fiber deposition 
and LbL assembly 
Shape: 5×5×2 mm
3
 
5×10
4
 cells 
on each 
scaffold 
(Hong et al., 2009) 
Rat 
DMEM, 15% FBS, 10 mM GP, 
0.28 mM ASC, 10
-8
 M Dex  
Culture Time: 14 days 
HA and starch–
polycaprolactone (SPCL) 
Scaffolds by sintering and 
melt spinning 
Shape: discs of 5 mm in 
diameter and 4 mm 
thickness 
5×10
2
, 1×10
3
, 
5×10
3
 and 
1×10
4
 cells 
on each 
scaffold (low 
seeding 
densities) 
(Oliveira et al., 
2009) 
Rat 
DMEM, 15% FBS, 10 mM 
GP, 50 μg/ml ASC, 10nM Dex  
Culture time: 21 days 
Poly(L-lactic acid) (PLLA) 
and nano-HA by phase 
separation 
Shape: 5×5×2 mm 
5×10
5
  cells 
in 50μl 
DMEM on 
each scaffold 
(Eslaminejad et al., 
2011) 
Rat 
DMEM, 10% FBS, 10nmol/L 
GP, 50 μmol/L ASC, 10 nmol/L 
Dex, 10 nmol/L 1α,25-
dihydroxyvitamin D3 
Culture time: 1,2 and 4 weeks 
PHBV-based Scaffold by 
electrospinning 
10 000 
cells/cm
2
 
(Lü et al., 2012) 
Rat 
α MEM, 10% FBS, 10 mM GP, 
50 μg/mL ASC, 10 nM Dex 
Culture time: 14 days 
PLA scaffold by phase 
separation  
Shape: discs of 16 mm in 
diameter and 1 mm 
thickness 
4×10
4
 cells 
on each 
scaffold 
(Lee et al., 2012) 
Rat 
DMEM, 10% FBS, 10 mM GP, 
50 μg/mL ASC, 0.1 μM Dex, 10 
PCL, PLGA by CO2 dense 
phase sintering 
552,000 cells 
in 55.2uL on 
(Bhamidipati et al., 
2013) 
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nM 1α,25 dihydroxyvitamin 
D3, 50 ng/mL BMP-2 
Culture time: 6 weeks  
Shape: discs of 7.8 ± 0.2 
mm in diameter and 1.7 ± 
0.7 mm in thickness 
each scaffold 
Rabbit 
DMEM, 10% FBS, 10 mM GP, 
50 mM ASC, 1 μM Dex  
Culture time: 10 days 
pearl/PLGA by low- 
temperature deposition 
manufacturing (LDM) 
Shape: 10×10×3 mm
3
 
2 ×10
6
 cells 
on each 
scaffold 
(Xu et al., 2010b) 
Human 
DMEM, 10% FBS, 3.5 mM GP, 
0.05 mM ASC, 10
-7
M Dex 
Culture time: 28 days 
Mineralized collagen by 
freeze drying followed by 
chemical crosslinking with 
collagen 
Shape: discs of 10mm 
diameter and 5mm height 
2×10
5
 cells in 
60μL of 
medium on 
each scaffold 
(Bernhardt et al., 
2009) 
Human 
DMEM, 10% FBS, 10mM GP, 
50mg/mL ASC, 100 nM Dex, 
Culture time: 45 days 
3D woven PCL 
Shape: discs of 7mm 
diameter and 1.3mm 
thickness 
1×10
6
  cells 
mixed with 
30μL of 0.6% 
(w/v) 
collagen type 
I gel 
(Abrahamsson et al., 
2010) 
Human 
α MEM, 10% FBS, 10 mM GP, 
0.05 mM ASC, 100 nM Dex,  
Culture time: 6 weeks 
 
Silk/HA Scaffolds by direct 
write assembly  
Shape: 8×8×∼1.2 mm3 
1×10
5
 cells 
in 100 μl of 
medium 
(Sun et al., 2012) 
   
2.2.3 Requirements for bone tissue engineering scaffolds 
Apart from the previously mentioned parameters, the 3D scaffold should also possess certain 
specific properties. The key function of the scaffold is the direction and guidance of the cell 
growth, either migrating from the surrounding tissues (for in vivo) into or those pre-seeded onto 
the scaffold (in vitro or in vivo). The scaffold acts as a mechanical support for the cell growth, 
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differentiation, proliferation, and other cellular functions. Moreover, it should possess appropriate 
mechanical structure for the transport of nutrient, waste and extracellular matrix (ECM) material. 
In this section, essential properties of the scaffolds (bone grafts) are discussed. 
   
2.2.3.1 Biocompatibility 
Biocompatibility is the most significant factor in the rapid and successful integration of the 
scaffold with the host tissue. The parameters that reflect the biocompatibility of a material are the 
absence of cytotoxicity, low or no immunogenicity and the presence or absence of carcinogenic 
effects. BIO-OSS (deproteinized bovine bone mineral), for example, is an efficient 
biocompatible bone substitutes that has been used for bone damage repair in a scaffold-
assisted bone regeneration process for quite some time (Carmagnola et al., 2003). On the other 
hand, implantation of a bio-incompatible scaffold at the injury site often leads to the induction of 
inflammatory responses as the body attempts to contain, neutralize and protect the damaged bone 
and the cells inside (Ratner, 2005) . Incompatibility of the foreign matrix with the biological 
environment of the defect could also lead to the secretion of toxic compounds, which might 
further trigger inflammatory responses of the body as well as infection (Athanasiou et al., 1996). 
Biocompatibility of the scaffold material is closely related to its biodegradation. Some scaffold 
materials like poly(lactic acid) release acidic by-products which are trapped at the damaged site 
and are lethal to osteogenic cells (Guo et al., 2004). 
Figure 2.6 illustrates how subcutaneously implanted polyethylene scaffolds in mice are 
encapsulated with layers of fibrous tissue as a foreign body inflammatory reaction to a bio-
incompatible material (Ehashi et al., 2014).  
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Figure  2.6: Foreign body reaction by disordered tissue formation (arrow) to bio-incompatible 
polyethylene material. The scaffold is represented by the letter S  (Ehashi et al., 2014) 
 
2.2.3.2 Biodegradation 
In most cases, the implanted scaffold should degrade and leave the host’s physiological system. 
In the case of metals, as bone grafts, a surgery is required to extract the foreign material from the 
body. In bone tissue engineering where mechanical strength is provided by the scaffold especially 
at the early stages of bone healing, the degradation rate of the material must be tailored in such a 
way that it comply with the growth rate of the new forming tissue (Wang et al., 2010). Ideally, 
the entire scaffold should be degraded by the time that the damaged tissue is totally renewed. 
Figure 2.7 illustrates the degradation behavior of biodegradable scaffolds made of porcine small 
intestinal submucosa implanted into the subcutaneous pocket of axilla (arm-pit) in mice (Kim et 
al., 2013). While tissue ingrowth is taking place, the scaffold is degrading after 28 days. It is clear 
that the rate of material degradation higher than that of the bone tissue formation leads to the 
collapse of the scaffold sooner than the bone tissue becomes self-supporting.   
 
Figure  2.7: Tissue ingrowth by hematoxylin and eosin (H&E) staining and in vivo degradation of 
the scaffold by near-infrared fluorescence (NIR) imaging (adapted from (Kim et al., 2013)) 
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2.2.3.3 Porosity, pore size and level of pore interconnectivity 
In order to provide the cells with nutrients and evacuate the waste products present from the 
defect site, the bone tissue needs to be highly vascularized. As explained in section 2.2.1.1, 
vascularization at the damaged zone also promotes the flow of neutrophils, macrophages, 
osteoblasts, mesenchymal cells and bioactive molecules to the site of injury which leads to the 
callus formation. In order to maintain high levels of vascularization, the scaffold should possess 
high levels of porosity and pore interconnectivity (Salgado et al., 2004). Also, porosity leads to 
an enhanced mechanical interlocking between the scaffold and the bone environment of the host 
tissue (Story et al., 1998). An example of the mechanical interlocking is illustrated in Figure 2.8 
where the osseointegration of the new bone into the porous titanium implant is evident (De 
Vasconcellos, 2012). High porosity which can also provide a high surface-to-volume ratio can 
optimize the interactions between the cells and the polymeric scaffolds by affecting the cellular 
adhesion. Low levels of pore interconnectivity, on the other hand, limits the formation of blood 
vessels in vivo, whereas extremely open networks might affect the cell seeding efficiency and 
cellular adhesion (Bai et al., 2010).  
 
Figure  2.8: Mechanical interlocking of the new bone into porous titanium scaffolds. The scaffold 
and new bone are represented by the letters S and B respectively (adapted from (De 
Vasconcellos, 2012)) 
There is a rule of thumb which establishes 90% porosity as the minimum porosity required for 
growing cells inside a scaffold. The main reason for this limit is that achieving high pore 
interconnectivities with porosities less than 90% is very difficult. As a matter of fact, this appears 
S 
B 
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to be the case when conventional scaffold fabrication methods like the solvent casting and 
particulate leaching are used. There have been a lot of works in the literature that attempted to 
establish the optimal porosity and pore size for tissue engineering applications. Nonetheless, 
these porosity/pore size limits are undoubtedly different from an application to another (tissue 
type). By increasing the porosity, the mechanical properties of the scaffolds which are of utmost 
importance in bone regeneration fall drastically. Therefore, many attempts have been made in the 
past to maintain the pore interconnectivity at high levels while keeping the mechanical integrity 
of the scaffold together with its load-bearing features (Karageorgiou & Kaplan, 2005).  
Depending on the materials and processing techniques used, bone ingrowth has been observed 
with porosities as low as 47% to 74% (Whang et al., 1999). Additionally, pore sizes ranging from 
50-710 μm are proposed for bone regeneration (Li et al., 2002b; Lu & Mikos, 1996). The effect 
of porosity and pore size on the efficiency of osteogenesis will be discussed in further detail in 
the next subsection. 
 
2.2.3.3.1 Effect of porosity on osteogenesis 
The effect of porosity on bone formation has been studied for both in vitro and in vivo 
experiments, and will be discussed in this section. 
2.2.3.3.1.1 In vitro 
The effect of porosity on the in vitro osteogenesis has been investigated for both osteoblasts and 
undifferentiated mesenchymal stem cells. However, while some studies showed that porosity 
does not affect bone formation, others argued otherwise. To begin with, regarding cellular 
proliferation, composites of apatite and collagen seeded with MC3T3-E1 preosteoblasts did not 
exhibit any improvements with increasing porosities from 49 to 79%  (Itoh et al., 2004). 
Contrarily, rat BMSCs seeded in non-woven fibers made of polyethylene terephthalate (PET) 
exhibited an increase in cellular proliferation with an increase in the scaffold porosity from 93 to 
97%,  which was attributed to a rise in the transport of oxygen and nutrients at higher porosities 
(Takahashi & Tabata, 2004). On the other hand, lower porosities (~93%) led to a higher 
expression of ALP and osteocalcin, which are markers for osteoblasts activities after 4 weeks of 
culture in normal and bone differentiation medium containing DMEM supplemented with 15% 
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FCS, 10 nM dexamethasone, 50 μg/ml ascorbic acid and 10 mM β-glycerophosphate (Figure 
2.9). The black bars in this figure denote high porosity samples and bear lower levels of ALP and 
osteocalcin than the low porosity samples (grey bars). This effect was attributed to the fact that in 
lower porosities, cell aggregation occurs which could stimulate the expression of these markers 
(Takahashi & Tabata, 2004).  
 
Figure  2.9: ALP and osteocalcin activity of mesenchymal stem cells in low porosity (grey) vs. 
high porosity (black) PET fibers. Small bars correspond to culture in non-osteogenic medium 
(Takahashi & Tabata, 2004)  
 
2.2.3.3.1.2 In vivo 
As discussed in this thesis, the scaffold-assisted in vivo osteogenesis involves the recruitment and 
penetration of cells and other agents from the neighboring tissue into the porous scaffold. 
Therefore, higher levels of porosity are expected to favor the osteogenesis process. Scaffolds 
fabricated by a poly(L-lactide-co-D,L-lactide) containing 20wt% β-tricalcium phosphate (TCP) 
with porosities ranging from 80-88% were implanted for the repair of rabbit craniums, and it was 
shown that higher tissue ingrowth occurred at higher scaffold porosities (Figure 2.10)  (Roy et al., 
2003).  
Higher porosities in HA/TCP scaffolds also led to higher ALP activities of skeletal stem cells 
after 28 days post-implantation in mice (Figure 2.11) (Aarvold et al., 2013). In another study, 
Low porosity 
High porosity 
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soluble calcium filler salts were incorporated with poly(propylene fumarate) to produce porosity 
in the scaffolds, More salt particles led to higher porosities, and in this case induced greater and 
deeper bone ingrowth for rat tibia repair (Lewandrowski et al., 2000). Also, the higher porosity 
(48% as opposed to 44%) in dental implant coatings by porous titanium led to a higher tissue 
ingrowth in canine mandible defects (Story et al., 1998). 
 
Figure  2.10: More new bone formation inside PLGA Scaffolds evidenced by SVG stain at 8 
weeks post-surgery in rabbit cranial defects with an increase in porosity towards the center of the 
scaffold (yellow rectangle). (adapted from (Roy et al., 2003)) 
 
 
Figure  2.11: Higher porosity in HA/TCP scaffolds leads to higher ALP activity (better 
differentiation of preseeded MSCs) (Aarvold et al., 2013) 
 
Higher porosity scaffold 
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Most of the works in the literature have shown that the porosity has a positive effect on new bone 
formation in vivo. However, Amemiya et al reported that the increase in the porosity has a neutral 
effect on tissue formation (Amemiya et al., 2012). 
 
2.2.3.3.2 Effect of pore size on osteogenesis 
2.2.3.3.2.1 In vitro 
As compared to in vivo investigations, the effect of pore size on in vitro osteogenesis has seen 
very little attention in the literature and there is good potential for further research in this field. In 
addition, the pore dimensions investigated in these few efforts are significantly smaller than the 
minimum pore size requirements for in vivo osteogenesis. Moreover, the results obtained from 
these studies are quite contradictory. For example, it was shown that while the surface 
modification of PolyHIPE polymer (PHP) scaffolds with HA has a considerable impact on 
biomineralization by primary rat osteoblasts after 28 and 35 days, the pore size increase from 40 
µm to 100 µm has no such effect (Figure 2.12) (Akay et al., 2004).  
 
Figure  2.12: Neutral effect of pore size on mineral nodule formation (Akay et al., 2004) 
 
Contrarily, a recent work by Huri et al. demonstrated that PCL scaffolds with pore sizes ranging 
from (0.5-1.5 mm) seeded with adipose derived stem cells (ASCs) showed higher levels of 
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mineral deposition via VK staining at larger pore sizes (Figure 2.13) (Huri et al., 2014). The 
reason for these inconsistencies in the literature might be due to different behaviors of 
undifferentiated stem cells and differentiated osteoblastic cells. Due to these controversial results, 
it is difficult to explain the effect of pore size for in vitro osteogenesis. 
 
Figure  2.13: Positive impact of the increase in pore size in the amounts of mineral deposits 
detected (adapted from (Huri et al., 2014)) 
 
In Chapter 6 of this thesis, we also try to investigate the effect of pore size on cellular adhesion, 
proliferation and biomineralization. 
 
2.2.3.3.2.2 In vivo 
Apart from the pioneer work by Hulbert et al who determined a minimum pore size of 100 µm 
for in vivo bone formation (Hulbert et al., 1970), other groups have determined higher values as 
optimum pore dimensions. For instance, a range of 300-600 μm was considered sufficient by 
Kuboki et al. for new bone formation as well as for observing high levels of ALP and osteocalcin 
expression (Kuboki et al., 2001). While these studies associated high levels of bone ingrowth 
with higher pore sizes than the initially proposed 100 μm, some controversial results 
demonstrated that the increase in the pore size can have no or negative effects on bone ingrowth 
and vascularization (Ayers et al., 1999; Bai et al., 2011). 
Karageorgiou et al concluded that the pore sizes of over 300 μm are able to promote 
vascularization (Karageorgiou & Kaplan, 2005). Lower values of pore size lead to hypoxic 
Increase in pore size (<0.5-1.5mm) 
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conditions that favor fibrosis or callus formation instead of osteogenesis. Also, such small pore 
sizes might not be adequate for cell migration and nutrient/waste transport inside the construct 
(Kuboki et al., 2001). Larger pore sizes, in contrast, promote the mass transport and cell 
migrations in the scaffold and are preferred due to their abilities to support the formation of 
capillaries (Kuboki et al., 2001; Tsuruga et al., 1997). However, large pore sizes are always 
associated with higher risks of mechanical failure due to an excess of void volume. 
 
2.2.3.4 Surface chemistry 
Cellular functions are highly dependent on the interaction between the cells and the surface of the 
scaffold material. Such interactions are primarily a function of the scaffold surface chemistry 
(hydrophilicity, surface charge) and topology (roughness) (Graziano et al., 2008; Luthen et al., 
2005). For instance, hydrophobicity of polymers like poly(lactic acid) and poly(glycolic acid) 
complicates the cell seeding procedures, since the cells tend to poorly adhere to these polymeric 
materials. Therefore, surface modification techniques are normally employed to enhance the 
surface chemistry of these scaffolds. One example of such surface modifications is blending these 
polymers with hydrophilic poly(vinyl alcohol) (PVA) (Oh et al., 2003). Chitosan has also been 
used in the past for improving the PLA cytocompatibility (Cui et al., 2003; Xiao et al., 2008). 
Figure 2.14 demonstrates the positive impact of surface modification of PLA discs by chitosan 
(white bars) on the viability of L929 (MTT method) as compared to the pure PLA (light grey) 
and tricalcium phosphate (TCP) discs as positive controls. *P < 0.05 (compared to cell density on 
PLA disks on the respective day), **P < 0.01 (compared to cell density on PLA disks on the 
respective day).  
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Figure  2.14: MTT assay showing the positive effect of chitosan modification after on the L929 
cell viability after 1, 3 and 5 days of culture as compared to pure PLA (Xiao et al., 2008) 
 
In Chapter 5, we also address an issue of poor surface chemistry in our material of interest (PCL) 
and we seek to modify the surface by using chitosan via a method of layer-by-layer self-assembly 
of polyelectrolytes.  
 
2.2.3.5 Mechanical properties 
Bone repair often requires a structural immobilization at early stages of healing, which is 
provided by a graft or scaffold. Clearly, there should be a good correlation between the 
mechanical properties of the scaffold and those of the tissue which is about to be produced. 
According to the mechanotransduction mechanisms by which cells convert mechanical stimulus 
into chemical activity, both high and low mechanical properties of a scaffold may affect the 
growth and integration of new tissue (Hing, 2004). The properties lower than a critical limit leads 
to the scaffold breakdown under normal or severe conditions, which would lead to tissue growth 
defects such as deformed tissue shapes or formation of no tissue at all. Moreover, mechanical 
properties higher than a specific threshold might inhibit the flexibility of the in vivo conditions 
required for the cell growth.  
According to mechanotransduction processes, the bone tissue uses stress as an indication to 
produce more bone cells. As a result, if the mechanical properties of the scaffold are much higher 
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than those of the surrounding bone, low levels of stress exerted on the bone itself prevents new 
bone formation and leads to a decrease in the density of the surrounding bone. This phenomenon 
is called “stress-shielding” (Chanlalit et al., 2012). Figure 2.15 illustrates how bone resorption 
(low bone density areas shown with arrows) might occur in the presence of bone implants due to 
the stress shielding phenomenon.  
 
Figure  2.15: X-ray radiographs of a human femur (a) without and (b) with an artiﬁcial hip joint 
(adapted from (Niinomi & Nakai, 2011)) 
 
2.2.4 Biomaterials of interest 
In this section of the dissertation, we only discuss the biomaterials of our interest in this 
thesis. However, for more detailed information on other materials used in bone tissue engineering 
and their contribution to this growing field, please refer to Appendix 1 of this report. During the 
current study, the following synthetic and natural polymers have been used:  
2.2.4.1 Poly(ε-caprolactone) 
PCL is also an aliphatic polyester which has recently received a lot of attention in bone and 
cartilage tissue engineering (Li et al., 2005; Yoshimoto et al., 2003). The chemical structure of 
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PCL is illustrated in Figure 2.16. 
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Figure  2.16: Chemical structure of polycaprolactone 
This chemical structure can be degraded by several mechanisms which makes it suitable for use 
in biomedical applications. PCL can be degraded by microorganisms, bulk hydrolysis under 
physiological conditions and finally by enzymatic surface erosion (Pitt et al., 1981). The 
degradation reaction of PCL involves a 2 step process: first, the amorphous region of the polymer 
degrades after hydration and newly mobilized low molecular weight amorphous chains start to 
recrystallize, and finally the breakup of the crystalline region occurs (Chu, 1981). The 
recrystallization step becomes the rate limiting step in the degradation process of PCL and makes 
it degrade in a period of more than two years. For example, an in vitro study in water 
demonstrated that only 27% of the PCL particle mass was degraded after 33 months (Pitt et al., 
1981). A rabbit calvarial defect in vivo model showed that molecular weight of the PCL scaffold 
dropped by 63% after 2 years implantation (Lam et al., 2009). Therefore, it is one of the most 
suitable biodegradable polymers that can be used for long-term implantable systems such as bone 
tissue engineering.  
Among aliphatic polyesters, PCL shows some unusual characteristics; its glass transition 
temperature and melting temperature are -72°C and 58°C, respectively (Mark, 2009). Due to its 
low glass transition temperature, PCL is a semi-crystalline polymer in its rubbery form at room 
temperature. Therefore, for increasing its mechanical strength and at the same time accelerating 
the process of degradation, blending or copolymerization of PCL and PLA can be done 
(Middleton & Tipton, 2000). PCL also has an unusually high decomposition temperature among 
aliphatic polyesters (which are normally decomposed in the range of 235-255 °C) which is 
350°C. This feature of PCL makes it an ideal polymer for its processing at high temperature. In 
our research, we use this intrinsic characteristic of PCL to increase the temperature far higher 
than its melting temperature in the annealing process.  
With regard to mechanical properties, PCL is considered as a tough polymer with tensile 
modulus of 0.21-0.44 GPa, which are values between those of low density polyethylene (LDPE) 
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and high density polyethylene (HDPE). The winning mechanical property of PCL is its 
elongation at break εb(%) which is reported to be more than 400% (Labet & Thielemans, 2009). 
Since the PCL is the building block material in the scaffolds fabricated in this study, its 
application in bone tissue regeneration is discussed further in this section. The application of PCL 
and its composites in bone tissue engineering has been studied since the year 2000 and a variety 
of PCL products have been investigated including PCL-only scaffolds (generated by Fused 
Deposition Modeling (FDM) (Choong et al., 2004), electrospun PCL (Yoshimoto et al., 2003), or 
solvent-extracted PCL (Ciapetti et al., 2003)), loaded PCL scaffolds (scaffolds containing 
transforming growth factor beta-1 (TGFβ-1) (Huang et al., 2002) or BMPs (Savarino et al., 2007; 
Williams et al., 2005)) as well as PCL composites (PCL combined with PLLA (Landis et al., 
2005), tricalcium phosphate (TCP) (Shao et al., 2006; Yeo et al., 2010), or collagen (Srouji et al., 
2008)). Yeo et al. demonstrated the potential of PCL-TCP composite scaffolds for bone 
regeneration in rabbit calvaria defects, as the scaffold is surrounded by new bone after 4 weeks 
post-surgery (Figure 2.17) (Yeo et al., 2010).   
 
Figure  2.17: Goldner's trichrome staining (mineralized tissue = green; osteoid (unmineralized) = 
red) reveals newly formed mineralized bone after 4 weeks post-implantation (adapted from (Yeo 
et al., 2010)) 
In vitro studies with cell-seeded PCL have shown osteogenic potential through the expression of 
ALP and mineral deposition (Ciapetti et al., 2003). However, conclusive results for the 
stimulation of osteogenesis in 3D scaffolds have not yet been produced. While most of the efforts 
PCL 
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for investigating the PCL polymer are concentrated on in vivo experiments, there is still lack of 
knowledge on whether PCL can systematically induce in vitro osteogenesis by primary bone 
stem cells. In Chapter 6 of this thesis dissertation we investigate the role of PCL to independently 
induce cell differentiation of BMSCs and biomineralization. 
In vivo studies have shown that PCL scaffolds exhibit osteoconductive, osteoinductive or 
osteogenic potential (when seeded with MSCs) in a variety of animal models (periosteal implant, 
trabecular bone defects, phalanges or calvarial defects) (Huang et al., 2002; Landis et al., 2005; 
Schantz et al., 2006; Schantz et al., 2003; Srouji et al., 2008; Williams et al., 2005; Yeo et al., 
2010)[8, 9, 11, 13-16], When seeded with MSCs, in vivo results were promising as they led to 
good tissue integration with the implant and sufficient vascularization (Srouji et al., 2008). 
However, none of these scaffolds has yet achieved clinical use for fracture repair, potentially due 
to lack of mechanical integrity and/or lack of structural requirements due to the limitations in the 
fabrication techniques as shown in a previous work (Sarazin et al., 2004).   
Because of the lack of functional groups in the backbone of PCL, this biomaterial is intrinsically 
hydrophobic, which makes its surface relatively non-adherent to cells and therefore is 
unfavorable for cell growth (Figure 2.18) (Sudarmadji et al., 2011).  
The water contact angle of pure PCL surfaces has been reported to be approximately 82°, which 
is considered to be fairly hydrophobic (Ma et al., 2007). Previous results showed that L929 
mouse fibroblasts tend to form spherical morphologies on electrospun PCL scaffolds 
(Mattanavee et al., 2009). Therefore, the surface of PCL should be modified in order to enhance 
the cytocompatibility of PCL through hydrophilic interactions. However, it is now a proven fact 
that both extremes of surface hydrophilicity and hydrophobicity are not suitable for cell 
attachments and rather moderate hydrophilicity is required for protein adsorption and positive 
cell response (Tziampazis et al., 2000).  
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Figure  2.18: Cytotoxicity assay of PCL by the extract dilution method: (a) Cell viability of 
osteoblasts by Picogreen assay;  cells in (b) negative control (fresh culture medium); (c) PCL 
extract; (d) positive control (extract from latex rubber gloves) (adapted from (Sudarmadji et al., 
2011)) 
 
2.2.4.2 Poly(ethylene glycol) (PEG) and PEG-based materials  
Poly(ethylene oxide) (PEO) also known as poly(ethylene glycol) (PEG) is one of the most 
studied biomaterials in biomedical applications due to its biocompatibility and hydrophilicity. 
This polymer with molecular weights lower than 100 kDa is usually termed PEG, while a higher 
molecular weight polymer is classified as PEO. PEG is able to form hydrogels using chemical or 
physical crosslinking which can further be used as scaffolds or drug carriers (Anseth et al., 2002). 
Due to its low mechanical strength, PEG hydrogels have only been used in cartilage repair in 
orthopedics (Bryant & Anseth, 2001). However, for using PEG in osteogenic applications, it 
should be reinforced by its blending with other biomaterials. For example, a blend of PEG and 
PLGA was used with bovine periosteal cells in order to generate osteochondral composites in 
vitro (Schaefer et al., 2000). In order to overcome its low barrier properties, PEG is 
functionalized through various approaches to make PEG-based materials such as PEG-diacrylate 
a 
b 
c 
d 
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(PEG-DA) and PEG-dimethacrylate (PEG-DM) which can make the base for the synthesis of 
PEG-based hydrogels (Williams et al., 2003). These hydrogels cannot degrade as easily as PEG 
itself and therefore should be blended or copolymerized with other polymers like PLA and be 
applied to the cartilage repair (Fisher et al., 2004). 
 
2.2.4.3 Chitosan 
Chitosan is a positively charged polysaccharide obtained by the deacetylation of chitin; another 
polysaccharide that can be extracted from the crustacean exoskeleton or by fungal fermentation 
processes (Wu et al., 2005). The chemical structure of chitosan is depicted in Figure 2.19. 
Chitosan is degraded in vivo by the lysozyme (enzyme that hydrolyzes glycosidic bonds), and the 
rate of degradation depends on the amount of residual acetyl content (Pachence, 1997). 
Moreover, the degradation products of chitosan are non-toxic. Since chitosan is a significant 
substance for this thesis dissertation and acts as a key player in Chapter 5 and Chapter 6, this 
section elaborates this material in detail. 
Chitosan is also demonstrated to support the attachment and proliferation of rat calvarial 
osteoblasts as well as mineral depositions in vitro (Seol et al., 2004). On the other hand, Guzman 
et al. showed that chitosan microparticles inhibit mineralization of hBMSCs (Guzmán-Morales et 
al., 2009). In this work, the cells were believed to actively pull and dislodge and internalize 
chitosan particles from the surface. Very recent study by Amir et al. contrarily demonstrated that 
chitosan particles permit biomineralization of macaque dental pulp stromal cells (Amir et al., 
2014). These controversial results have potential to be studied in more detail. 
One of the most interesting properties of chitosan is the flexibility of modifications that it can go 
through in order to produce diverse derivatives with different chemical and mechanical 
properties; it can be combined with a variety of materials including ceramics and polymers to 
yield composite scaffolds with superior mechanical and biological properties. These modified 
chitosan scaffolds have also been proved osteoconductive in vivo in surgically created bone 
defects in sheep femoral condyle and mouse calvarial defects (Jin et al., 2012; Muzzarelli et al., 
1994).  
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Figure  2.19: Chemical structure of chitosan (Hoemann et al., 2013) 
 
Pure chitosan scaffolds are not generally regarded as a suitable material for bone regeneration 
application due to its poor mechanical strength. Moreover, the fabrication of pure chitosan 
scaffolds is not a straightforward process. Thermally-induced phase separation (Phase separation 
and lyophilization) is one of the most frequently used methods for the production of chitosan 
scaffolds. In this process, a dilute chitosan solution is made in acetic acid, introduced into a mold 
of interest and subjected to freezing. Ice crystals are formed in the freezing step and separated 
from the acetate salts of chitosan through sublimation in the freeze-drying step, which leads to a 
porous structure (Seol et al., 2004). Lower freezing temperatures and higher chitosan 
concentrations in this process are known to reduce the pore size (Jana et al., 2012; Madihally & 
Matthew, 1999). Nonuniform porosity, formation of surface skin and low levels of pore 
interconnectivity are the major drawbacks of this technique (Dalton et al., 2009). Moreover, it is 
very difficult to prepare chitosan solutions in acetic acid with a chitosan concentration above 4 
wt% due to the high solution viscosity which is a constant problem in all chitosan solution based 
techniques. Thermally-induced phase separation technique and its characteristics are discussed in 
detail in Appendix 2 in this thesis dissertation.   
 
2.2.5 Bone scaffold fabrication techniques 
Having selected the best biomaterials for the scaffold or implant, this material must be processed 
to generate an ideal three-dimensional porous network with interconnected pores to be able to 
physically and biologically support bone ingrowth according to the requirements mentioned in 
section 2.2.3. Some of the common scaffold fabrication techniques for the generation of porous 
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polymer scaffolds are listed in Figure 2.20 along with their pros and cons (Dalton et al., 2009). 
The most common fabrication techniques are discussed in further detail in Appendix 2. 
The method used for the generation of three-dimensional scaffolds most importantly depends on 
the biomaterials used. For example, almost all processes used for the fabrication of ceramic 
scaffolds involve sintering. Other fabrication techniques commonly employed for the production 
of bone scaffolds include solvent casting and particulate leaching, gas foaming, phase separation 
and freeze-drying. Nonetheless, other techniques such as melt molding/particulate leaching and 
electrospinning have also been used. Modern rapid-prototyping methods like 3D printing (3DP), 
selective laser sintering (SLS) and fusion deposition modeling (FDM) have also been developed 
for the production of scaffolds.  
Table 2.3 summarizes the use of various fabrication techniques, the materials used, generated 
pore size and their application in bone tissue engineering. 
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Figure  2.20: Fabrication techniques for the production of polymer scaffolds (Dalton et al., 2009) 
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Table  2-3: Summary of the fabrications techniques, materials used and porous network generated 
for bone tissue engineering 
Fabrication 
Technique 
Material(s) 
Pore Size 
(μm) 
Porosity 
(%) 
Reference 
Sintering 
HA 400, 800 60, 70 (Kruyt et al., 2003) 
Natural coral 150-200 36 (Chen et al., 2002) 
Solvent casting 
and particulate 
leaching 
Hyaluronic acid 100–600 80-90 
(Kim & Valentini, 
2002) 
Poly(ε-caprolactone) 
< 500-
1500 
65 (Huri et al., 2014) 
Gas foaming 
Biphasic calcium phosphate 
(HA) 
300-800 75-85 (Kim et al., 2012) 
Poly(propylene fumarate) 70 51 
(Lewandrowski et 
al., 2003) 
Thermally-
induced phase 
separation (TIPS) 
Biphasic calcium phosphate 
/polyamide 6 
100-900 77-89 (Shen et al., 2010) 
Poly(l-lactide-co-glycolide) 75-400 84-90 (Yang et al., 2008) 
Freeze drying 
Collagen/HA 30-100 85 
(Lickorish et al., 
2004) 
Collagen and elastin 130, 340 90-98 
(Buttafoco et al., 
2006) 
Electrospinning Poly(lactide-co-glycolide) 2-465 92 (Li et al., 2002b) 
Rapid prototyping Poly(ε-caprolactone) 
1750-
2500 
63-79 
(Williams et al., 
2005) 
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2.3 Melt blending of polymers 
2.3.1 Fundamentals 
Section 2.2.5 elaborated the most common scaffold fabrication techniques. By knowing their 
characteristics and their major drawbacks, newer methods could be devised so that polymer 
scaffolds of more suitable properties could be produced and applied in bone tissue engineering. 
Most common disadvantages of the mentioned techniques include the use of toxic solvents, 
limitations imposed by the use of a third party agent (shape of the porogen phase in the case of 
solvent casting/particulate leaching), low levels of pore interconnectivity, high processing 
temperatures, large pore size distributions and high processing costs. These negative points 
guided the scientists towards developing the approach of melt blending of polymers in order to 
fabricate scaffolds that also has potential to be applied to osteogenic applications.  
The requirements for polymeric materials have become continuously stricter in order to meet 
specific and targeted applications. A quick response for the production of polymers with the 
imposed specific requirements is polymer synthesis. Nevertheless, due to strenuous intricacies 
and high production costs of the polymer synthesis, other alternatives such as melt blending of 
polymers have been developed to produce an array of optimal requirements such as 
physicochemical, mechanical and electrical properties in the final product by employing the 
intrinsic characteristics of the individual homopolymers used. For instance, osteoconductive 
properties of polymeric scaffolds could be considerably enhanced by blending hydroxyapatite-
based ceramics with polymers. At the same time, biodegradation and mechanical property 
adjustments could be provided by the polymer phase. Sometimes, however, the idea of blending 
comes into play in order to facilitate the production of a particular morphology as required by the 
final application of the product. For example, major physical requirements needed in bone tissue 
engineering scaffolds include porosity and pore interconnectivity which could be provided by the 
blending technique as will be demonstrated in this dissertation. In this part of this dissertation, the 
basics of the melt blending technique are going to be discussed.  
There are two thermodynamically different types of polymer blends: miscible and immiscible. A 
miscible polymer blend is defined as a system which is homogeneous down to the molecular 
level and form a single phase structure. On the other hand, immiscible polymer blends are 
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systems which are phase separated due to the independent existence of the individual blend 
ingredients. This type of polymer blends is known to be the most populous group. These 
definitions can be translated thermodynamically by use of the equation of Gibbs free energy of 
mixing: 
                         
Where       is the Gibbs free energy of mixing,       is the enthalpy of mixing, T is the 
mixing temperature, and       is the entropy change by mixing.  
Like any mixing system, a negative Gibbs free energy for polymer blends represents miscibility 
and the formation of a single phase.  
                                                
The term        is always positive due to an increase in the entropy of the system by mixing. 
Thus, for low molecular weight materials, increasing the temperature leads to a negative 
contribution of        to the       and therefore increasing the miscibility. However, 
considering the lattice theory of Flory-Huggins, by increasing the molecular weight and reaching 
the range corresponding to that of macromolecules, this increase in the entropy becomes 
negligible and its contribution in the equation above becomes minimal (Sperling, 2005). 
Therefore, for macromolecular chains, the term       will only depend on the enthalpy of 
mixing. For most of the polymer blends, the enthalpy of mixing is a positive value. In this case, 
by considering the Flory-Huggins solution theory and Hildebrand-Scatchard-van Laar equation: 
          
      
  
 
               
  
                     
                 
               
Where    is the volume fraction of phase A,    is the molar volume of phase A,     is the 
interaction parameter between phase A and B,      is the volume of the mixture, R is the ideal 
gas constant and    is the solubility parameter of component A of the blend. It is concluded that 
the term     is closely related to       which is closely related to the differences in the 
solubility parameters of the components A and B. The closer the solubility parameters of the 
blend components, the smaller the interaction parameters between them and therefore the more 
compatible or miscible they become. 
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Consequently, unless there are specific interactions between the blend components such as 
attractive forces like dipole-dipole, hydrogen bonding and acceptor-donor interactions, 
spontaneous miscibility cannot be obtained. Therefore, a negative enthalpy of mixing is a 
necessary requirement for miscibility. However, this is not the case for most of the polymer pairs 
and that is why most of the polymer blend systems are immiscible.  
Although negative       is a necessary requirement for miscibility of polymers, the sufficient 
criterion for miscibility is that the second derivative of the Gibbs free energy with respect to 
composition, at constant temperature and pressure must be positive: 
 
       
    
            
Similarly, the sufficient requirement for a polymer blend to be immiscible is that this second 
derivative of the free energy becomes negative, even if       might remain negative. This means 
that in a window of volume fraction of component i where this second derivative becomes 
negative, a phase separation occurs into phases with both of the blend components but rich in one 
of them.  
It should be noted that among all investigated polymer pairs, a small percentage of them were 
determined to be miscible. Some examples of these polymers include polystyrene/poly(phenylene 
oxide), poly(ethylene terephthalate)/ poly(butylene terephthalate) and poly(methyl methacrylate)/ 
poly(vinylidene fluoride).  
 
2.3.2 Immiscible polymer blends 
As explained by the Gibbs free energy in the previous section, most of the polymer pairs are 
immiscible, and although obtaining miscible polymer blends might be considered as an 
achievement over immiscible blends in the production of materials with enhanced properties due 
to the lack of weak component interfaces, immiscibility is sometimes the only choice for the 
fabrication of a highly specific morphology. In the case of producing porous morphologies, for 
instance, miscible polymer blends cannot be of any use since there is no possibility for the 
formation of the pores, whereas melt blending of immiscible polymer pairs can lead to the 
production of sophisticated morphologies with interconnected pores as required by the specific 
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bone tissue engineering application.   
Melt blending of the immiscible polymers are commonly exercised in an internal mixer, where 
the two polymers are homogeneously mixed with each other in a confined chamber through 
strong shearing forces provided by two counter-rotating blades, as demonstrated in Figure 2.21. 
  
Figure  2.21: (a) Rotor-blades of an internal mixer (ISMAC); and (b) Schematic of internal 
mixing (adapted from (Xiang et al., 2009)) 
 
In order to achieve the desired morphological structure, the intrinsic properties of the system such 
as molecular weight and the chain nanostructure of the polymers, as well as the processing 
conditions like mixing temperature and shear rate are of ultimate importance. All these key 
factors come down to two key parameters: kinetic and thermodynamic. Kinetic parameters 
include mixing conditions such as mixing temperature and shear rate and rheological properties 
of the blend components such as viscosity and elasticity. As its name suggests, the latter type of 
morphology-controlling parameters involves the thermodynamic properties of the blend system 
such as the interfacial characteristics of the blend materials (Reignier & Favis, 2000). By 
modifying these parameters in the melt blending process, a wide range of phase (pore) sizes from 
the nanometer scale up to hundreds of microns together with various shapes (cylindrical, 
spherical, ellipsoidal, ribbon-like, subinclusion and cocontinuous type morphologies) can be 
obtained (Utracki, 2002). There are two basic processes in the droplet scale that make up the final 
morphology in the product: deformation/breakup and coalescence. Although these processes are 
the building blocks of the melt-blending approach, their details are out of the scope of this thesis. 
Among all the morphologies named above, cocontinuous structures are the way to go for the 
a b 
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production of porous scaffolds with interconnected pores. As a matter of fact, the level of pore 
interconnectivity in the porous construct is closely related to that of co-continuity. 
In immiscible polymer blends, there are basically two main types of morphologies: dispersed 
droplet and co-continuous morphology. Figure 2.22 demonstrates the scanning electron 
microscopy images for poly(L-lactide)/polystyrene (PLLA/PS) blends at 80/20 and 60/40 v% 
compositions. 
 
 
 
 
 
 
 
Figure  2.22 : SEM micrographs of PLLA/PS binary blend at a) 80/20 and b) 60/40 v% (adapted 
from (Sarazin & Favis, 2003)) 
 
The figure above clearly demonstrates that by a slight change in the composition of the 
components, completely different morphologies can be obtained: in micrograph (a) clearly 
droplets of PS are dispersed in a matrix of PLLA and in micrograph (b) by a 20% increase in the 
composition of PS, the droplets of polystyrene coalesce and form a network. This type of 
microstructure in which the distinction of the droplets and matrix phase becomes almost 
impossible is called co-continuous morphology.   
This phenomenon can also be observed by transmission electron microscopy images from 
poly(methyl methacrylate) PMMA/PS blends illustrated in Figure 2.23.  
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Figure  2.23: Transmission electron micrographs for PMMA/PS blends at different blend 
compositions: (a) 90/10, (b) 50/50, (c) 30/70 (Steinmann et al., 2001) 
 
According to this figure, by increasing the concentration of the droplet phase in a binary blend, a 
phase inversion takes place which replaces the droplets and matrix positions. This window of 
composition is called the phase inversion region. The phase inversion region is defined as the 
composition at which the blend phases switch their role, i.e. the dispersed phase droplets combine 
to form the matrix and the matrix breaks up to form droplets. In the proximity of the phase 
inversion concentration, the other morphology of the immiscible polymer blends is achieved 
which is called co-continuity region. In the co-continuous region, none of the phases can be 
considered as droplets or the matrix. The two phases interpenetrate in a manner that can only be 
described as two continuous pathways.  
In order to achieve porosity at cocontinuous composition, one of the two continuous phases 
should be selectively extracted. Given the blends are prepared at co-continuous compositions, the 
pores formed are completely interconnected due to nature of co-continuity. In Figure 2.24, a 
binary blend of A and B at the cocontinuous composition is demonstrated, where the extraction 
of any of the phases leads to the generation of an interconnected porous network of the extracted 
component (porogen). 
By adding other components to a binary blend (to make ternary or quaternary blends) other 
interesting morphologies can also be obtained. For instance, subinclusions or composite droplet 
(droplet in droplet) morphologies have also been studied in this research group. PMMA droplets 
located inside a thin shell of PS while dispersed inside a matrix of high density polyethylene 
(HDPE) are an example to these relatively complex morphologies (Reignier & Favis, 2003; 
Virgilio et al., 2005).  
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Figure  2.24: Schematics of a co-continuous structure in the binary blend A/B: (a) phase A is 
extracted, (b) phase B is extracted (adapted from (Gergen W.P., 1996)) 
  
2.3.3 Co-continuity in polymer blends 
Thus far, we have established that in order to be able to use polymer blends as the means to 
fabricate bone tissue engineering scaffolds, the formation of a highly interconnected porous 
network is required. Therefore, the phenomenon of co-continuity or dual phase continuity, as 
described in the previous section, can be employed to achieve such requirement. Consequently, 
the aforementioned objective requires a more specific and detailed understanding of the 
development of co-continuity in polymer blends, i.e. how it is characterized and how it can be 
controlled to serve our mission.   
2.3.3.1 Percolation theory and the development of co-continuity 
Since the concept of co-continuity lies on the concept of phase inversion for which the former 
droplets become the matrix and the former matrix becomes the droplets, the development of co-
continuous structures can to some extent be explained by the percolation theory.  
Percolation theory divides a system including a polymer inside a solvent or another polymer in 
the case of polymer blends, into a number of lattices with a defined shape. “p” is designated to 
the fraction of lattices that randomly contain at least one building block of the polymer. By 
increasing the amount of the polymer in the system, the probability of finding these occupied 
lattices also increases and clusters are formed by adjacent occupied lattices. Above a critical 
a b 
A 
B 
A 
B 
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number of lattices (pc) containing the polymer building blocks (monomers), an infinite continuity 
of the occupied lattices will occur. This limit is called the percolation threshold (Hsu & Wu, 
1993). 
The concept of percolation threshold can also be applied to the development of co-continuity. By 
increasing the composition of the droplet phase in a binary blend, the level of interconnection of 
occupied lattices and formed clusters also increases and the system ultimately reaches the 
percolation threshold which is in fact the onset of co-continuity and the beginning of phase 
inversion. The percolation concept has also been applied to investigate the mechanical properties 
of the blends in the phase inversion region as a function of the morphology. Such attempts 
showed that the percolation theory could be readily applied for explaining the phase inversion 
phenomenon (Arends, 1992; Hsu & Wu, 1993). The transition process from a dispersed droplet 
morphology to a co-continuous morphology according to the percolation theory is illustrated in 
Figure 2.25.  
 
Figure  2.25: Co-continuity explained by the percolation theory (Hsu & Wu, 1993) 
The percolation threshold or the onset for co-continuity varies from one system to another. Also, 
the width of the region in which phases are co-continuous depends on many parameters such as 
the viscosity ratio and the interfacial tension of the blend components. As an example, by use of 
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the percolation theory, Lyngaae-Jorgensen et al. demonstrated that the onset of the co-continuity 
region occurs at the volume fraction of 0.19 ± 0.09 (Lyngaae-Jørgensen & Utracki, 1991).  
 
2.3.3.2 Characterization of co-continuity or pore interconnectivity 
Co-continuous structures can generally be characterized by using imaging techniques such as 
SEM, transmission electron microscopy (TEM) and atomic force microscopy (AFM). However, 
dual phase continuity is not a two-dimensional concept, as the phases form completely 
intertwining and irregular three-dimensional structures which cannot be fully characterized by 
photomicrographs. As a result, the aforementioned approaches are normally combined with fairly 
new statistical quantitative tools to support the two-dimensional images.  
 
2.3.3.2.1 Image analysis 
SEM is the classical approach for phase size and phase size distribution measurements. However, 
the polymer domains in a co-continuous structure are not well defined for the SEM approach to 
be able to analyze them. Therefore, the use of SEM for the evaluation of the co-continuous 
structure becomes strenuous if not impossible (Arns et al., 1999). For resolving this issue, other 
statistical techniques such as form factors and interfacial area could aid SEM to characterize the 
co-continuous morphology. 
Form factor (ff) is a measure of the deviation of a finite shape from circularity (sphericity in 3D). 
This parameter can be very useful in determining the co-continuous region, as the structure 
completely deviates from the spherical droplets within the matrix. The form factor is defined as 
follows: 
     
 
  
       
Where A is the area and P is the perimeter of the domains. Since for a circle, there is no deviation 
from circularity, the ff becomes 1 and more irregular domains deviate from unity and for 
infinitely irregular shapes, where the perimeter tends to infinity the form factor becomes 0. 
This approach has been used to characterize the co-continuous morphology and to determine the 
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cocontinuous composition for a blend of PMMA/PS (Steinmann et al., 2001; Weis et al., 1998). 
The SEM images used for the analysis showed that at all ranges of composition, circularity with 
ffc close to unity existed, as well as irregular domains with different sizes. Therefore, the form 
factor for these latter domains ffirr were calculated separately and the region where the most 
deviation from unity was observed was considered as the region of dual phase continuity as 
demonstrated in Figure 2.26.  
 
Figure  2.26: Mean form factors for both circular and irregular domains of PMMA/PS blends as a 
function of composition (Steinmann et al., 2001) 
 
Galloway and Macosko presented another image analysis technique which measured the amount 
of interfacial area per unit volume for a blend of PS/PEO, and they showed that this value 
exhibits two maxima (35 and 65 wt%) for blend compositions at the extremes of the 
cocontinuous region (Figure 2.27) (Galloway & Macosko, 2004). 
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Figure  2.27: Interfacial area per unit volume of the blends as a function of composition in 
PS/PEO blends. The composition range of 35-65% is considered co-continuous (Galloway & 
Macosko, 2004) 
 
2.3.3.2.2 BET and mercury intrusion porosimetry (MIP) 
BET (Brunauer, Emmet and Teller) nitrogen adsorption and the mercury intrusion porosimetry 
has also been employed for the analysis of co-continuous morphologies (Li & Favis, 2001). For 
both of these techniques, one of the binary blend components should be selectively extracted in 
its specific solvent to give a porous construct. 
In the BET technique, nitrogen gas passes through the porous construct, after which it is 
quenched down by liquid nitrogen. This rapid quenching causes the nitrogen gas to condense and 
adsorb on the internal porous structure of the sample. By measuring the volume of the adsorbed 
nitrogen on the surface and assuming that only one layer of nitrogen molecule is adsorbed on the 
surface, the surface area of the construct is calculated by using the following equation: 
  
      
  
       
Where S is the surface area of the sample, Vm is the volume of the gas required for monolayer 
adsorption, N is the Avogadro’s number, a is the area of one adsorbed nitrogen molecule which is 
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             and VM is the molar volume of the gas. 
By assuming that the pores are interconnected cylinders and that the volume of the pores (V) is 
equal to that of the extracted phase, the average pore diameter (d) can be calculated according to 
the following equation: 
   
 
 
       
Mercury intrusion porosimetry is based on the capillary law governing the penetration of mercury 
as a non-wetting liquid into the small pores. In this method, dry porous samples are exposed to 
mercury under vacuum, after which pressure is applied to the mercury for it to penetrate into the 
pores of the construct. Mercury porosimetry uses the Washburn equation to describe the relation 
between the porous structure dimensions and the pressure applied to the mercury (Washburn, 
1921).  
                  
Where P is the applied pressure, r is the radius of the pores, σ is the surface tension (480 mN/m) 
and θ is the contact angle of mercury (140°).  
The fact that these two methods do not involve two-dimensional micrographs as a representation 
of a three-dimensional sample is an advantageous factor for these two techniques.  
2.3.3.2.3 Gravimetric measurements 
Gravimetric measurement is the simplest and the most common approach for the determining the 
co-continuous region. This method is based on the weight of the sample before and after selective 
extraction of one of the phases (porogen). The quantitative parameter calculated in this approach 
is % continuity.  
             
                              
              
        
The only challenge in calculating the % continuity is to find the initial weight of the porogen 
phase, since                                is in fact the difference between the weight 
of the whole sample, before and after the extraction, assuming the solvent selectively extracts 
only the porogen phase. The initial weight of the porogen phase can be estimated by multiplying 
50 
 
the initial weight of the whole sample by the weight fraction of the porogen phase. Therefore, 
Equation 10 simplifies to the following equation: 
            
                            
                            
        
Where                is the weight fraction of the porogen phase.  
Although this approach is quite classical and simple, many researchers have recently used this 
method for characterizing co-continuity (Antunes et al., 2011; Filippone et al., 2010; Kucharczyk 
et al., 2012). 
Co-continuity is reported to have synergistic effects on the properties like high modulus or high 
impact strength in commercial blends. Co-continuity also provides high rigidity during 
deformation (elongation), good barrier and conduction properties. Poly(ethylene terephthalate) 
(PET)/ polycarbonate (PC), Poly(butylene terephthalate) (PBT)/PC, Acrylonitrile butadiene 
styrene (ABS)/PC and ABS/ polyamide (PA) are examples of commercial co-continuous blends. 
In this thesis, the concept of co-continuity is going to be used for the fabrication of a highly 
porous scaffold with high levels of pore interconnectivity for tissue engineering applications. Our 
research group has previously developed a novel melt blending technique for the formation of co-
continuous structures (Sarazin & Favis, 2003; Sarazin et al., 2004; Yuan & Favis, 2005). Former 
studies have also investigated various parameters that can control the morphology of the co-
continuous system reflecting the porosity and pore diameter of the final porous structure. 
Composition, components viscosity, viscosity ratio, interfacial tension and interfacial 
modification via compatibilizers and annealing are the factors that affect the morphology of a co-
continuous blend. The following section elaborates the parameters that are in the scope of this 
study. 
 
2.3.3.3 Parameters affecting the co-continuous morphology 
In order to generate an apt porous material for orthopedic applications, a high level of control 
over the porous network is considered a powerful tool. In the case of immiscible polymer blends, 
this level of control can be precisely achieved at a submicron scale. As mentioned in section 
2.3.2, there are many parameters (kinetic or thermodynamic) that can affect the morphology of a 
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polymer blend, some of which are discussed in further detail in this section. 
2.3.3.3.1 Composition and viscosity ratio of the blend components 
Composition is the most important parameter for the formation of the co-continuous morphology. 
As discussed above, the increase in the composition of the minor phase is the main reason for the 
transformation of the morphology from the droplet/matrix system to the co-continuous system. 
Favis and Chalifoux (1988) investigated a blend of PC dispersed in the polypropylene (PP) 
matrix, and by increasing the composition, they witnessed an increase in the phase size of PC 
droplets. However, it is believed that the change in the composition does not independently 
influence the phase (pore) size in the co-continuous region (Favis & Chalifoux, 1988).  
Significant efforts have been done in the past to determine the composition where the phase 
inversion occurs. However, the idea of finding this specific composition could only be valid for 
high interfacial tension systems. For other types of systems, a wider window of compositions 
exists rather than a single point of phase inversion. Some mathematical-experimental methods 
have been suggested to estimate the co-continuous composition either based on the viscosity ratio 
or elasticity ratio. Generally, viscosity ratio-based models place the low viscosity component in 
the matrix, while elasticity ratio-based models reserve the matrix position for highly elastic 
materials. 
In 1976, the co-continuous composition was related to the viscosity ratio of the blend 
components by Avgeropoulos et al (Avgeropoulos et al., 1976). Such correlation was later 
generalized empirically by Paul and Barlow and was put in the form of Equation 11 for 
determining the phase inversion composition (Paul & Barlow, 1980). Equation 11 was later 
extended for the viscosities calculated at the shear rate of mixing (Miles & Zurek, 1988). 
  
  
 
  
  
        
Where    is the volume fraction of component i at phase inversion, and    is the viscosity of 
component i. 
Also, based on Tomotika’s theory of capillary instabilities, the ratio of volume fractions at phase 
inversion was related to the viscosity ratio according to Equations 12 and 13 (Metelkin & Blekht, 
1984). 
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Where   
  
  
 and    is the viscosity of component i at the shear rate of mixing. 
The models above can give fairly precise values for the phase inversion composition when the 
viscosity ratio (   approaches unity. However, by increasing the value of the viscosity ratio, these 
equations demonstrate a rapid change in the value of   . 
There are many other models that could be used for the estimation of the phase inversion 
composition such as that of Krieger and Dougherty’s model for highly viscous systems, semi-
empirical model of Willemse et al., model of Steinman et al, and elasticity dependent model of 
Van Oene and that of Bourry and Favis (Bourry & Favis, 1998; Krieger & Dougherty, 1959; 
Steinmann et al., 2002; Vanoene, 1972; Willemse et al., 1998). Nevertheless, none of the 
aforementioned equations can precisely predict the composition of phase inversion or the 
composition window over which co-continuity exists and consequently experimental methods 
have to be employed. 
 
2.3.3.3.2 Interfacial tension and interfacial modification 
The interfacial tension between the two blend components has a major effect on the morphology. 
In order to understand the effect of interfacial tension on the morphology of polymer blends, Li et 
al. investigated three distinct systems with regards to their interfacial tension: I) low interfacial 
tension system like high density polyethylene (HDPE)/styrene-ethylene-butylene-styrene 
(SEBS), II) high interfacial tension system like HDPE/PS and finally III) compatibilized (or 
interfacially modified) system such as that of type II compatibilized with SEBS (Li et al., 2002a).  
First, the mechanisms associated to type I, II and III blend systems were reported to be fiber-fiber 
coalescence, droplet-droplet coalescence and hindered droplet-droplet coalescence, respectively. 
As illustrated in Figure 2.28a, a low onset and a wide range of co-continuity with invariant 
domain sizes were observed for type I systems. In the case of the high interfacial tension system, 
where droplet-droplet coalescence mechanism is governing in the formation of the co-continuous 
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morphology, a higher onset yet a smaller range of phase inversion was evident. Moreover, an 
increase in the composition led to a higher phase size (Figure 2.28b). Type III system which is a 
hindered type II system demonstrated an even higher percolation threshold and even a narrower 
co-continuity region. It must be noted that partial miscibility of the polymer blend components 
can push the phase inversion to occur at higher compositions of the minor phase. This was 
investigated by Marin et al. for the case of partially miscible poly(methyl methacrylate) 
(PMMA)/PC blends (Marin & Favis, 2002). 
Interfacial modifiers or compatibilizers are known to reduce the interfacial tension and prevent 
the coarsening phenomena. Regarding the dispersed droplet/matrix structure, the most 
noteworthy observation is that the phase size decreases with the increase of the interfacial 
modifier composition. Willis and Favis studied the polyamide/polyolefin (PA/PO) blends, and 
the trend of phase size with the addition of an ionomer as the interfacial modifier can be best 
described as a rapid decrease followed by a plateau (Willis et al., 1991; Willis & Favis, 1988). 
Also, Matos et al, in a comprehensive study, investigated the interfacial modification of PS/PE-
PP rubber (Matos et al., 1995). 
The effect of interfacial modification is different for co-continuous morphologies. In this case, 
interfacial modification reduces the interfacial tension between the blend components which is 
favorable for the formation and the stability of the co-continuous structure. On the other hand, 
interfacial modification suppresses the coarsening phenomenon or coalescence. This can hinder 
the formation of co-continuous morphology. However, once the co-continuous morphology is 
formed, such reduction in the coarsening actually leads to the stability of the morphology. 
Adding interfacial modifiers to the system also reduces the phase sizes in the co-continuous 
system. The reduction of the interfacial tension or the increase of the interfacial adhesion 
strengthens the interface and as a result a finer morphology is achieved. 
The interfacial modifiers or compatibilizers are normally block (diblock, triblock or branched) or 
grafted copolymers with sections containing each of the immiscible homopolymers of the blend. 
Therefore, each section of these copolymers has affinity toward one of the phases of the blend. 
Diblock copolymer was used by Elemans et al. in the introduction of the breaking thread method 
and it was found that the addition of the diblock copolymer leads to the decrease of the interfacial 
tension by a factor of 4, and therefore the stabilization of the melt was clearly observed as the 
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break-up lasted for a longer time (Elemans et al., 1990). 
 
Figure  2.28: Effect of interfacial tension for different blend systems on (a) Continuity 
development, (b) Pore size as a function of minor phase composition (Li et al., 2002a) 
 
Mekhilef and coworkers investigated the interfacial modification of the PS/PE blends and they 
also observed a reduction in the dispersed phase size by the addition of the modifier (SEBS, a 
triblock copolymer). The co-continuous region was also considered in this work, as they also 
observed the inhibition of coalescence, which was attributed to the steric stabilization of the 
a 
b 
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morphology with the addition of the modifier (Mekhilef et al., 1997). Figure 2.29 demonstrates 
the impact of the addition of the copolymer on the PE particle size. The reduction in the phase 
size by the addition of the interfacial modifier to the system was also shown by a work by Li and 
Favis (Li & Favis, 2002). 
The addition of a copolymer could also have potential to transform the co-continuous 
morphology into the dispersed phase morphology. However, the time needed for such 
transformation depends on the concentration of the interfacial modifier (Dedecker et al., 1998). 
 
Figure  2.29: The effect of copolymer content on the average size of PE in a PS90/PE10 blend 
(Mekhilef et al., 1997) 
 
2.3.3.3.3 Annealing 
The concept of annealing was first introduced to immiscible polymer blends by Xie et al in 1992. 
They investigated the morphology of a dispersed droplet/matrix system of poly(propylene) (PP)/ 
ethylene vinyl acetate copolymer (EVAc), and they noticed an increase in the droplet size with 
increasing the annealing time (Xie et al., 1992). Like interfacial modification, the annealing 
process has different effects for dispersed droplets and co-continuous morphologies. 
According to Yang et al, the annealing process increases the domain size and broadens the phase 
size distribution. Moreover, it was shown that annealing at higher temperatures leads to faster 
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phase growth and coalescence (Yang & Han, 1996).  
Nevertheless, many studies report a breakup in the co-continuous morphology and its 
transformation to a dispersed droplet system while static annealing took place, which suggests 
that the annealing process effectively reduces the composition window over which the 
morphology is co-continuous (Mekhilef et al., 1997; Willemse et al., 1999). However, Willemse 
et al. demonstrated that such breakup into the dispersed droplet morphology only occurs when 
the composition is below a critical limit (          ) (Willemse, 1999). Above this critical 
concentration, the co-continuous morphology becomes stable and the coarsening phenomenon 
will become effective as the phases can readily grow while maintaining their continuity.  
The coarsening rate in the annealing process was investigated by Veenstra et al. and it was shown 
that the phase growth (dr/dt) is directly proportional to the interfacial tension and inversely 
proportional to the viscosity (Veenstra et al., 2000). This is shown in Equation 14: 
  
  
  
 
  
        
Where r is the average pore radius, c is a dimensionless coefficient specific to the blend system, γ 
is the interfacial tension of the blend components and    is the effective viscosity which is the 
weighted average viscosity at zero shear rate of the blend components. This equation proves that 
the coarsening phenomenon is driven by the interfacial tension but hindered by the viscous nature 
of the polymers. 
By using the principles above, Yuan and Favis studied the effect of static annealing on the  co-
continuous system of PS/PLLA for the generation of micro-porous structures with pore sizes 
varying from 1 to hundreds of microns due to the effects of annealing time and temperature 
(Yuan & Favis, 2004). In another study, they proposed a mechanism for the coarsening 
phenomenon during the quiescent annealing process by use of a conceptual model of co-
continuity based on thin and thick rods. They demonstrated that the driving force for the 
coarsening phenomenon is the difference between the capillary pressure, which leads to the 
merging of thin parts (rods) into thick ones (Yuan & Favis, 2005). In this theory, the thick rods 
cannot break up due to the existence of thin rods that merge into them. By taking thick rods as 
threads, the Tomotika’s breaking thread principles were also applied for estimating the 
coarsening rate dr/dt (Equation 15). 
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Where    is the initial distortion amplitude,    is the initial thread radius,   is the interfacial 
tension,        is the complex function (distortion function) from the Tomotika equation, and    
is the zero shear viscosity of the continuous phase. As a result, the easier the domains break, the 
readier they can grow and coarsen during the static annealing.  
It has also been reported that for the co-continuous regions occurring far from the asymmetric 
compositions, the annealing process might push the system from the co-continuous morphology 
towards the dispersed droplet/matrix structure. Contrarily, symmetric co-continuous 
compositions are reported to be more stable and comprising of a wider range of co-continuity. 
Figures 2.30 and 2.31 demonstrate the effect of annealing time and annealing temperature on the 
phase growth of the domains (pores). 
In this thesis, the polymer blends derived from the two immiscible biomaterials of interest PCL 
and PEO previously discussed in section 2.2.4 will be investigated. The blends of PCL and PEO 
are going to be prepared at the cocontinuous composition, and consequently annealed for 
achieving the desired pore size. Since PEO is a water soluble polymer, it can be used as the 
porogen phase and be selectively extracted from the blend system after annealing. This will 
provide the PCL scaffolds with precisely controlled morphology and highly interconnected 
porous structure.  
 
Figure  2.30: Effect of annealing time on the pore size in a blend of PLLA/PCL at 50/50 % (a) no 
annealing, and (b) 2h annealing (adapted from (Sarazin et al., 2004)) 
 
a b 
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Figure  2.31: Effect of annealing temperature for on the pore size in a blend of PLLA/PS (a) 
190°C, (b) 200°C, and (c) 220°C (adapted from (Yuan & Favis, 2004)). All the blends have been 
annealed for t = 1h. 
 
2.4 Surface modification of polymers 
Since porous PCL scaffolds derived from the melt blending approach are going to be used in in 
vitro osteogenic assays (Chapter 6 in this dissertation), the hydrophobic nature of PCL (as 
discussed in section 2.2.4.1) can negatively interfere with the cell adhesion and hence other 
cellular functions. Therefore, it will be established that the surface modification of PCL with a 
hydrophilic material becomes inevitable for culturing fibroblasts and BMSCs. The hydrophilic 
material which is going to be used for the surface modification of PCL is chitosan whose 
properties are elaborated in section 2.2.4.3. Therefore, this section is dedicated to the methods 
used for the surface modification of polymers and specifically PCL. 
There are many structural materials that possess favorable physical and chemical characteristics 
which make them attractive candidates for clinical biomedical applications. However, in many 
cases, the clinical use of these materials becomes highly limited due to unfavorable parameters 
such as undesirable (non-specific) adsorption as well as conformational changes of proteins on 
the surface of these biomaterials (Groth et al., 1994). Surface modification of polymers is a 
booming approach that can provide the exact required characteristics according to specific tissue 
engineering applications. Since the biomaterials are in intimate contact with the cells and the 
biological environment, the appropriate surface chemistry (such as hydrophilicity) is believed to 
be only required in a scale of a few nanometers to a micrometer underneath the external surface 
(Groth et al., 2010).  
a b c 
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There have been lots of efforts in the past to bring hydrophilicity to the surface of polymers. 
Plasma treatment is considered as a convenient measure for this purpose. In this technique, 
polarized functional groups such as hydroxyl, carboxyl, amino and sulfate groups can be 
introduced to the surface of polymer surfaces in general by using various reactive gases such as 
oxygen (Ma et al., 2007). Another common method used for surface modification is to graft 
hydrophilic polymers through copolymerization on the polymer substrate of interest. For this 
method, like any other polymerization reaction the existence of initiators is crucial. The initiators 
(such as radicals) should be incorporated to the substrate by other methods such as plasma 
treatment (as a separate step), ozone oxidation, γ-ray, electron beam and laser treatment (Abbasi 
et al., 2002; Poncin-Epaillard et al., 1994; Shim et al., 2001; Steffens et al., 2002). 
 
2.4.1 Methods for the surface modification of polymers 
There are generally two categories for surface treatments of polymers: physical methods and 
chemical methods. As their name implies, physical approaches involve the formation of physical 
bonds such as electrostatic, van der Waals, hydrogen bonding, and hydrophobic interactions, and 
they include surface self-assembly (Croll et al., 2006), coating (Vonarbourg et al., 2006) and 
vapor deposition (Klee et al., 2003). Chemical approaches mainly involve the addition of 
functional groups to the surface of the polymer through covalent bonds such as surface grafting 
or surface etching methods (Guo et al., 2008). Chemical surface modification techniques include 
plasma treatment, UV-induced or ozone grafting polymerization, and aminolysis (Groth et al., 
2010). These methods have been put to use in order to incorporate hydrophilic components 
specifically on the surface of our polymer of interest PCL (Darain et al., 2010; Domingos et al., 
2013; Siri et al., 2010; Zhu et al., 2002a; Zhu et al., 2002b). The hydrophilic groups that are used 
for surface modification of PCL are mostly extracellular matrix components such as collagen or 
small peptide sequence molecules containing RGD (Arg-Gly-Asp).  
There has always been competition between the physical and chemical approaches for modifying 
polymeric surfaces. While physical approaches provide simplicity and cost-efficiency, low 
stability of the modified surface due to the physical nature of the bonds has constantly been an 
issue. Chemical surface modification techniques, on the other hand, can use various functional 
compounds to alter the surface, but complications exist due to the intrinsic limitation of the 
60 
 
number of functional groups per surface area (Zajac & Chakrabarti, 1995). Given that the 
polymer surface in chemical surface modifications is a reaction site, other limitations do exist, 
such as lack of initiators and their improper surface concentrations, steric hindrance leading to 
non-uniform grafting, and finally side reactions which lead to nonspecific surface bonds 
(Edmondson et al., 2004; Fukuda et al., 2000).   
In this thesis, a physical approach of Layer-by-Layer (LbL) deposition of electrolytes has been 
used to homogeneously modify the surface of PCL, and therefore will be discussed in further 
detail in the next section.  
 
2.4.2 Layer-by-Layer deposition of polyelectrolytes 
Originally introduced by Decher et al. in 1992, Layer-by-Layer (LbL) deposition of polymers 
(polyelectrolytes) is an exceptionally simple and cost-effective technique which has become a 
powerful tool for the production of molecularly controlled ultrathin multilayer films. This method 
involves the sequential adsorption of oppositely charged polyelectrolytes on a charged planar 
substrate (Decher et al., 1992). The charged species inside the solution can be kinetically trapped 
on the substrate and generate a film assembly whose thickness can be precisely controlled from a 
few angstroms to a couple of microns (Decher, 1997). Adsorption of each polyelectrolyte on the 
substrate inverses the surface charge promoting the addition of the next layer. Electrostatic 
interactions between the polyelectrolyte pairs (polycations and polyanions) are the most studied 
driving forces for making film assemblies on substrates. LbL approach has been vastly used to 
produce thin films as corrosion protectors, antibacterial layers, sensors and antistatic coatings 
(Decher et al., 1992; Farhat & Schlenoff, 2002; Graul & Schlenoff, 1999; Rudra et al., 2006).  
The key players in the LbL technique are the polyelectrolytes. These materials have both 
characteristics of polymers and electrolytes, i.e. they produce viscous charged solutions while in 
aqueous media. The LbL technique involves subsequent submersion of the substrate into an 
oppositely charged polyelectrolyte solution, followed by a rinsing step to remove the unbound 
material, until the desired thickness or charge is obtained. The thickness of each deposited layer 
is dependent upon the polyelectrolyte chain geometry (Decher, 1997). The schematic of the LbL 
technique is illustrated in Figure 2.32. 
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Figure  2.32: Schematic of the Layer-by-Layer (LbL) deposition technique. The substrate is 
positively charged in this case (adapted from (Decher, 1997)) 
 
The characterization of the multilayer assemblies could be done by several techniques such as 
gravimetric analysis, UV-VIS adsorption, quartz crystal microbalance (QCM), and ellipsometry 
(Adusumilli & Bruening, 2009; Ravati & Favis, 2011; Richert et al., 2003). The reproducibility 
of the adsorption process from layer to layer was demonstrated by Ferreira et al. by using UV-Vis 
adsorption measurements (Ferreira & Rubner, 1995). The permeability and stability of 
polyelectrolyte multilayer films along with the effect of pH on the layer thickness were 
investigated using in-situ ellipsometry by Harris and Bruening (Harris & Bruening, 1999).  
 
2.4.2.1 Mechanism of LbL deposition of polyelectrolytes 
The main driving force for the formation of polyelectrolyte multilayer films on a substrate is 
known to be charge overcompensation, i.e. the adsorption of the subsequent polyelectrolyte 
layers reverses the charge on the substrate by over-compensating the charge so that the next 
polyelectrolyte layer can be adsorbed on the surface (Schlenoff & Dubas, 2001; Schlenoff et al., 
1998). The formation of the precursor layer is very important since the polyelectrolyte can be 
62 
 
added via electrostatic or hydrophilic forces and therefore can or cannot be strong enough to 
support the multilayer assembly of the next attaching polyelectrolyte layers. 
The thickness of the formed multilayer assembly usually increases linearly with the number of 
adsorbed polyelectrolyte layer (Caruso et al., 1997; Ramsden et al., 1995; Ruths et al., 2000). 
However, in cases where a high level of polyelectrolyte interdiffusion into the entire assembly 
occurs, an exponential growth of layer thickness has been recorded (Hübsch et al., 2004).  
 
2.4.2.2 Determining parameters in LbL deposition of polyelectrolytes 
The formation of a desired assembly of layers on a substrate depends on several parameters such 
as the nature of the polyelectrolytes, polyelectrolyte concentration and molecular weight, pH of 
the polyelectrolyte solutions, presence or absence of salt and adsorption time. In this section, 
some of these determining parameters and their effects are discussed. 
2.4.2.2.1  Effect of salt concentration 
Salt can act as a supporting electrolyte in an LbL system. In the absence of salt, the 
polyelectrolytes extend their chains on the substrate in such a way that the distance between the 
charges on their backbone is maximized. As a result, the established layer on the substrate 
becomes ultrathin and the charge overcompensation becomes minimal (Schwarz & Schönhoff, 
2002). As an example, the thickness of 20 layers of poly(sodium 4-styrenesulfonate) (PSS) / 
poly(diallyl dimethyl ammonium chloride) (PDADMAC) film in the absence of salt is about 60 
Å, which establishes an average thickness per layer of only 3 Å (Dubas & Schlenoff, 1999). The 
addition of salt to the LbL system, on the other hand, leads to a thousand times this value. In this 
case, salt particles locate themselves between the polyelectrolyte repeating units and therefore 
stabilizing the coil-structure, and inhibit rod-like adsorptions on the substrate (Lvov et al., 1993; 
Schwarz & Schönhoff, 2002). Figure 2.33 demonstrates the effect of salt on the adsorption 
behavior of the polyelectrolytes. 
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Figure  2.33: Effect of the addition of salt on the adsorption behavior of polyelectrolytes (Schwarz 
& Schönhoff, 2002) 
 
Many studies have shown the effect of salt concentration on the thickness of the polyelectrolyte 
multilayer assembly (Dubas & Schlenoff, 1999; Guzman et al., 2009). Dubas et al, in a 
comprehensive study, demonstrated that there is a linear increase in the layer thickness with the 
salt concentration (Dubas & Schlenoff, 1999). Figure 2.34 demonstrates the evolution of the 
thickness of 10-bilayers of PSS/PDADMAC with an increase in the salt concentration. Apart 
from salt concentration, many studies also investigated the effect of salt type (El Haitami et al., 
2009; Salomäki et al., 2004), which are not going to be discussed here. 
 
Figure  2.34: Thicknesses of LbL (PSS/PDADMAC)10 films deposited on silicon wafers using a 
series of NaCl concentrations (Dubas & Schlenoff, 1999) 
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2.4.2.2.2 Effect of polyelectrolyte type 
The polyelectrolyte type is of crucial significance in the quality of multilayer films formed on a 
substrate. Strong polyelectrolyte pairs such as PSS/ poly(allylamine) hydrochloride (PAH) form 
distinct layer assemblies whose thickness varies linearly with the number of depositions (Caruso 
et al., 1997). On the other hand, PGA/poly(L-lysine) (PLL), PGA/PAH, and HA/chitosan form 
assemblies with thicknesses exponentially growing with the addition of layers (Boulmedais et al., 
2002; Kujawa et al., 2005; Lavalle et al., 2003). For a PDADMAC/PSS LbL system also used in 
this thesis, a linear variation of assembly thickness with the number of added bilayers was 
observed after the addition of 3 bilayers (McAloney et al., 2001), as illustrated in Figure 2.35. 
 
Figure  2.35: Thickness of a (PDADMAC/PSS)n multilayer film deposited from a 1.0 M NaCl salt 
solution versus the number of bilayers (McAloney et al., 2001) 
 
The effect of molecular weight on the thickness is not very straightforward. While some reports 
showed that the thickness of the assembly is independent of the molecular weight (Lösche et al., 
1998; Porcel et al., 2004), others have discussed variable trends of thickness with a change in the 
molecular weight (Porcel et al., 2007; Richert et al., 2003). 
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2.4.2.2.3 Effect of polyelectrolyte concentration 
One of the main parameters that can affect the deposition of polyelectrolyte multilayer films is 
the concentration of the polymers in the solution. Many scientific groups reported that there is an 
increase in the amount of adsorbed polyelectrolyte with increasing the polyelectrolyte 
concentration (Dubas & Schlenoff, 1999; Wang et al., 1999). Figure 2.36 demonstrates that there 
is approximately 150 Å of increase in the thickness of 5 bilayers of PSS/PDADMAC on silicon 
wafers with an increase of polyelectrolyte concentration from 2mM up to 50mM (Dubas & 
Schlenoff, 1999). It should be noted however that the effect of polymer concentration is not as 
significant as that of the addition of salt (See Figure 2.34) 
 
Figure  2.36: Thickness of (PSS/PDADMAC)5 films as a function of polyelectrolyte concentration 
(NaCl salt concentration of 1M) (Dubas & Schlenoff, 1999) 
 
The reason for such increasing trend of thickness with concentration is explained as follows: at 
high polyelectrolyte concentrations, many polymer chains can adhere to few available binding 
sites on the surface leading to thick films, whereas, at low concentrations, few polymer chains 
find many available binding sites and therefore can form thin films by rod-like depositions (Fleer, 
1993).   
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2.4.2.2.4 Effect of deposition pH (degree of ionization of polyelectrolytes) 
The thickness, permeability and morphology of multilayer thin films also depend on the degree 
of ionization of the polyelectrolytes used in the LbL process, which depends on the pH of the 
deposition solution. Strong polyelectrolytes such as PAH/PSS and PDADMAC/PSS pairs are 
fully ionized for a wide ranges of pH. However, in the case of weak polyelectrolytes, the charge 
density on the polymer backbone is highly dependent upon the ionization of groups such as 
amines and carboxylic acids which vary considerably with the pH (Aulin et al., 2008; Lulevich & 
Vinogradova, 2004). 
In a system of PAH/ poly(acrylic acid) (PAA), when the pH of both electrolytes changed from 
2.5 to 4.5, the thickness of an assembly of 30 bilayers changed from 120 to 210 nm, which is due 
to the fact that the fraction of ionic carboxylates also increases from 30 to 70% (Yoo et al., 1998). 
The same system was again studied at a wide range of pH and it was determined that each PAH 
and PAA layer can vary in thickness from 5 up to 80 Å depending on the pH (Shiratori & 
Rubner, 2000).  
 
2.4.2.2.5 Effect of deposition time 
Several studies in the literature have investigated the effect of deposition time on the thickness of 
multilayer films (Angelatos et al., 2008; Dubas & Schlenoff, 1999; M. Lvov et al., 1998). The 
differences in the molecular weights, chemical structures and deposition pH of each 
polyelectrolyte in a pair, necessitate short or high times of deposition. One main reason for longer 
deposition times is the limitations that exist in the mass transport of the polyelectrolyte from the 
solution to the surface of the polymer. These limitations could be overcome by using efficient 
methods like spin-coating, and hence the rate of layer formation could be enhanced (Cho et al., 
2001; Dubas & Schlenoff, 1999). It is known that most of the deposition (95%) occurs in the first 
minute of exposure to the polyelectrolyte deposition (Garg et al., 2008). However, longer times 
are needed for polyelectrolyte rearrangements and complete depositions on the surface of the 
substrate (Garg et al., 2008). It is evident that performing the LbL process on a 3D substrate (like 
in the case of our study) rather than 2D also could require longer periods of deposition due to 
penetration limitations inside a 3D sample.   
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Surface modification of PCL by the LbL technique has seen little attention in the literature. 
Moreover, none of the works done in this field aimed to modify the surface of a virtually three-
dimensional PCL construct, i.e. a substrate whose third dimension is in the same order of 
magnitude of the other two, such as cubic or large irregular structures. A qualitative study has 
investigated the LbL surface deposition on PCL nanofiber films (Dubas et al., 2009). Also, due to 
the fact that the PCL film is only weakly charged at the surface, this study lacks solid proof of the 
efficiency of the depositions. In another work, PCL films were coated by the LbL technique 
using chitosan and heparin as polyelectrolytes (Lv et al., 2008). However, due to the fact that 
both heparin and chitosan are weak polyelectrolytes, the uniformity of the layers formed is still 
an issue. 
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CHAPTER 3 ORGANIZATION OF THE ARTICLES 
This section is dedicated to the scientific contribution of this thesis in the form of three original 
journal articles. 
The first part of the study involves the fabrication and characterization of the PCL scaffolds. The 
article is entitled “Poly(ε-caprolactone) Scaffolds of Highly Controlled Porosity and 
Interconnectivity Derived from Co-Continuous Polymer Blends: Model Bead and Cell Infiltration 
Behavior”. In this paper, the melt blending of the immiscible polymers PCL and PEO followed 
by controlled static annealing and selective extraction is used for the generation of porous 3D 
PCL constructs with 100% pore interconnectivity with pore sizes ranging from 41-212 μm. 
Although scaffold infiltration by cells is of ultimate importance in the quality of the final tissue 
formed in vitro and in vivo, this parameter has seen very little attention specifically for in vitro 
studies. In this paper, a novel assay is presented to compare scaffold infiltration by trypsinized 
hBMSCs and that of model polystyrene beads of the same size. Through this assay, a threshold 
for the pore size will be determined beyond which the cells behave more like the beads as they 
homogeneously populate the scaffold. Finally, the cytotoxicity of the PCL scaffolds is going to 
be studied. The results obtained from the cytotoxicity assay guides this thesis toward modifying 
the PCL surface. This paper has been published in the “Journal of Materials Science: Materials in 
Medicine” (Ghavidel Mehr et al., 2014b). 
The second article entitled “Chitosan Surface Modification of Fully Interconnected 3D Porous 
Poly(ε-caprolactone) by the LbL Approach” investigates the surface wettability modification of 
the intrinsically hydrophobic PCL by hydrophilic chitosan according. By comparing the common 
dip-coating strategy and the controlled LbL self-assembly of polyelectrolytes via surface 
characterization techniques, this original paper presents a thorough investigation of chitosan 
coating on porous PCL constructs via the LbL technique for the first time. The minimum number 
of required polyelectrolyte layers is determined by surface elemental analysis by X-ray 
photoelectron spectroscopy, in order to obtain well defined polyelectrolyte layers and a more 
uniform chitosan deposition. Furthermore, the deposition of chitosan is going to be examined on 
and in the depth of a 3D cubic construct whose three spatial dimensions are of considerable and 
comparable values. Finally, the morphology, surface roughness and thickness of the multilayer 
assembly will be determined. This work will establish the foundation for our third and last paper 
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in which the effect of such homogeneous chitosan coating in a 3D structure will be studied and 
the contribution of our PCL constructs to scaffold-assisted bone tissue engineering will be 
discussed. This article has been submitted to the journal of “ACS Applied Materials & 
Interfaces” (Ghavidel Mehr et al., 2014a).  
Having generated the PCL scaffolds with appropriate characteristics for bone tissue engineering 
and brought hydrophilicity to the PCL surface with chitosan, we can finally test our hypothesis 
that in vitro osteogenesis by hBMSCs is achieved in our 3D PCL scaffolds and enhanced when 
pore surfaces are coated with chitosan via the LbL techniques. Therefore, two principal 
parameters are going to be thoroughly discussed in this last paper: 1) The effect of pore size (84 
μm and 141 μm); and 2) The effect of chitosan surface modification. However, the novel beads 
assay in the first paper of this thesis showed that the pore size can highly affect the infiltration 
behavior of hBMSCs. Therefore, in order to faithfully examine the effect of pore size and that of 
chitosan coating, the cell seeding protocol should reflect the maximum possible homogeneity of 
cell distribution at various depths inside the scaffold. Thus, the optimal seeding protocol with the 
most uniform cell distribution is going to be suggested and applied to the three-week hBMSC 
osteogenic assay in the scaffolds. The main parameters to be investigated in this work are the 
following: cell morphology and surface attachments, cell-biomaterial interactions in the presence 
or absence of the chitosan coating, ECM formation and finally mineral deposition in the outer 
and inner pores. This original paper entitled “Osteogenic mesenchymal stem cells populate 3D 
poly(ε-caprolactone) scaffolds with interconnected pores and preferentially mineralize LbL 
chitosan-coated surfaces” has been submitted to the journal of “Tissue Engineering Part A” 
(Ghavidel Mehr et al., 2014c).  
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CHAPTER 4 ARTICLE 1: POLY(Ε-CAPROLACTONE) SCAFFOLDS 
OF HIGHLY CONTROLLED POROSITY AND INTERCONNECTIVITY 
DERIVED FROM CO-CONTINUOUS POLYMER BLENDS: MODEL 
BEAD AND CELL INFILTRATION BEHAVIOR 
 
The objective of this study is to fabricate and fully characterize bone tissue engineering scaffolds 
made of PCL. The requirements that are going to be assessed in this chapter are pore 
interconnectivity, pore size, cytocompatibility (i.e. surface chemistry) and infiltration properties. 
In this section, we seek to generate a range of highly controlled, fully interconnected, porous PCL 
constructs based on the melt blending of co-continuous immiscible polymers. Many scientific 
groups have investigated various in vitro tissue engineering studies. Yet, we believe that little 
attention has been given to an efficient seeding protocol that can lead to a homogeneous cell 
distribution within 3D scaffolds. These lacking studies become crucial due to the scarcity and 
high cost of bone-derived mesenchymal stem cells (BMSCs). Therefore, in this chapter, we 
present a novel in vitro approach using non-interacting model bead infiltration to mimic BMSCs 
which allows evaluating the potential of the interconnected pathways in the scaffolds to retain 
cells. We will later investigate how the cells are distributed inside the scaffolds as a function of 
their pore size, and we compare this distribution with that of the model beads. The topic of cell 
infiltration and efficient seeding protocol will be further studied in Chapter 6. 
 
This article has been published in the “Journal of Materials Science: Materials in Medicine”. 
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Abstract 
Porous structures destined for tissue engineering applications should ideally show controlled and 
narrow pore size distributions with fully interconnected pores. This study focuses on the 
development of novel poly(ε-caprolactone) (PCL) structures with fully connected pores of 84, 
116, 141, and 162 micron average diameter, from melt blending of PCL with poly(ethylene 
oxide) (PEO) at the co-continuous composition, followed by static annealing and selective 
extraction of PEO. Our results demonstrate a low onset concentration for PEO continuity and a 
broad region of phase inversion. A novel in vitro assay was used to compare scaffold infiltration 
by 10-micron diameter polystyrene beads intended to mimic trypsinized human bone marrow 
stromal cells (hBMSCs). Beads showed a linear increase in the extent of scaffold infiltration with 
increasing pore size, whereas BMSCs infiltrated 162 and 141 micron pores, below which the 
cells aggregated and adhered near the seeding area with low infiltration into the porous device. 
While providing a baseline for non-aggregated systems, the beads closely mimic trypsinized cells 
at pore sizes equal to or larger than 141 microns, where optimal retention and distribution of 
hBMSCs are detected. A cytotoxicity assay using L929 cells showed that these scaffolds were 
cytocompatible and no cell necrosis was detected. This study shows that a melt blending 
approach produces porous PCL scaffolds of highly controlled pore size, narrow size distribution 
and complete interconnectivity, while the bead model system reveals the baseline potential for a 
homogeneous, non-aggregated distribution of hBMSCs at all penetration depths. 
Keywords: scaffold, co-continuous morphology, pore size, interconnectivity, cell infiltration, 
model bead   
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4.1 Introduction   
A variety of synthetic or natural polymers have been proposed for the preparation of three-
dimensional porous scaffolds for tissue engineering [1]. Among them, poly(ε-caprolactone) 
(PCL) has been widely used as the material of choice in tissue engineering and drug delivery 
owing to its favorable mechanical and biodegradable properties. Mechanical stability of PCL 
scaffolds facilitates to withstand early functional loads as crucial criteria suggested by Hutmacher 
[2]; PCL degrades at a slow rate with results showing that it can persist in vivo for up to two 
years [3]. Even if the mechanical properties of PCL are similar to trabecular bone, these 
properties can be easily enhanced and tailored by incorporating micro and nanoparticles into the 
PCL matrix [4, 5]. PCL scaffolds have been characterized by their biocompatibility, low 
immunogenicity, processability and long degradation time and considered as a promising 
candidate for various tissue engineering applications including bone regeneration [6-11]. 
The success of tissue engineering scaffolds highly depends on their infiltration capacity which is 
greatly affected by cell/pore size and pore size distribution [12]. A small pore size resulting from 
a dense network hinders cell inﬁltration and ultimately reduces their use in replacing large tissues 
that require ample vascularization and nutrient diffusion [13]. A large pore size might promote 
angiogenic ingrowth into the scaffold, however, cell seeding of scaffolds with large pore sizes 
run the risk of poor cell retention during in vitro cell seeding, and biomechanical failure due to 
excess void volume [14].  
Melt blending of immiscible polymers at co-continuous compositions followed by static 
annealing and selective extraction, among various methods for fabricating porous scaffolds, could 
be a robust approach specifically for the production of porous constructs for tissue engineering 
purposes. The region of co-continuity, a notion used in the fabrication method in this study, is 
defined as the zone in which neither dispersed nor matrix phase in a binary blend can be 
distinguished. The morphology in immiscible binary blends depends on the interfacial properties 
and the composition of the components. Co-continuous polymer blend structures have been 
examined in the past and show the potential for the production of highly controlled structures 
[15-17], however, very few works have investigated porous structures of highly controlled 
morphology derived from co-continuous blends for tissue engineering applications. This 
approach allows the production of a variety of structures with controlled pore diameters with 
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narrow pore size distribution and full interconnectivity. By using static annealing after melt 
blending as the principle approach, significant control over the phase dimensions in co-
continuous morphologies can be exercised [16]. By using this method, many disadvantages of 
other fabrication techniques could be overcome, such as the use of toxic solvents, limitations 
imposed by the shape of the porogen phase, low levels of pore interconnectivity, high processing 
temperatures, large pore size distributions and high processing costs [18]. Rapid prototyping, as 
an example, has the advantage of structuring the pore geometry in terms of pore orientation and 
can control the pore size through the choice of strand diameter, but is limited in its ability to 
prepare small pore sizes [19, 20]. The melt blending approach together with the static annealing 
can be used to control pore sizes from less than 1 micron to hundreds of microns. Previous 
studies applied to polyethylene and polylactic acid based blends have shown that this can be done 
in a highly controlled and quantitative fashion [21, 22].  
In this study, static annealing is applied to PCL/PEO blends leading to precisely controlled PCL 
phase/pore sizes. In addition, poly(ethylene oxide) (PEO) is used as a porogen in the blend, 
mainly due to its biocompatibility, high water solubility and its extensive use in many medical 
applications such as drug delivery systems using liposomes, nano- and micro-particle carriers 
[23-25]. A previous qualitative study has shown that PCL/PEO blends provided an uncontrolled 
porous morphology with anisotropic microstructure at the surface and in the core of the sample 
[26]. Moreover in this prior study, quantitative estimations of pore size, size distribution and pore 
interconnectivity were lacking.  
The objective of this study is to prepare a range of highly controlled and quantitatively 
characterized isotropic, fully interconnected, porous PCL microstructures based on the melt 
blending of co-continuous immiscible polymers. The pore interconnectivity, the level of control 
over the pore size and pore size distribution will be evaluated in order to verify the applicability 
of such constructs as potential bone tissue engineering scaffolds. An in vitro approach using 
model bead infiltration to mimic bone-derived stromal cells will be developed to evaluate the 
capacity of the controlled interconnected pathways in the fabricated scaffolds to retain cells. Cell 
distribution within the scaffolds will also be examined and compared to that of the beads. The 
scaffolds will be further characterized for cytotoxicity and cell viability. 
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4.2 Materials and methods 
4.2.1 Materials 
The commercial-grade poly(ε-caprolactone) (PCL, CAPA 6800) was supplied by Solvay 
(Brussels, Belgium). Poly(ethylene) oxide (PEO) water-soluble polymers (POLYOX™ WSR-
N10) was purchased from Dow (Midland, MI, USA). See Table 4.1 for further characteristics. 
 Table  4-1: Characteristics of the polymer materials used to create the porous scaffold 
Materials 
Molecular 
Weight 
(Mw) 
Density at 100°C 
(g/cm
3
) 
Zero Shear 
Viscosity 
(Pa.s) 
Supplier 
PCL (Capa 6800) 80,000 0.961 7,261 Solvay 
PEO (WSR-N10) 100,000 1.000 31,508 Dow Chemicals 
 
4.2.2 Blend preparation 
Blends of PCL and PEO were prepared at 45PCL/55PEO vol% in a Brabender internal mixer 
under a constant flow of dry nitrogen for the prevention of thermo-oxidative degradation of 
components. Mixing was done at 100°C for 7 min with the rotation speed of 50 rpm. The blends 
were quenched in liquid nitrogen right after mixing in order to freeze-in the morphology. The 
amount of material in every batch of mixing was maintained at 80% of the total capacity. All the 
concentrations are reported as volume percent and were estimated experimentally according to 
their melt densities at 100°C as tabulated in Table 4.1.  Melt densities at 100°C were measured 
using a SWO pvT-100 apparatus.  
 
4.2.3 Rheology 
Discs of PCL Capa 6800 and PEO WSR-N10 were produced by a compression molding press at 
100°C. The rheological characterization was performed using a Rheometric Scientific SR5000 
stress-control rheometer under the flow of nitrogen and a parallel plate geometry with a 1 mm 
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gap was selected. Time sweep tests were used to determine polymer stability while stress sweep 
tests were performed to determine the region of linear viscoelasticity. The zero shear viscosities 
of the polymers in Table 4.1 were estimated by the time weighted relaxation spectrum approach 
and were verified by the Carreau-Yasuda model [27]. 
 
4.2.4 Annealing and sample preparation 
Static annealing of the PCL/PEO blends was performed in a compression molding press. Small 
pieces of the blend were cut, sandwiched in aluminum foil and subsequently transferred into the 
cavity of a frame. The blends and the frame were then put between the two metal plates of the 
press, so that the above press just touched the top of the samples while annealing took place. This 
arrangement imposed no external pressure on the samples and hence deformation and flow of the 
polymer blend were minimized. The annealing process was performed under constant flow of 
nitrogen in order to reduce the risk of thermo-oxidative degradation of the blend components. 
The annealing temperature was selected to be 160°C which is 30°C lower than the degradation 
temperature of PEO as measured by a thermogravimetric analysis apparatus (TGA Q-500 V6.7). 
After annealing, the samples were quenched in liquid nitrogen to freeze-in the morphology. The 
annealing times 0.5, 1, 1.5, 2, 2.5 and 3h were selected in order to ultimately generate a range of 
pore sizes suitable for tissue engineering applications. After annealing, samples were shaped into 
discs of 3 mm in diameter and 1.5-2 mm in thickness, by using a mechanical punch and a fresh 
razor blade. 
 
4.2.5 Pore continuity/interconnectivity 
Selective extraction of PEO in the blends was performed in deionized water at ambient 
temperature in 50 mL Fisherbrand tubes for 7 days. In order to calculate continuity, some 
scaffolds were subjected to two months of extraction to reach constant weight. Gravimetric 
measurements were used for the calculation of continuity of PEO as the porogen phase according 
to Equation 16. This approach allows for the quantitative estimation of pore interconnectivity. 
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4.2.6 Scanning electron microscopy 
For the purpose of visualization by scanning electron microscopy (SEM), annealed samples were 
cut into small pyramids and microtomed at -160˚C under liquid nitrogen using a glass knife, 
perpendicular to the machine direction. The instrument used for microtomy was a Leica-Jung RM 
2165 equipped with a Leica LN 21 type cryochamber. After annealing for different durations, the 
microtomed samples were then subjected to extraction to remove the PEO porogen phase and 
yield porous structures. After drying for 24h the samples were coated with a gold-palladium alloy 
and observed by a Jeol JSM 840 scanning electron microscope operating at a voltage range of 5-
10 kV. 
 
4.2.7 Mercury intrusion porosimetry/sample designation 
Volume average pore diameter and pore size distribution of the extracted samples were measured 
by an Autopore IV 9500 V1.06 mercury intrusion porosimeter. Mercury porosimetry is based on 
the capillary law governing the penetration of mercury as a non-wetting liquid into the small 
pores. Mercury porosimetry uses the Washburn equation (Equation 17) to describe the relation 
between the intrusion of mercury into the porous structure and the pressure applied to the 
mercury [28]:  
(17)       Cos 2- r  P  
Where P is the applied pressure, r is the radius of the pores, σ is the surface tension and θ is the 
contact angle. For these experiments, a contact angle of 140° and surface tension of 0.48 N/m for 
mercury were considered.  
Each blend was subsequently classified by its pore size and a number: 40 micron-Sample 1, 84 
micron-Sample 2, 116 micron-Sample 3, 141 micron-Sample 4, 162 micron-Sample 5, and 212 
micron-Sample 6.  The non-annealed blend was designated as 0.87 micron-Sample 0. 
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4.2.8 Cell culture 
Human bone marrow stromal cells (hBMSCs), obtained by bone marrow aspirates from healthy 
consented donors under institutional-approved protocols, were purchased from Texas A&M 
Institute for Regenerative Medicine (Temple, TX, USA). hBMSCs were cultured and expanded 
in complete culture media (CCM), which consisted of alpha minimum essential medium (αMEM, 
Sigma-Aldrich, Oakville, ON, Canada), 16% fetal bovine serum (FBS, Atlanta Biologicals, 
Atlanta, GA, USA), 2 mM L-glutamine (Sigma-Aldrich), and 100 units/ml Penicillin/100 μg/ml 
Streptomycin (Sigma-Aldrich). The cells were used between passage numbers of three and five in 
this study. 
L929 cells (NCTC clone 929, American Type Culture Collection, Manassas, VA, USA) were 
cultured and expanded in αMEM supplemented with 10% FBS at 37 °C in an humidified 
atmosphere of 5% CO2.  
 
4.2.9 Bead/cell infiltration 
For bead/cell infiltration analysis, 2% agarose gels with 3 mm diameter holes were created into 
which each scaffold disc was press-fit, to study depth-wise infiltration of a controlled number of 
beads or cells, while minimizing escape or infiltration along the edges of the scaffold. Briefly, 1 
mL of 2% warm agarose solution was pipetted into each well of a 24-well tissue culture plate 
(BD Biosciences, Mississauga, ON, Canada) and cooled down at 4°C. Once solidified, a 3 mm 
diameter hole was made in the center of the agarose gel by a 3 mm Miltex dermal biopsy punch. 
The cylindrical scaffolds were then fit to the bottom of the holes. Four pore sizes of scaffolds (84 
micron-Sample 2, 116 micron-Sample 3, 141 micron-Sample 4 and 162 micron-Sample 5) were 
tested for bead/cell infiltration analysis in triplicate.  
A novel approach of using polystyrene beads (size: 10 μm, dark red, Sigma-Aldrich) was first 
applied to mimic cell infiltration longitudinally into each scaffold cylinder. The particle size of 
the beads (n=462) was verified and determined to be 10 ± 0.1 microns through image analysis 
using a Nikon Optiphot-2 light microscope and StreamPix v.III and Sigmascan Pro v.5 software. 
As an economical model, beads closely mimic the size of trypsinized hBMSCs, which would be 
ultimately used for clinical bone regeneration applications. 126,500 beads in 2 µL water 
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suspension were transferred to the top surface of the scaffold. After passive penetration by 
gravity for 30 min, the scaffolds were transferred to a new culture plate containing fresh 2% 
melted agarose solution and the beads fixed in place by solidification of agarose gel in 4°C. The 
scaffolds were then cut in half to generate two semi-cylinders and the transverse cross sections of 
the scaffold were photodocumented with a Zeiss AxioVert S100 microscope. The number of 
beads that passed through the scaffold and remained in the bottom of the well was quantified by 
the countess automated cell counter (Invitrogen). The number of retained beads in the scaffold is 
simply calculated by the subtraction of the number of escaped beads from the total number of 
seeded beads (126,500). Retention capacity was calculated by dividing the number of beads that 
remained in the scaffold by the original number of beads seeded.  
For cell infiltration analysis, scaffolds were sterilized by 70% ethanol followed by sterile water 
washes and fit as described above into agarose wells. 126,500 freshly trypsinized hBMSCs 
suspended in 20 µL CCM were seeded on the scaffolds (N=4 per pore size). After 2h incubation 
at 37°C, the scaffolds were transferred to a new culture plate; cells escaped from the scaffolds 
were then trypsinized and seeded in a new 96-well culture plate containing a standard curve of 
increasing hBMSC number. Cells in the 96-well plate and scaffolds seeded with cells were 
maintained in CCM overnight, fixed with 4% Paraformaldehyde in PBS for 20 min and the cell 
nuclei stained with Hoechst 33342 (Invitrogen) for 5 min. The fixed cells were visualized with 
the Zeiss AxioVert S100 microscope and images were captured using the QImaging QICAM 
FAST 1394 digital camera and Northern Eclipse software. The total number of escaped cells was 
determined by automated counting using ImageJ software against the standard curve; cell 
retention capacity was calculated as the number of retained cells divided by total cells seeded; 
The scaffolds were cut in half into two semi-cylinders, and the cross sectional area of the semi-
cylinder scaffolds was imaged with the Olympus FV1000-IX81 confocal microscope system. 
 
4.2.10 Cell viability assays 
L929 cells are commonly used for viability assays to assess the biocompatibility of scaffolds. 
3x10
4
 cells were resuspended in CCM and seeded onto the scaffolds. After 20h culture at 37°C, 
AlamarBlue® cell viability reagent (Invitrogen) was added to each well at 1:10 v/v and cultured 
for 4h. The fluorescence of the conditioned media was read by a Tecan plate reader at 560 
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nm/590 nm excitation/emission. Cell viability was reported as relative fluorescence units and the 
test was repeated 4 times (N=4).  
The viability of L929 cells attached on the scaffolds was also evaluated by a live/dead assay 
using 1 μM green-fluorescent Calcein AM (Invitrogen) and 1 μM red-fluorescent Ethidium 
homodimer-1 (Invitrogen) for 30 min at 37°C. The top of the scaffolds and the cells escaped from 
the scaffold were then imaged. For brightfield microscopic analysis, separate wells of seeded 
scaffolds were left undisturbed and were imaged by the Zeiss AxioVert S100 microscope. 
 
4.2.11 Statistical analyses 
Mean and standard deviation (SD) values were calculated for each group of data. Student’s t-test 
was used to analyze experimental groups with two samples, with p<0.05 taken as statistically 
significant. 
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4.3 Results and discussion 
4.3.1 Rheology 
The rheology of the materials is important in determining how the co-continuous morphology is 
formed. Figure 4.1 demonstrates the trend of complex viscosity as a function of frequency for 
PCL and PEO pure materials. Time sweep tests were done to prove the stability of the polymers 
in the course of the rheological measurements. At 100°C PCL is mostly characterized by a 
Newtonian plateau in almost all the ranges of shear rate, as opposed to PEO which demonstrates 
a more shear thinning behavior in the probed frequency range. It is clear that for low frequencies 
(less than 3 rad/s), PEO is more viscous than PCL and for higher frequencies the opposite 
behaviour is observed. There was a similar frequency dependent behaviour in the storage 
modulus of the two polymers as a measure of their elastic properties.  
 
Figure  4.1: Complex viscosity and storage modulus as a function of frequency at 100°C 
 
4.3.2 Morphology  
SEM images in Figure 4.2 demonstrate the evolution of pore size in the co-continuous 
microstructure as a function of annealing time at a constant annealing temperature of 160°C. 
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Non-annealed constructs have a negligible pore size (0.87 microns) and their structure will be 
discussed in more detail below. The SEM photos qualitatively demonstrate a high level of 
continuity at all annealing times and this is further confirmed quantitatively below.  Clearly, the 
increase in the annealing time leads to significantly increased phase/pore sizes over a very wide 
range of scale. This approach will be used to ultimately create a large window of pore sizes to be 
studied for cell retention capacity. 
 
    
Figure  4.2: SEM micrographs of 45PCL/55PEO annealed at 160°C for a, b, c and d represent 30 
min, 1h, 2h, and 3h, respectively.  Scale bar = 200 microns 
 
The increase in the volume average pore diameter as a function of annealing time at a given 
temperature (160°C) is also demonstrated in Figure 4.3 which demonstrates a linear correlation 
between the volume average pore diameter and the annealing time. This linear correlation in the 
a b 
c d 
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phase coarsening follows an      relationship, where R is the average pore radius and t is the 
annealing time as suggested by Yuan et al. [17]. The coarsening rate       which is closely 
controlled by the interfacial tension and zero shear viscosity of the surrounding media is constant 
and was calculated as 33.4 μm/hr. This demonstrates that the average pore size can be highly 
controlled in a quantitative fashion by modifying the annealing time. 
  
 
Figure  4.3: Volume average pore diameter as a function of annealing time. The pore diameter 
was directly proportional to the annealing time (r2 = 0.99), thus providing the ability to create 
pores between 40 and 212 μm by simply altering the duration of annealing 
 
Such alterations in the annealing time could lead to a 230-fold increase in the pore size from 
approximately 0.87 microns in non-annealed samples to 212 microns in 3h annealed scaffolds. 
Table 4.2 summarizes the values of the volume average pore diameter as a function of the 
annealing time. 
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Table  4-2: Quantified volume average pore diameter as a function of annealing time for 
45PCL/55PEO vol% after extraction of PEO 
Sample 
Annealing 
Time 
Sample 
0  0h 
Sample 
1 0.5h 
Sample 
2  1h 
Sample 
3  1.5h 
Sample 
4  2h 
Sample 
5  2.5h 
Sample 
6  3h 
Volume 
average 
pore 
diameter 
(μm) 
                                                                
Continuity 
(%) 
~100                                                    ~100 
 
Figures 4.4 and 4.5 depicts the pore size distribution of 4 different porous samples 0.87 micron-
Sample 0 (non-annealed), 40 micron-Sample 1, 84 micron-Sample 2 and 141 micron-Sample 4. 
Peak analysis of the non-annealed samples in Fig. 4a showed the existence of two groupings of 
pore sizes at 890 nm and 12.5 μm, as well as shoulders occurring at 2 and 4 μm which indicate 
the polymodal/irregular nature of the pore size distribution for the non-annealed sample. As 
shown in Figure 4.4, these irregularities are absent for each annealed sample where only one 
sharp unimodal peak is observed (Figure 4.5). Evidently, the coarsening effect caused by static 
annealing of the samples eliminates the polymodal/irregular behaviour in the pore size 
distribution.  
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Figure  4.4: Pore size distribution as a function of annealing time for a non-annealed vs. 1h 
annealed scaffold. Non-annealed scaffolds display a polymodal pore distribution consisting of 
much smaller pores 
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Figure  4.5: Pore size distribution as a function of annealing time for a 0.5h and 2h annealed 
scaffolds. Annealed scaffolds are made up of larger unimodal sized pores 
 
4.3.3 Continuity measurements  
The continuity percentage of the porogen phase in non-annealed scaffolds as a measure of pore 
interconnectivity was analyzed by gravimetric measurements in blends containing up to 55 vol% 
PEO and is illustrated in Figure 4.6. There was a broad region of PEO continuity starting from 35 
v/v % up to 55% v/v PEO, which demonstrated that virtually all the pores in the samples were 
accessible to the solvent (water). This was a lucid indication of the high level of pore 
interconnectivity for this binary blend type scaffold. The blends containing 60 vol% PEO 
porogen phase and higher were not self-supporting and collapsed after extraction. In this article, 
all the co-continuous blends were prepared with the composition ratio of 45PCL/55PEO vol%. 
Calculation of the co-continuity as a measure of pore interconnectivity was also performed for 
the annealed blends and is shown in Table 4.2. For almost all annealing times, the quantitative 
level of continuity, and hence the pore interconnectivity, was nearly 100%. Hence the virtually 
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perfect interconnectivity is maintained with annealing. Also, a constant weight in the gravimetric 
studies was obtained in a shorter period of time as the annealing time increased.  
 
Figure  4.6: Continuity percentage of PEO porogen phase as a function of PEO composition. The 
broad region of continuity between 35% and 55% demonstrated that all the pores were accessible 
to the solvent, and thus pore interconnectedness was evident 
 
The concentration of residual organic solvents in the course of the fabrication of scaffolds should 
be reduced to an acceptable window for them to be used in the human body [29]. By using water 
at ambient temperature as the solvent for the PEO phase, the added problems of toxicity due to 
residual solvent and deformations at high temperatures are fully overcome. Also, due to the 
hydrophobic nature of PCL, any low level residual PEO in the blend could in fact increase the 
hydrophilicity of the system since PEO has been previously used in the surface modification of 
PCL nanofiber webs to increase the hydrophilicity of the polymer surface [30]. As a result, even 
small amounts of PEO remaining in the blend could potentially enhance cell attachment.  
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4.3.4 Bead/cell infiltration 
Due to the scarcity and high cost of primary hBMSCs, a rapid screening method using 10-micron 
polystyrene beads was developed to assess cell infiltration and retention in the scaffolds. The 
setup of the infiltration assay is illustrated in Figure 4.7. 
 
Figure  4.7: Infiltration assay setup where migrating agents seeded in the scaffolds can either be 
beads or hBMSCs 
 
Figures 4.8 and 4.9 show the model bead retention behavior as a function of pore size and it can 
be seen that a linear relationship is obtained between bead escape/retention % and pore size. As 
an example, knowing that for 84 micron-Sample 2 with the smallest pore size, approximately 
5,000 beads have escaped the scaffold (Figure 4.9) and total beads seeded inside were 126,500, 
the retention capacity (%) is calculated as [(126,500-5,000)/126,500] × 100 which gives 96% 
bead retention. This retention value is reported in Figure 4.8. The maximum bead retention 
capacity is 96%, observed for the 84 micron-Sample 2, and the minimum bead retention capacity 
is 83% for the 162 micron-Sample 5. Figure 4.10 shows that the beads infiltrate efficaciously into 
the center of the scaffold. Such a high level of infiltration into the scaffold reflects the high level 
of continuity of the porous structure and the tortuous pathways within the 3D constructs. 
The cell escape/retention behavior is also depicted in Figures 4.8 and 4.9 and it can be seen that 
the pore size of the scaffold has little influence on cell escape/retention up to approximately 120 
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micron pore size. In that pore size range a very high retention and very low escape of cells is 
observed. This behavior differs markedly from the model beads.  
 
Figure  4.8: Cell/Bead retention capacity. 141 micron is the pore size threshold beyond which 
cells behave like model beads and infiltrate the scaffolds more homogeneously 
 
Figure  4.9: Cell/Bead escape. 141 micron is the pore size threshold beyond which cells behave 
like model beads and infiltrate the scaffolds more homogeneously 
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Figure  4.10: Phase contrast images of the rectangular cross section as a qualitative measure of 
bead penetration from the top toward the bottom of the scaffolds; dark spots (arrows) are beads. 
The panels correspond to 84 micron-Sample 2 (a), 116 micron-Sample 3 (b), 141 micron-Sample 
4 (c) and 162 micron-Sample 5 (d) scaffolds. At low pore size, model beads penetrate toward the 
center. Scale bar = 100 microns 
 
Figure 4.11(a, b) explains this discrepancy as high levels of surface aggregation of the cells at the 
top of the 3D scaffold are observed. Higher retention values of the cells as compared to those of 
the beads are explained by hBMSCs forming undesired cell-cell interactions in the seeding area, 
which limit their penetration into the lower pore size constructs. Clearly at 84 and 116 micron 
pore sizes (Figure 4.11(a, b)), the cells are aggregated at the top of the scaffold. At higher pore 
sizes (Figure 4.11(c, d)), the hBMSCs are able to penetrate the scaffold. 
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Figure  4.11: Confocal images of the scaffolds showing cell penetration from the top toward the 
bottom of the scaffolds; white spheres (arrows) are fluorescent cell nuclei, dashed line represents 
the seeding area or top of the scaffolds. The panels correspond to 84 micron-Sample 2 (a), 116 
micron-Sample 3 (b), 141 micron-Sample 4 (c) and 162 micron-Sample 5 (d) scaffolds. At low 
pore size, cells tend to self-aggregate at the top of the scaffolds. Scale bar = 100 microns 
 
Considering the slopes (m) on the graphs for cell escape/retention in Figure 4.8 and 4.9, three 
main regions with different characteristics are observed. At low pore sizes (84 and 116 microns), 
there is no dependence (zero slope) of cell escape/retention on pore size due to the cell 
a b 
c d 
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aggregation at the top of the scaffold post-seeding. With an increase in the pore size (116-141 
microns), a transition region is observed where more cells tend to pass the top surface barrier and 
enter the structure at deeper levels and a cell escape/retention dependence of positive/negative 
slope is observed. At pore sizes of 141 and 162 microns there is complete penetration of the cells 
into the 3D construct and the slope of cell escape/retention with pore size is identical to that of 
the model beads. It must be noted that the onset pore size above which the cells behave like 
model beads depends on various parameters such as cell type, cell-surface interactions and cell 
seeding density. It is expected that by reducing the cell seeding density, the model bead behavior 
could potentially be observed for cells at lower pore sizes.   
These results indicate the value of carrying out model bead experiments as they can provide the 
baseline for perfectly non-aggregated systems. The above analysis also emphasizes the fact that 
cell aggregation behavior can have a significant role in determining optimum pore sizes for 
scaffolds in tissue engineering experiments, i.e. even if the trypsinized cells used in this study are 
nominally in the order of 10 microns in size, their effective aggregated size can be many times 
greater than that value.  
In this study the 141 micron-Sample 4 (Figure 4.11c) and 162 micron-Sample 5 (Figure 4.11d) 
demonstrate a homogeneous distribution with a low amount of cell aggregation on the top in 
comparison with other pore sizes, indicating that the open network of pores allowed cells to settle 
from the top surface throughout the scaffold. However, the 162 micron-Sample 5 demonstrated 
the highest bead escape level of 17% and a 6% loss of cells as shown in Figure 4.9. Therefore, it 
can be stated that the 141 micron-Sample 4 demonstrates the best combination of cell retention 
capacity and distribution inside the scaffold and is hence considered to be the scaffold with 
optimum morphology. Moreover, according to results by Hulbert et al.[31], such a large pore size 
should be able to support bone ingrowth and qualify for optimal osteogenesis prerequisites.  
 
4.3.5 Cytotoxicity and cell viability   
AlamarBlue® assay was carried out to verify the cytotoxicity of the scaffolds. The exposure of 
L929 cells to PCL scaffolds induced a slight decrease of average cell metabolism, but the effect 
was not significant (p=0.11, Figure 4.12), implying that the PCL scaffolds were not cytotoxic. 
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Figure  4.12: AlamarBlue® assay was used to measure cell viability of L929 cells cultured on 
PCL scaffolds as compared to a control monolayer culture, n=4 
 
Live/dead cell assay in 141 micron-Sample 4 confirmed the cytocompatibility of the scaffold 
(Figure 4.13(a,b)). The monolayer cells were visualized to grow directly underneath the scaffold 
without necrosis or detachment and presented similar morphology (Figure 4.13d) to the control 
monolayer culture (Figure 4.13c). Nevertheless, there was a slight difference in cell morphology 
on tissue culture wells with a more elongated, spindle shaped and fibroblast-like phenotype, 
compared to that on the PCL scaffold where the majority of cells remained spherical. This was in 
agreement with results obtained by Mattanavee et al. who observed rounded L929 cells cultured 
on electrospun PCL scaffolds [32], which is best explained by an intrinsic hydrophobic PCL 
surface that is relatively non-adherent for cells [33]. Future work will focus on the surface 
modification of the melt-blended PCL scaffold to enhance cell attachment, spreading and 
differentiation into osteoblasts. 
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Figure  4.13: (a-b)  Fluorescent images of L929 cells inside the scaffold, (c) Fluorescent image of 
subconfluent L929 cells on the tissue culture plate (positive control), Live and dead cells are 
represented by green and red color, respectively. (d) Phase contrast image of L929 cells and PCL 
scaffold. PCL scaffolds were not cytotoxic as the monolayer cells grow directly underneath the 
scaffold without necrosis. Scale bar = 100 microns 
 
4.4 Conclusion 
To date, a thorough investigation of tissue engineering scaffolds of significantly different and 
highly controlled pore sizes at the microscopic level including scaffold infiltration as a crucial 
parameter has not been done. The melt blending of PCL and PEO as a co-continuous immiscible 
polymer blend followed by static annealing is a robust approach for the creation of highly 
controlled 3-dimensional scaffolds destined for tissue engineering applications. Close to 100% 
pore interconnectivities, sharp unimodal pore size distribution, along with precise and unique 
control over the pore size varying over two orders of magnitude are the main advantages of the 
technique. Porosimetry measurements show that the static annealing of the blends can yield a 
a b 
c d 
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sharp unimodal pore size distribution, as opposed to non-annealed structures that demonstrate a 
polymodal and irregular size dispersity. Infiltration studies using model 10-micron beads as a 
new approach show that the fabricated scaffolds bear high retention capacities and demonstrate 
effective infiltration of the beads into the scaffold. Such a high level of infiltration into the 
scaffold reflects the high level of continuity of the porous structure and the tortuous pathways 
within the 3D constructs. 
However, it is shown that, unlike beads, cells do not act as single entities and tend to form 
aggregates on the seeding area of the small pore size scaffolds which impedes penetration into the 
porous device. This phenomenon necessitates the use of large pore size scaffolds to avoid such 
non-uniform cell distribution. The model bead experiments are important as they can provide the 
baseline for perfectly non-aggregated systems and the beads closely mimic trypsinized cells at 
pore sizes equal to or larger than 141 microns. The novel bead system reported in this paper can 
be used as a reference model for devising proper seeding protocols to overcome retention and 
distribution issues. According to our studies, PCL scaffolds of 141-micron average pore have the 
best bead/cell retention and distribution within the scaffold. Cytotoxicity assays demonstrate that 
there is no significant difference in cell viability after incubation of L929 cells in contact with the 
scaffold as compared to that of the control monolayer cells, and few necrotic cells were detected 
by a fluorescent live-dead cell assay.  
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CHAPTER 5 ARTICLE 2: CHITOSAN SURFACE MODIFICATION OF 
FULLY INTERCONNECTED 3D POROUS POLY(Ε-CAPROLACTONE) 
BY THE LBL APPROACH  
 
Although the PCL scaffolds generated in Chapter 4 were not cytotoxic, we attributed the 
observed rounded morphologies of some hBMSCs on the surface of the constructs to the 
hydrophobic surface chemistry of PCL. Hence, the surface modification of PCL scaffolds to 
increase their cytocompatibility is inevitable. Chapter 5 focuses on the surface modification of 
PCL with chitosan as a hydrophilic cytocompatible compound, which has been shown to improve 
osteogenesis in vitro. Layer-by-Layer (LbL) self assembly of polyelectrolytes has been vastly 
studied in our laboratory in the recent years. In this part of the study, we use the LbL technique to 
incorporate chitosan on the surface of 2D and 3D PCL and hence improve its surface wettability. 
The existence and homogeneity of a chitosan layer on the surface of the scaffolds are of ultimate 
significance, and their qualitative and quantitative evaluation becomes crucial in the case of 3D 
constructs with considerable and comparable dimensions. As a result, various characterization 
techniques such as gravimetric measurements, X-ray photoelectron spectroscopy (XPS) and time 
of flight secondary ion mass spectrometry (ToF-SIMS) are going to be used to assess the 
uniformity of the coatings.   
 
This article has been submitted to the journal of “ACS Applied Materials & Interfaces”. 
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Abstract 
In this study, the deposition of a homogeneous chitosan layer on the surface of a 3D 
interconnected porous network of poly(ε-caprolactone) (PCL), prepared from a co-continuous 
polymer blend of PCL/PEO (poly(ethylene oxide)), was achieved. A Layer-by-Layer (LbL) self-
assembly of polyelectrolytes (PDADMAC as polycation and PSS as polyanion) followed by 
chitosan deposition was compared with a traditional dip-coating strategy of chitosan on pure PCL 
surfaces. LbL with polyelectrolytes and PSS as the final layer prior to chitosan addition 
potentially allows for the preparation of a negatively charged surface that can then subsequently 
interact with the positively charged chitosan. Gravimetric measurements were done to estimate 
the deposition efficiency of up to 8 layers of polyelectrolytes on the 3D porous substrate. Few 
layer depositions lead to an interpenetration of polyelectrolyte molecule chains, however upon 
increasing the number of layers, more well defined layers are formed. X-ray Photoelectron 
Spectroscopy (XPS) on 2D solid discs was used to compare the 4 layer deposited samples with 
the 8 layer deposited ones. The oxygen/carbon, nitrogen/carbon and sulfur/carbon ratios clearly 
showed that the PSS molecule dominated the surface as the last deposited layer at higher number 
of depositions (n=8). The further addition of chitosan as the top layer by LbL was demonstrated 
to be superior as compared to the dip-coating technique since uniform local deposition of 
chitosan on the LbL coating was observed in both 2D solid discs and 3D porous cubes at various 
depths within the scaffolds. SEM imaging shows the multilayer assembly ranges in thickness 
from 550 to 700 nanometers. These data demonstrate that the LbL technique of polyelectrolyte 
deposition followed by chitosan addition provides a route towards stable and homogeneous 
surface modification and has the potential to transform a classic fully interconnected porous 
synthetic polymer material to one with essentially complete chitosan-like surface characteristics.   
Keywords: Poly(ε-caprolactone), scaffold, 3D, co-continuous, coating, Layer-by-Layer, X-ray 
Photoelectron Spectroscopy 
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5.1 Introduction 
PCL is a biodegradable polyester that has been proposed for use in drug release, cutaneous 
wound repair and also cartilage and bone in-growth and regeneration [1-4]. Degradation of PCL 
occurs due to the bulk and surface hydrolysis of ester linkages which result in a slow 
biodegradation which can also be altered according to specifications needed for each application 
[5]. In addition, PCL is biocompatible, easily processable and does not elicit immune responses 
which add to its potential to be used in bone regeneration applications. The application of PCL 
and its composites in bone tissue engineering has been studied and a variety of porous PCL 
products have been investigated including PCL-only scaffolds (generated by Fused Deposition 
Modeling (FDM) [6], electrospun PCL [1], or solvent-extracted PCL [7]), loaded PCL scaffolds 
(scaffolds containing transforming growth factor beta-1 (TGF-β-1) [8] or BMPs [9, 10]) as well 
as PCL composites (PCL combined with PLLA [11], tricalcium phosphate (TCP) [12, 13], or 
collagen [14]). In vitro studies with cell-seeded PCL have shown alkaline phosphatase activity 
and mineral deposition. However, none of these scaffolds has yet achieved clinical use for non-
union bone fractures, potentially due to lack of mechanical integrity and/or lack of structural 
requirements due to the limitations in the fabrication techniques as shown in a previous work 
[15].  
Recently, the melt blending of polymers and copolymers based on component compositions and 
material properties such as interfacial tension and viscosity has been examined as a robust 
approach for the production of tissue engineering scaffolds of 100% pore interconnectivity [16-
18]. In a recent study, this laboratory prepared PCL scaffolds of highly controlled porous 
structure with a fully interconnected internal network via melt blending of PCL and poly(ethylene 
oxide) (PEO) and it was shown that they have structural features compatible with bone tissue 
engineering [19]. However, the same study reported that L929 mouse fibroblasts tend to form 
spherical morphologies on the PCL scaffolds post-seeding which was also in accordance with 
previous results for the attachment of these cells on electrospun PCL scaffolds [20]. This 
phenomenon could be best explained by the intrinsic hydrophobicity of PCL, which makes its 
surface relatively non-adherent to cells and therefore is unfavorable for mesenchymal cell growth 
that normally requires substrate anchorage [21]. It is clear that the surface of PCL should be 
modified in order to enhance the cytocompatibility of PCL through hydrophilic interactions. 
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Numerous techniques such as plasma treatment, UV-induced or ozone grafting polymerization, 
and aminolysis have been put to use in order to incorporate hydrophilic components onto the 
PCL surface [22-26]. These hydrophilic third party groups that are used for surface modification 
of PCL are mostly extracellular matrix components such as collagen and chitosan or small 
peptide sequence molecules containing Arg-Gly-Asp (RGD). Most of the surface treatment 
techniques used to alter the surface of PCL involve grafting components containing hydroxyl, 
carboxyl or amine functional groups, upon which proper active bio-macromolecules could be 
incorporated. Since the surface of PCL is considered as a reaction site for these methods, 
common limitations exist such as steric hindrance leading to non-uniform grafting and inevitable 
non-specific interactions [27].  
Layer-by-Layer (LbL) self-assembly of polyelectrolytes is a simple, straightforward yet powerful 
technique to physically modify the charge on the surface of a substrate without the need to a 
grafting reaction on the surface of the PCL scaffold. LbL surface deposition is based on the 
electrostatic attraction of oppositely charged polyelectrolytes while they adsorb on the 
surface[28]. Although poly(dialyldemethylammunium chloride) (PDADMAC) and polyanion 
poly(sodium 4-styrenesulfonate) (PSS) are not known as biodegradable polyelectrolytes, they 
have been used as LbL components for tissue engineering in vitro studies [29-31]. A qualitative 
study has investigated the LbL surface deposition of these polyelectrolytes on PCL nanofiber 
films [32]. Also, due to the fact that the PCL film is only weakly charged at the surface, this 
previous study lacks solid proof of the efficiency of the depositions. Chitosan, an important 
member of the polysaccharide family, is derived from the cuticle of crustaceans and has been 
widely used in various biomedical applications such as tissue engineering, drug delivery systems 
and wound dressing [33-35]. Also, glycol-chitosan/hyaluronic acid polyelectrolyte multilayer 
films have been recently used as a substrate mediated gene-delivery system [36]. Recent findings 
demonstrated that chitosan promotes bone formation through differentiation of human bone 
mesenchymal stem cells (h-BMSCs) via the upregulation of genes associated with calcium 
binding and mineralization [37]. While Guzman et al. showed that chitosan microparticles inhibit 
mineralization of hBMSCs [38], Amir et al. demonstrated that chitosan particles permit 
biomineralization of macaque dental pulp stromal cells [39]. With a high positive charge density 
in acidic solutions, chitosan can therefore be used as an apt polyelectrolyte osteogenic surface, 
provided it can be firmly adsorbed to a surface of adequate negative charge. Moreover, due to its 
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degradation at low temperatures, chitosan is not melt processable and it is therefore deprived of 
the versatile structures provided by melt blending techniques.        
In this study the objective is to use the LbL approach to manipulate the electric charge of the 
internal surface of a fully interconnected, porous 3D PCL construct, in order to be able to deposit 
chitosan as the bioactive macromolecule that provides hydrophilicity to the PCL surface. The 
rigorous examination of the LbL self–assembly process and the homogeneity of the chitosan 
deposition will be examined and compared to a classic dip-coating technique. 
 
5.2 Materials and Methods 
5.2.1 Materials 
The commercial-grade poly(ε-caprolactone) (PCL, CAPA 6800, Mw=80kDa) was supplied by 
Solvay (Brussels, Belgium). Poly(ethylene) oxide (PEO) water-soluble polymers (POLYOX™ 
WSR-N10, Mw=100kDa) was purchased from Dow (Midland, MI, USA). Polycation 
poly(dialyldemethylammunium chloride) (PDADMAC), Mw 100000–200000, and polyanion 
poly(sodium 4-styrenesulfonate) (PSS), Mw 70000 were purchased from Sigma-Aldrich. 
Autoclave-sterile solutions of 20 mg/mL chitosan (DDA=98% and pre-autoclave weight-average 
molecular weight Mw=237,000) and 0.9% mol/mol RITC/chitosan, (DDA=98% and 
Mw=237,000) were supplied by the Biomaterials and Cartilage Laboratory (BCL) at École 
Polytechnique de Montréal. Chitosan was amine-derivatized with rhodamine isothiocyanate 
(RITC) as described by Ma et al [6].  
 
5.2.2 Blend preparation 
Blends of PCL and PEO were prepared at 45PCL/55PEO vol% in a Brabender internal mixer 
under a constant flow of dry nitrogen in order to prevent the thermo-oxidative degradation of 
components. The mixing was carried out at 100°C for 7 minutes with a rotation speed of 50rpm. 
The blends were quenched in liquid nitrogen right after mixing in order to freeze-in the 
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morphology. The amount of material in every batch of mixing was maintained at 80% of the total 
capacity of the internal mixer. All the concentrations are reported as volume percent.   
5.2.3 Annealing  
For the purpose of increasing the phase sizes, static annealing of the blends was performed in a 
compression molding press. Small pieces of the blends were cut, sandwiched in aluminum foil 
and subsequently transferred into the cavity of a frame. The blends and the frame were then put 
between the two metal plates of the press, so that the above press just touched the top of the 
samples while annealing took place. This arrangement imposed no external pressure on the 
samples and hence deformation and flow of the polymer blend were minimized. The annealing 
process was performed under static conditions at 160°C for 2 hours under a constant flow of 
nitrogen in order to reduce the risk of thermo-oxidative degradation of the blend components.  
 
5.2.4 Scaffold preparation and designation 
After annealing, samples were cut into three distinct shapes: 1) 3D porous cubes of 5×5×5 mm
3
 
dimension (razor cut); 2) 2D solid discs of 3mm in diameter and 2mm in thickness were 
mechanically punched from larger PCL discs and trimmed on the side with a fresh razor blade; 
and 3) large 3D porous substrates of 2cm (l) x 2cm (w) x 1cm (h). The 3D porous cubes and 2D 
solid discs were used for surface characterization. The 2D solid discs allowed for a more 
simplified and intermediate modeling step for the ToF SIMS and XPS of dip coated and LbL 
depositions. The use of the large 3D porous substrates was for the LbL gravimetric study in order 
to build up sufficient quantities for measurement.  
 
5.2.5 Solvent extraction 
The PEO porogen phase was selectively extracted from the 3D samples for 7 days in 50mL of 
deionized water at ambient temperature under constant shaking. Water was refreshed twice in this 
period. After the extraction, the samples were dried for 24h at 40°C in a vacuum oven.  
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5.2.6 Surface modification via dip coating and LbL deposition of 
polyelectrolytes 
Dip-coating of pure PCL scaffold in chitosan was first tested as a coating strategy. PCL scaffolds 
were dip-coated by submerging in 300 µL of 50 µg/mL unlabeled (pH=4) or RITC-labeled 
chitosan solution (pH=5.6) and incubated at 37°C for 1 hour, followed by rinsing in cell culture 
media for 1 hour and air drying overnight. RITC-chitosan was only used for fluorescent 
microscopy. 
PDADMAC polycation and PSS polyanion were used in aqueous solution containing 10 mg/mL 
of polyelectrolyte, 1 M NaCl, adjusted to pH=8 with NaOH, or pH=2 with HCl. A pH of 8 was 
selected for the precursor PDADMAC solution according to the work done by Manso et al [40]. 
In that study it was shown that at high pH values the zeta potential of PCL film lies at its highest 
negative values which is an indication of considerable negative surface charge. Also, pilot studies 
showed that a pH of 8 leads to the highest mass increase after the PDADMAC precursor layer 
deposition (Data not shown). These polyelectrolytes were used to alter the surface charge of the 
different PCL polymeric substrates. PCL samples (discs and cubes) were exposed to PDADMAC 
and PSS polyelectrolyte solutions with pH=2 for 1 hour. After each polyelectrolyte deposition, a 
water rinsing step was performed for 1 hour. In order to always keep the substrates in contact 
with the solution and increase the contact surface, metal wires were used to prevent the samples 
from floating. LbL deposition was performed on substrates up to layer n=4 and n=8 with PSS as 
the final deposited layer. Samples were then dipped in 2 mg/mL chitosan solution pH=4 for 4 
hours at 37°C  as the concluding layer followed by water rinsing for 1 hour.   
 
5.2.7 Gravimetric measurements 
In order to have a quantitative evaluation of the layers deposited on the surfaces of the large 3D 
porous PCL substrates, gravimetric measurement was done on a dedicated set of scaffolds 
following the deposition of each layer, deionized water (dd-H2O) rinsing and vacuum drying for 
3 hours. The values are reported as the percentage of mass increase as compared to the initial 
sample weight. The experiment was repeated three times.   
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5.2.8 Fluorescent microscopy 
3D porous cubes of pure PCL scaffold were dip-coated in RITC-chitosan solution, after which 
they were then cut in half and the transverse cross-section was imaged with an inverted Zeiss 
Axiovert fluorescence microscope (EC Plan-Neofluar 1.25x/0.3 NA objective, Carl-Zeiss 
Canada, Toronto, Ontario, Canada), CCD Hitachi camera (Tokyo, Japan), and Northern Eclipse 
software (Empix, Mississauga, Ontario, Canada). For the sake of comparison, the exposure 
settings on the Northern Eclipse software were kept constant for both cases of before and after 
RITC-chitosan dip-coating.  
 
5.2.9 Time of flight secondary ion mass spectrometry (ToF-SIMS) 
ToF-SIMS studies were performed on 2D solid discs dip-coated in chitosan by a ToF-SIMS IV 
(IONTOF, GmbH, Münster, Germany). Oxygen was leaked in the analyzing chamber to a 
pressure of 2 × 10
-7
 Torr during the measurements in order to limit surface charging of the 
sample. Samples were bombarded with Bi1 primary ions at an energy level of 15 keV in bunch 
mode with a pulse of 19.9 ns. The gun operated with a 2.3 pA pulsed ion current over a frame 
area of 500 μm × 500 μm for a dosage below the threshold level of 5 × 1011 ions/cm2 for static 
SIMS. Measurements were taken with an acquisition time of 100 s. The maximum mass 
resolution, R = m/Δm, was ≥ 9000 on 29Si+, where m is the target ion mass and Δm is the 
resolved mass difference at the peak half-width. Effective charge compensation was obtained 
using the electron flood gun. Positive and negative ion spectra were calibrated using H
+
, H2
+
, H3
+
, 
CxHy
+
 and C
−
, CH
−
, C2
−
, C2H
−
, C3
−
 and C3H
−
 peaks, respectively. Integration of the signals was 
performed using the Poisson correction. 
 
5.2.10 X-ray photoelectron spectroscopy (XPS) 
The chemical composition of the coatings on 2D solid discs dip-coated with chitosan, and 3D 
porous cubes with LbL-only or LbL-chitosan coatings, were examined by X-ray photoelectron 
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spectroscopy (XPS). An ESCALAB MKII apparatus (VA Scientific Limited, U.K.) was used to 
analyze the relative concentration of C, O, N and S according to their respective peaks. An Mg 
Kα X-ray source (hυ = 1253.6) with an analyzer pass energy of 100 eV was operated at 12 mA 
and 18 kV. For all the measurements, an ultrahigh-vacuum (UHV) chamber with a base pressure 
of less than 10
-8
 Torr was utilized. For the whole experiment, the binding energy of the C 1s core 
levels (285 eV) was used as an internal standard to determine the charge shift. Various elemental 
analyses were performed on cube and disc shaped PCL substrates with and without 
polyelectrolyte/chitosan coatings. Relative atomic concentration (%) is calculated with respect to 
the total number of present atoms (except H and He). For 2D solid discs and 3D porous cubes, 
measurements were done on right, center and left positions of each sample. As for the 3D porous 
cubes, regional relative atomic concentration were also measured in 1/4 thickness from the top 
and in the middle (1/2 from the top) level of the cubes as well as the top surface, in order to 
evaluate the existence of a homogeneous chitosan layer in the depth of a porous structure.  
 
5.2.11 Scanning electron microscopy 
2D solid discs and 3D porous cubes coated by LbL were treated with a gold-palladium alloy by 
plasma deposition and observed by a FEG-SEM scanning electron microscope, type JEOL(JSM-
7600TFE), operated at a voltage of 2 keV–5 keV. SigmaScan Pro software was used for image 
analysis to determine the thickness of the layers deposited on the substrate.  
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5.3 Results and discussion 
5.3.1 Dip coating pure PCL in slightly acidic chitosan solutions leads to an 
inhomogeneous surface coating  
5.3.1.1 Fluorescent microscopy  
Figure 5.1 demonstrates the fluorescent imaging of 3D porous cubes before and after dip-coating 
in RITC-chitosan.  It is evident that there is an attractive driving force between the PCL surface 
and the RITC-chain molecules.  
 
Figure  5.1 : Fluorescent imaging of 3D porous cubes (a) before and (b) after submersion in 50 
µg/mL RITC-chitosan for 5 min, rinsing and drying. The exposure was maintained constant to 
permit a direct comparison 
 
The red signal in this figure is RITC-chitosan, which clearly shows that even by using a very 
dilute solution of RITC-chitosan, and after rinsing and drying in the dip-coating procedure, there 
is an RITC-chitosan layer retained on the PCL scaffold surface. Since it is well known that 
chitosan contains positively charged amine groups at low pH [41] and PCL as a polyester 
contains partially negatively charged oxygen atoms in its carboxylic groups, the potential exists 
for electrostatic attraction. Manso et al. reported negative values of zeta potential in a wide range 
of pH for PCL films, which are in close relationship with their surface charge [40]. While this 
figure provides clear evidence that chitosan can bind to the PCL surface with a simple dip coating 
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technique, it does not give any information on the quantity or surface homogeneity of the coating 
formed. 
5.3.1.2 XPS and ToF-SIMS analysis 
For PCL substrate surfaces coated with chitosan, the only source for nitrogen atoms is from the 
chitosan itself because PCL is devoid of nitrogen. Therefore, such nitrogen specificity can be 
used as a probe for the detection of chitosan at the surface by surface characterization techniques 
such as XPS or ToF-SIMS. Relative nitrogen concentrations (%) on two distinct 2D solid discs 
(PCL1 and PCL2) are shown in Figure 5.2b according to the positions 1, 2 and 3 depicted in 
Figure 5.2a.  
 
Figure  5.2: Evaluation of coating homogeneity using the dip-coating strategy on 2D solid discs of 
pure PCL: (a) Schematic of the 2D solid discs with X-ray emission at positions 1,2 and 3, (b) 
XPS measurements of the relative nitrogen concentration (%) on two identical random discs 
(PCL1 and PCL2) at positions 1, 2 and 3 
 
PCL1 and PCL2 were subjected to exactly the same preparation process and dip-coating 
conditions nevertheless they clearly show non-uniform and more importantly zero chitosan 
depositions at different positions on the samples, i.e. for PCL1 there is no deposition detected at 
the center of the disc, whereas for PCL2, an absence of chitosan is recorded near the edge. These 
a b 
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results demonstrate that the coating is deposited in a random non-homogeneous fashion with 
some areas rich, some poor and some even devoid of chitosan coating.  
Figure 5.3 illustrates high resolution ToF-SIMS images of the surface distribution of C6H11O3
-
 
and CNO
-
 ions that are specific to PCL and chitosan molecules, respectively.  
 
 
Figure  5.3: ToF-SIMS Analysis of (a) C6H11O3
-
 as the characteristic ion for PCL and (b) CNO
-
 as 
the characteristic ion for chitosan on the coated samples   
 
While characteristic ions of PCL are distributed evenly across a 500 µm x 500 µm surface area, 
there is a large regional variation of concentration intensity of chitosan specific ions, i.e. the 
chitosan concentration appears to be higher on the bottom left corner of the coated surface 
(yellow areas, potentially chitosan aggregates), as opposed to the top right corner where a low 
amount of chitosan is detected. Also, in the center, zero CNO
-
 ions are detected, whereas in the 
same area, the presence of C6H11O3
-
 ions is evident, which shows that chitosan deposition failed 
in this specific position. Previously, negative zeta potentials for PCL nanofiber scaffolds have 
been measured which clearly demonstrates that the negative carbonyl oxygen is present at the 
surface [42, 43]. Clearly, the dip coating strategy carried out in this work fails to deposit a 
controlled homogeneous chitosan coating on both 2D solid discs of pure PCL. The principal 
a b 
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explanation for the failure in achieving homogeneous layer deposition via the simple dip-coating 
technique is that the PCL surface is only slightly negatively charged [44] and the interaction with 
the positive charge on the chitosan chain is not strong enough. Evidently, the PCL surface will 
need to be modified in order to generate strong interactions with the positively charged chitosan. 
Ideally, such powerful bonds should exist throughout the scaffold area at various depths of the 
structure, i.e. the cells for future seeding experiments should all be in contact with such uniform 
chitosan coating layer all through the scaffold thickness. In the next section we examine the 
potential of LbL surface deposition of polyelectrolytes in order to prepare a more uniform 
chitosan surface coating.     
 
5.3.2 LbL surface deposition of polyelectrolytes  
5.3.2.1 Gravimetric measurements 
Figure 5.4 illustrates the mass increase percentage after the deposition of each layer on the PCL 
surface followed by rinsing and freeze drying. In this figure, odd and even layer numbers are 
associated with the addition of the PDADMAC polycation and PSS polyanion, respectively. This 
graph determines the efficacy of LbL depositions and also how effective the polyelectrolytes are 
in building up layers on the surface of the PCL porous polymer. According to Figure 5.4, three 
characteristic regions can be distinguished: Region I, comprised of layers 1-3 includes a window 
of deposited layers with a % mass increase slope value of as low as 0.2% per added layer. It 
appears that indistinct interpenetrating layers are formed in this region likely resulting from a 
balanced, as opposed to a distinct and alternating charge deposition. Therefore, this window of 
initial disordered layers is named “Surface Preparation” region. The existence of a region of 
precursor layers with equal slopes for % mass increase was also witnessed in previous work by 
Roy et al which could be due to the interdiffusion of PDADMAC and PSS layers [45]. After the 
addition of the fourth PSS layer, there is an approximately 2-fold rise in the % mass increase of 
the samples, which leads to the formation of a transition Region II, comprised of layers 3-5. This 
region could potentially be attributed to the onset of the layer buildup phenomenon, where layer 
deposition starts to achieve a certain uniformity. It is clear that in Region III, comprised of layers 
5-8, a significant and much more uniform buildup of layers is observed. In this latter window of 
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layer depositions, therefore, it is believed that the polyelectrolytes transit from an interdiffusion 
of adjacent layers at low deposition number to apparently more well-defined layers at higher 
layer deposition numbers. Further analysis was carried out to confirm this hypothesis. The slopes 
of % mass increase highly depend on the internal surface, material density and surface charge, 
and therefore are different from polymer to polymer even when using the same polyelectrolytes. 
For instance, the three regions observed in Figure 5.4 for PCL were not observed in a previous 
work in this laboratory when depositing the same LbL coating on PLLA and HDPE substrates 
[46]. However, the slopes for the addition of PDADMAC and PSS layers on the PLLA substrate 
in that study are in accordance with the slopes obtained in Figure 5.4 where the addition of PSS 
leads to a higher mass increase than that of PDADMAC.  
 
Figure  5.4: Weight increase (%) of large 3D substrates as a function of the number of deposited 
polyelectrolyte layers in the LbL approach. Odd and even layer numbers represent PDADMAC 
and PSS depositions respectively. Three main regions are detected according to point to point 
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slopes: Region I or the surface preparation region where interpenetration of layers is dominant. 
Region II as an onset for layer buildup phenomenon, and Region III where more well-defined 
layers are established 
 
5.3.2.2 XPS analysis of the layers 
In order to verify the results obtained by gravimetry, a more detailed surface characterization 
study by XPS was performed on the layers deposited by the LbL technique. Samples with four 
and eight deposited polyelectrolyte layers were considered in this experiment. Elemental relative 
compositions of carbon, oxygen, nitrogen and sulfur atoms were quantified according to C 1s, O 
1s, N 1s and S 1s spectra given by XPS. It should be noted that after four or eight layers, PSS is 
the final layer deposited on the structure. In this study, the fourth and eighth layers fall into 
Region II and Region III of Figure 5.4, respectively. Figure 5.5 illustrates the chemical structure 
and molecular formula of PDADMAC and PSS.  
 
Figure  5.5: Chemical structures of PDADMAC and PSS polyelectrolytes 
  
Figure 5.6 summarizes the O 1s:C 1s, N 1s:C 1s and S 1s:C 1s ratios after n=4 and n=8 layers are 
deposited. The XPS apparatus typically provides information about the elemental composition up 
to a maximum of 10 nm from the top surface. Bragaru et al. report on the average thickness of 
individual PSS or PDADMAC layers, on silica as being between 4.5-6.5 nm [47]. Roy et al. 
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report a thickness of 100 nm for 1 layer of PSS, 5 layers of PDADMAC and 4 layers of bovine 
serum albumin. When PSS and PDADMAC films are deposited in the presence of salt, as is the 
case in this study and all the studies reported above, the thickness of the layers has been reported 
to be as high as 15 nm per layer [48]. The thickness of individual PSS or PDADMAC layers 
established on silicon wafers according to the conditions used in this study (polyelectrolyte and 
salt concentrations) was approximately 5.6 nm [48]. Hence, although some XPS signal could 
potentially also be detected from the layer underneath the final layer [25], the principal peaks 
should be from the outer layer.  
 
Figure  5.6: Effect of the number of deposited layers on the atomic composition of the outermost 
layers on the 2D solid disc substrate. n=4 and n=8 both represent PSS as the outermost layer. 
Data shown as mean ± standard deviation, N=3 
 
This XPS study on 2D solid discs comparing layers 4 and 8 is used to confirm the observation 
that layers 5-8 are more distinct as presented in Figure 5.4. Figure 5.6 clearly shows that this is 
the case with a decrease in the N 1s:C 1s ratio (specific to PDADMAC); and an increase in the O 
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1s:C 1s and S 1s:C 1s  ratios (specific to PSS). The O 1s:C 1s ratio increases from 0.25 after the 
deposition of 4 layers to 0.34 after that of 8 layers. This recorded ratio is very close to the actual 
value for the PSS repeating unit molecule which is 0.37. Moreover, knowing that the only source 
for the nitrogen atom in the polyelectrolyte assemblies is the PDADMAC polymer chain, low 
values for the N 1s:C 1s ratio necessarily concludes that the PDADMAC layer is well masked 
below the final PSS layer. A 60% reduction in the N 1s:C 1s ratio after 8 layers as compared to 4 
layers indicates that the level of interdiffusion of PDADMAC polymer chains within those of the 
PSS has been dramatically reduced. Furthermore, the sulfur atom is only specific to the PSS 
repeating unit and, as a result, the higher the value of S 1s:C 1s and the closer it gets to 0.125 
which is the value of the mentioned ratio in PSS molecule, the more distinct the final PSS layer 
becomes and the more homogeneous the negative surface charge is distributed. Figure 5.6 shows 
that the S 1s:C 1s ratio doubles when going from layer 4 to layer 8 again confirming the 
formation of more distinct PSS chains on the PCL surface.  Data in Figure 5.6 therefore support 
the concept presented in Figure 5.4 of poorly defined polyelectrolyte layers 1 to 4 that become 
more well-defined as the number of layers is increased. However, Figure 5.6 demonstrates that 
even at 8 layers a significant level of interpenetration of layers is still occurring. In a recent work, 
Gilbert et al. also used the XPS approach for the analysis of interlayer diffusion in polyelectrolyte 
multilayers (PEMs) [25]. It has been reported that for the case of classic layer-by-layer deposition 
where strong polyelectrolytes such as PDADMAC and PSS are used, discrete polyelectrolyte 
layers are formed [49]. Our surface analysis studies demonstrate that the formation of more 
distinct layers in LbL occurs at higher numbers of layer depositions, whereas interdiffusion of 
layers always exists.  
Having determined the optimal conditions for the LbL self-assembly of polyelectrolytes on the 
co-continuous PCL structure, the quality of the chitosan coating on the final negative layer has to 
be evaluated. To do so, three different cases were considered: 2D solid discs (2D-nonporous) as 
the positive control; top section of 3D porous cubes (Top-3D); and the middle section of the same 
samples (Inside-3D). The amount of chitosan coating on the top section of the scaffold is of 
importance, as it is the first part of the scaffold with which the cells establish initial contact post-
seeding. Obtaining a homogeneous chitosan coating in the middle section of the scaffolds is of 
equal significance as the cells migrate toward deeper levels and therefore has to be taken into 
consideration in this study.   
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Figure 5.7 demonstrates XPS spectra for a 2D solid discs coated with chitosan by the LbL 
technique (LbL-chitosan), where the N 1s peak is evident at 401 eV as compared to 2D solid 
discs of PCL with LbL coating but without the addition of chitosan (LbL-only) where the 
nitrogen peak is present due to the existence of nitrogen containing PDADMAC underneath the 
final PSS layer but it appears to be very weak. The addition of chitosan on the LbL modified PCL 
amplifies the nitrogen on the surface which clearly points to a successful surface deposition. 
 
 
Figure  5.7: Efficiency evaluation of the chitosan layer deposition via the LbL approach on 2D 
solid discs: XPS spectra of neat and 8 layer LbL coated PCL. Nitrogen peak is observed at 401 
eV for the coated sample 
 
Local chitosan deposition by the LbL strategy on two identical 2D solid discs (designated as 
PCL1 and PCL2) is demonstrated in Figure 5.8 according to the same positions (1, 2 and 3) 
depicted in Figure 5.2a.  The XPS results for the N 1s concentration after chitosan surface 
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modification by LbL at the different positions in the disks show that none of the areas sampled 
have zero depositions with the LbL technique and indicate a homogeneous local distribution, as 
opposed to the dip-coating strategy (Figure 5.2b).  
 
Figure  5.8: XPS measurements of the relative nitrogen concentration (%) on two random discs 
(PCL1 and PCL2) at positions 1, 2 and 3 mentioned in Figure 5.2a 
 
Figure 5.9 summarizes the XPS readings of the relative nitrogen concentration % on the 
examined surfaces of 2D-solid, Top-3D porous cube and Inside 3D porous cube samples after 
chitosan surface modification by LbL. According to Figure 5.9, a high level of chitosan is 
detected on the surface of the 2D-solid, Top-3D cube and Inside 3D cube samples. This indicates 
a successful penetration of the LbL chitosan right into the middle of the 3D construct. It can also 
be seen that the nitrogen concentration decreases by 60% in going from 2D-solid to Top-3D cube 
to inside 3D cube. This decrease is expected due to the porous nature of the 3D construct. The 2D 
solid disc has no pores and possesses an even horizontal surface available for chitosan deposition 
and subsequent analysis. In the Top 3D cube sample the surface is porous, i.e. some of the top 
surface is horizontal/flat and the rest of the signal comes from pore depressions along the 
horizontal surface. Lastly the Inside 3D cube sample only provides the porous surface for 
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chitosan deposition and the signal comes from the surface of pores that are oblique to the 
horizontal surface.  
 
Figure  5.9: Effectiveness of chitosan coating by using the LbL approach in 3D porous cubes: 
Relative nitrogen concentration (%) on 2D solid discs (2D-solid) as the positive control; top 
section of 3D porous cubes (Top-3D cube); and the middle section of the same samples (Inside-
3D cube). Data shown as mean ± standard deviation, N=3. Bars with the same symbols (*, #) 
show significant differences with p < 0.05 
   
The X-ray emission at different positions and different depths for 3D porous cubes are illustrated 
in Figure 5.10a. Relative nitrogen concentrations are demonstrated in Figure 5.10b according to 
the positions 1, 2 and 3 and depths A, B and C. Levels D and E were not considered because due 
to symmetry they are redundant with A and B. Our results show a relatively uniform local 
distribution of chitosan with at least 1% relative nitrogen concentration (chitosan) detection at all 
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the scanned points within the cubic construct. Also, the drop in the level of chitosan deposition is 
evident at levels B and C, in comparison to level A (Top-3D). There is no significant difference 
between the amounts of chitosan detected by the XPS at levels B and C. Our results show that 
chitosan can be uniformly deposited on a co-continuous porous structure even at deep levels of 
3D porous cubes with the LbL self-assembly of polyelectrolytes. 
 
 
Figure  5.10: (a) Schematic of the 3D porous cubes with X-ray emission at different positions and 
different depths. (b) Local distribution of the LbL coated chitosan by XPS measurements 
performed at positions 1,2 and 3 and at levels A, B and C. At least 1% of chitosan was detected at 
all the scanned points 
 
5.3.2.3 Scanning electron microscopy 
SEM image on Figure 5.11a provides the morphology of the assembly of 8 polyelectrolyte layers 
with the final addition of chitosan on 2D solid discs. According to this figure, the assembly of 
layers form a microscopically rough surface morphology. The partial detachment of the layers for 
microscopic observation can be attributed to sample cutting by razor. Image analysis on high 
resolution FEG-SEM images demonstrated that the thickness of the multilayer assembly ranges 
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from 550 up to 700 nm.  Considering that the average layer thickness for PSS or PDADMAC is 
between 4.5-6.5 nm per layer [47, 48], the measured thickness in this study could mostly be 
attributed to chitosan. Furthermore, SEM imaging of PCL with the LbL coating (Figure 5.11b) 
clearly demonstrates that the addition of chitosan creates the observed surface roughness. 
According to Deligianni et al., cell adhesion and proliferation of human bone marrow cells 
increased with the level of roughness on hydroxyapatite surfaces [50]. Thus, the surface 
roughness observed in this surface preparation approach may have advantageous effects for the 
adhesion and proliferation of cells.   
 
Figure  5.11: FEG-SEM images of the LbL chitosan coated sample: (a) Microscopic roughness of 
the final layer assembly. An average thickness value of 610 nm was estimated using image 
analysis; and (b) Pore surface of a 3D porous cube after LbL but without chitosan coating. The 
scale bar represents 1 micron 
 
5.4 Conclusion 
To our knowledge, a thorough investigation of chitosan coating on porous PCL constructs using 
LbL self-assembly of polyelectrolytes has never been done. PCL structures of highly controlled 
morphologies using co-continuous polymer blends have been tested via dip-coating and LbL in 
both 2D and 3D for the evaluation of the efficacy of chitosan coating.  Gravimetric 
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measurements, fluorescence microscopy, ToF-SIMS analysis, x-ray photoelectron spectroscopy 
and scanning electron microscopy were used to examine these deposition strategies. The classic 
dip coating technique succeeded in the deposition of chitosan on PCL scaffolds due to the 
intrinsic attraction between the positively charged chitosan and slightly negatively charged PCL, 
but failed to produce homogeneous deposits, and hence areas devoid of chitosan were detected. 
In the layer-by-layer deposition approach, gravimetric measurements revealed the existence of 
three main regions according to the number of assembled layers: a surface preparation region 
comprised of indistinct layers; an onset region for layer buildup; and a more well-defined layer 
region. The existence of these regions was strongly suggested by higher Sulfur/Carbon and lower 
Nitrogen/Carbon ratios for 8 layers of polyelectrolytes as compared to 4 layers reflecting a more 
uniform PSS final layer. The LbL strategy was found to be superior to the dip-coating technique 
since uniform local deposition of chitosan was observed in both 2D solid discs and 3D porous 
cubes at various depths within the scaffolds. SEM imaging revealed that there is a 
microscopically rough coating ranging in total thickness from 550 to 700 nanometers. This layer 
thickness appears to be principally related to the chitosan part of the coating. This study proposes 
an adaptation of the LbL technique as a solution to the existing issues related to chitosan coating, 
such as heterogeneous local distribution in virtually 3D constructs, and provides characterization 
and analysis techniques to support the methodologies used. This work shows that the LbL 
technique of polyelectrolyte deposition followed by chitosan addition provides a route towards 
stable and homogeneous surface modification and has the potential to transform a classic fully 
interconnected porous synthetic PCL polymer material to one with essentially complete chitosan-
like surface characteristics.  In a future work, the produced scaffolds with hydrophilic chitosan 
coating will be put into practice in order to evaluate their potential to support human 
mesenchymal stem cell osteoblastic differentiation and biomineralization.  
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CHAPTER 6 ARTICLE 3: OSTEOGENIC MESENCHYMAL STEM 
CELLS POPULATE 3-D POLY(Ε-CAPROLACTONE) SCAFFOLDS 
WITH INTERCONNECTED PORES AND PREFERENTIALLY 
MINERALIZE LBL CHITOSAN-COATED SURFACES   
 
Having successfully modified the surface of the intrinsically hydrophobic PCL by chitosan, and 
hence giving chitosan a fully interconnected porous microstructure, we will finish this thesis by 
evaluating the osteogenic potential of such hybrid scaffold in bone tissue engineering. The effect 
of pore size as well as that of the chitosan coating is of central attention in this chapter. However, 
since the pore size highly influences the scaffold infiltration behavior as demonstrated in Chapter 
4, optimization of the cell seeding protocol is essential in order to have comparable cell densities 
and distributions within scaffolds of different pore sizes. Therefore, several seeding protocols 
will be presented and assessed in order to obtain the optimal infiltration conditions. Then, 
hBMSCs will be seeded according to the optimal seeding protocol onto the scaffolds of two pore 
sizes (one above and one under 100 μm) in the presence or absence of the chitosan coating. 
Therefore the effects of pore size and LbL surface modification by chitosan on the matrix 
mineralization of hBMSCs during three weeks of osteogenesis are studied via scanning electron 
microscopy, micro-CT, and qualitative/quantitative histological analysis.   
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Poly(ε-caprolactone) (PCL) is a promising but hydrophobic material for bone tissue engineering 
applications. We tested the hypothesis that human bone mesenchymal stem cells (hBMSC) 
seeded in 3D PCL scaffolds with fully interconnected pores of 84 micron or 141 micron average 
diameter show more biomineralization when pore surfaces are coated with chitosan, via Layer-
by-Layer (LbL)-deposited polyelectrolytes. Optimization studies revealed that freshly trypsinized 
hBMSCs best populated all depths of the 1mm-thick scaffolds when seeded at 4°C in a medium 
containing 2% FBS. hBMSCs cold-seeded in scaffolds coated or not with LbL-chitosan were 
cultured for 10 days in proliferation medium then 21 days in osteogenic medium. At day 2, 
hBMSCs formed sparse monolayers with rounded cell morphologies in PCL-only pores, and a 
more spread morphology in chitosan-coated pores. At day 10, cells migrated onto secreted 
collagen networks that filled interpore spaces, proliferated on LbL-chitosan-coated pore surfaces, 
and formed external monolayers. At day 31, a similar level of tissue formed in scaffolds with and 
without LbL-chitosan coating, with higher tissue deposition in edge vs inner pores, and 
significantly more biomineralized matrix in the inner 84 micron pores with LbL-chitosan coating  
(p<0.05). Haphazard mineral deposits formed in outer layers and highly colonized inner 141 
micron pores of all scaffolds. On 2D control surfaces, hBMSCs showed higher alkaline 
phosphatase staining but failed to mineralize on chitosan coatings. This study showed that 
hBMSCs survive, proliferate, and attach to fibrotic matrix rather than the PCL-only scaffold pore 
surfaces. LbL-chitosan-coating guided osteogenesis to the pore surfaces and promoted 
mineralization deeper in smaller-pore size scaffolds. 
Keywords: PCL, 3D, pore size, chitosan, hBMSC, osteogenesis, mineralization, cell infiltration   
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6.1 Introduction   
An important aim and challenge of bone tissue engineering is to develop three-dimensional 
porous constructs that can serve as temporary bone void fillers to repair non-union bone fractures. 
Structurally stable bone voids can self-repair through woven bone growth at the edges of bone 
wounds [1]. In scaffold-assisted repair, a 3D structure needs to serve as a supportive bridge or 
skeleton which due to its specific microstructure facilitates the migration, attachment and 
distribution of the cells involved in vascular bone in-growth and healing of the target defect [2]. 
Biocompatibility, biodegradability, mechanical properties, surface chemistry and highly 
interconnected porous networks with adequate pore size and pore size distributions can influence 
the performance of a substitute bone graft [3-7]. Transitioning from an inert scaffold to a living 
tissue requires osteoconduction, or new bone deposition on the scaffold surface. Cues that guide 
stem cells to deposit bone on the scaffold inner surfaces are still under investigation. 
Poly(ε-caprolactone) (PCL) shows much promise as a bone scaffold polymer for its 
biocompatibility, high toughness, ability to support early loads, and slow biodegradability [8, 9]. 
PCL scaffolds fabricated using a unique melt-blend approach were previously shown to create 
fully-interconnected pore structures with discrete pore diameters from 40 to 200 µm [10], and 
present novel scaffolds for bone reconstruction; however the ideal pore size for obtaining in vitro 
mineralization is unclear. One purpose of the current study was to test the hypothesis that 
osteogenesis can take place in the 3D environments created by co-continuous PCL scaffolds of 
different pore sizes (84 or 141 µm pores). Nevertheless, the hydrophobic nature of PCL makes it 
an unfavorable surface for cell adhesion and growth, and therefore needs to be altered by the 
proper surface modification technique [11, 12].  
To improve cell attachment to PCL, the polymer surface can be rendered hydrophilic (plasma 
treatment, UV/ozone grafting, aminolysis) [13-16], or by immobilization of bioactive agents 
(Arg-Gly-Asp (RGD), adenoviral Runx2, bone morphogenetic protein-2, BMP-2) [17-19]. Layer-
by-Layer (LbL) self-assembly of polyelectrolytes has also been used to deposit hydrophilic 
compounds on the surface of PCL fibers and films [20, 21]. Chitosan is a cationic linear 
polysaccharide used in wound dressings and drug delivery [22-25], and was also shown to 
support the attachment, proliferation, and end-stage differentiation of human mesenchymal stem 
cells to osteoblasts [26, 27]. Since chitosan is not melt-processable because of its low degradation 
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temperature which occurs before melting, production of chitosan scaffolds has been limited to 
solution-based fabrication techniques such as phase separation and lyophilization [26]. 
Furthermore, chitosan can be deposited uniformly on PCL pore surfaces using an LbL approach 
(Ghavidel Mehr et al, submitted). When chitosan is incorporated on a PCL scaffold produced by 
melt-processing, chitosan is given the versatile skeletal design as well as the more robust 
mechanical properties of the PCL polymer. 
Although many cell infiltration protocols have been developed for 3D scaffolds [28, 29], static 
seeding remains the most common method, despite low seeding efficiencies as well as poor cell 
distribution [30]. Although strenuous efforts have been made to overcome these limitations, in 
dynamic, vacuum, magnetic, electrostatic, and centrifugal seeding, static seeding is still the 
preferred approach for scaffold infiltration due to its simplicity. In this study, we developed an 
innovative modification of static cell seeding to obtain a more uniform initial cell infiltration, to 
test the hypothesis that an LbL-chitosan coating promotes human primary bone mesenchymal 
stem cell (hBMSC) cell attachment, extracellular matrix deposition and mineralization in the 
three-dimensional environment.  
 
6.2 Materials and methods 
6.2.1 Materials 
 Commercial-grade poly(ε-caprolactone) (PCL, CAPA 6800) was supplied by Solvay (Brussels, 
Belgium). Poly(ethylene) oxide (PEO) water-soluble polymers (POLYOX™ WSR-N10) was 
purchased from Dow (Midland, MI, USA). Poly(dialyldemethylammunium chloride) 
(PDADMAC), Mw 100000–200000, and Poly(sodium 4-styrenesulfonate) (PSS), Mw 70000 were 
purchased from Sigma-Aldrich. Chitosan (DDA=98% and Mw=237,000, <500 EU, <0.2% protein 
and <5ppm heavy metals) free-base powder was generated from raw materials and characterized 
by the Biomaterials and Cartilage Laboratory (BCL) at École Polytechnique de Montréal. 
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6.2.2 Scaffold fabrication 
As previously described [31, 32], PCL and PEO blend components were melt-blended at the co-
continuous composition of 45PCL/55PEO vol% in a Brabender internal mixer at 100°C for 7 min 
with the rotation speed of 50 rpm and under a constant flow of dry nitrogen, then the blends were 
immediately quenched in liquid nitrogen to freeze-in the morphology. The blends were then 
annealed at 160°C in a compression molding press under a constant flow of nitrogen for one and 
two hours. Annealed samples were then quenched in liquid nitrogen and shaped into discs of 3 
mm in diameter and 1.5-2 mm in thickness, by using a mechanical punch and a fresh razor blade. 
PEO was finally selectively extracted in 50 mL deionized water for 7 days under agitation at 
ambient temperature, leaving a microporous structure. One and two hour annealing of the 
samples led to the production of scaffolds with 84 and 141 micron average pore diameter, 
respectively as determined by mercury intrusion porosimetry [10]. PCL scaffolds were 
designated as PCL1 (84 micron) and PCL2 (141 micron).  
 
6.2.3 Surface modification of PCL via LbL self-assembly 
Aqueous 10 mg/mL solutions of PDADMAC (polycation) and PSS (polyanion) were used as 
polyelectrolytes. PCL discs were first incubated in PDADMAC solution of pH=8 for an hour, 
rinsed in deionized water, then exposed to alternating polyelectrolyte solutions of opposite 
charges in 1 M NaCl, pH=2 for 1 hour until the eighth layer is deposited corresponding to the 
negatively charged PSS outermost layer. After each polyelectrolyte deposition, an hour of water 
rinsing was performed to remove the unbound polyelectrolyte material. Metal wires were used to 
keep the discs submerged in the solutions and water at all times. Samples with negatively charged 
surface were then sterilized in 70% v/v ethanol, rinsed in water 3 times, dipped in 0.22 µm filter 
sterilized 0.2% w/v chitosan HCl solution with a positive charge at pH=4 for 4 hours under slow 
shaking as the concluding layer followed by rinsing in sterile deionized water for 1 hour.  
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6.2.4 Scaffold characterization by micro-computed tomography (µ-CT) 
Scaffolds were freeze-dried, stacked vertically with thin separators in tubes made from yellow 
pipette tips and scanned (Skyscan-1172, version 1.5, Belgium) at 33 kV, 198 μA, 5 μm pixel size; 
no filter applied; 0.42° rotation step and 3s frame averaging. Each scan lasted ~30 min. 3D 
sample reconstruction was carried out using NRecon software (version 1.6.2.0; Skyscan), and 
data analyses performed by CTAnalyser software (version 1.10.1.1; Skyscan). 
  
6.2.5 Cell expansion and static cell seeding 
Under institutional-approved protocols, hBMSCs from bone marrow aspirate from a single 
healthy consented donor at passage 2 were purchased from Texas A&M Institute for 
Regenerative Medicine (Temple, TX, USA). Primary cells were cultured and expanded in tissue 
culture flasks at 37 °C in a humidified atmosphere of 5% CO2 in complete culture media (CCM): 
alpha minimum essential medium (αMEM, Invitrogen, Life Sciences, Burlington, Ontario), 16% 
fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA, USA), 2 mM L-glutamine (Sigma-
Aldrich), and 100 units/ml Penicillin/100 μg/ml Streptomycin (Sigma-Aldrich). The cells were 
passaged twice before seeding in the scaffolds. Scaffolds were sterilized in 70% ethanol for 1 
hour and rinsed 3 times in sterile water, air-dried overnight and fully sealed into sterile Petri 
dishes until further use.  
A cell infiltration protocol was optimized with 140 µm scaffold discs, 3 mm diameter and 1 mm 
thick, press-fit into 3 mm diameter holes generated with a biopsy punch in sterile 2% agarose 
solidified in 24-well culture plates, as previously described [10]. Three different seeding 
protocols using 250,000 freshly trypsinized hBMSCs were investigated: 1) classic seeding of 
cells in 25 µL warm CCM with 16% FBS then incubated for 2 hours at 37°C, 2) cold seeding 
with cells in 25 µL in 2% FBS medium at 4°C, incubated at 4°C for 1 hour, then at 37°C for 2 
hours; 3) a 2-step seeding protocol, where 12.5  µL with 125,000 cells is applied twice with a one 
hour interval at room temperature, followed by 2 hours at 37°C. N=3 scaffolds were tested for 
each seeding protocol. Scaffolds were covered with medium at all times. After seeding, scaffolds 
were transferred to 24-well culture plates, and % escaped cells in the seeding plate determined 
indirectly by AlamarBlueR assay (Invitrogen). Seeded scaffolds were cultured overnight, fixed in 
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4% paraformaldehyde in PBS for 20 minutes, stained with Hoechst 33342 (Invitrogen), and cut 
transversely in half, for fluorescence microscopy of cell nuclei retained at the scaffold surface, 
using a Zeiss AxioVert S100 microscope, QImaging QICAM FAST 1394 digital camera and 
Northern Eclipse software (Empix, Mississauga, Ontario, Canada), and for imaging the 
transverse cut plane with an Olympus FV1000-IX81 confocal microscope system. The cross-
section of the scaffold image was divided into top, center and bottom levels, and the cell nuclei in 
each level counted by automated counting using ImageJ software. The percentage of cells 
observed at each level was calculated with respect to the total number of counted cells at all the 
levels, considering that 33% of all cells should ideally populate each of the three different 
penetration depths. The deviation from the homogeneity (i.e., 33%) at each level is calculated 
similarly to the calculation of the standard deviation according to the following general equation: 
            
          
   
  
 
 
 
 
  
        
where            is the deviation from homogeneity,          is the average percentage of cells 
observed at the specific level.   is number of level sections in the scaffold thickness (L=3) and N 
is the total number of samples studied (N=3).   
 
6.2.6 Osteogenic culture in 2D and 3D 
For 2D monolayer control cultures, 33 µL filter-sterile chitosan (0.5 µg/mL) was allowed to air-
dry in 96 well plate a sterile laminar flow hood. 150 µL of CCM containing 600 live trypsinized 
hBMSCs were seeded on chitosan-coated and uncoated wells. For 3D cultures, 250,000 hBMSCs 
in 25 µL of media were cold-seeded in PCL1 and PCL2 scaffolds press-fit in sterile agarose 
wells, as described in section 6.2.5. The scaffolds were transferred to 96-well plates and 200 µL 
of CCM added. The medium for both 2D and 3D cultures was changed twice weekly for 10 days, 
then the medium was replaced with an osteogenic medium containing CCM supplemented with 5 
mM disodium β-glycerophosphate, 100 µM L-Ascorbic acid 2-phosphate and 10 nM 
dexamethasone (all from Sigma-Aldrich), and changed twice a week until day 31. Some samples 
were observed to become flipped during medium replacement. 2D cultures were stained at days 
10 and 31 for in situ alkaline phosphatase and alizarin red. 3D discs were harvested at days 2, 10 
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and 31 for ESEM, micro-CT, and histological evaluations. At harvesting, scaffolds with any 
monolayer attached were carefully scraped from the well bottom with a small weigh spatula then 
fixed in 4% paraformaldehyde in PBS (pH=7.4)  for 20 min and rinsed 3X in PBS.   
 
6.2.7 Microscopic evaluations using environmental scanning electron 
microscopy (ESEM) 
2% glutaraldehyde-fixed PCL1 and PCL2 samples from culture days 2, 10 and 31, and unseeded 
scaffolds cultured in parallel, were cut in half using a fresh razor, rinsed in water, air-dried and 
gold coated using plasma deposition and imaged (ESEM, Quanta 200 FEG, FEI Company, Czech 
Republic) under high vacuum pressure mode and at a voltage of 20kV.  
 
6.2.8 Histology and quantitative histomorphometry 
Scaffolds were cryoprotected in graded sucrose solutions, embedded in Tissue-Tek OCT (4583S, 
Cederlane, Hornby, Ontario, Canada), and cryosections 10 µm thick collected using the CryoJane 
tape transfer system. Sections were stained with hematoxylin and eosin (H&E), and alizarin red. 
Sections were either dried overnight and mounted directly in Permount® to retain PCL or carried 
through toluene which cleared the PCL. Images were obtained with a Zeiss Axiolab microscope 
equipped with a digital Hitachi HV-F22F camera. 
Histomorphometric analyses were performed by 2 blinded observers (N.G.M. and G.C.) on H&E 
and AR stained sections from N=4 distinct day 31 scaffold samples per condition, with day 2, 
with day 10 and cell-free scaffolds as negative controls. 10x magnification images were taken 
systematically from the corner of each PCL cross-section with the highest cell density, then 
regions of interest were cropped: “edge” containing the 300 µm thick scaffold top and side-wall 
excluding any monolayer growing on the surface, and “inner” rectangular area 300 µm to 600 µm 
deep in the scaffold.  An ImageJ plug-in was used to adjust the HSV thresholds to quantify 
positively stained pixels distinct from background stain. It was assumed that the regions stained 
pink or purple with H&E constitute tissue and those stained dark red with AR were calcium 
deposits. The percentage of in vitro tissue (H&E stain, matrix %) and mineralized matrix (AR 
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stain, mineral %) was determined by dividing the stained pixels by the total pixels in the image 
by an in-house MATLAB (Mathworks) routine (R2011a) [33].  
 
6.2.9 Statistical analyses 
The mean and standard deviation were calculated for each dataset. Student’s t-test was used to 
analyze differences between two experimental groups. p<0.05 was taken as statistically 
significant. 
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6.3  Results 
6.3.1 Scaffold structural characterization with and without LbL-chitosan 
µ-CT scans of PCL scaffolds with 84 and 141 micron pore size (PCL1 and PCL2, respectively) 
showed a relatively uniform 3D structure of interconnecting pores (Figure 6.1(a, b)). The 
unmodified PCL scaffolds showed smooth pore surfaces after 2 days incubation in CCM (Figure 
6.1(c-f)), that after LbL-chitosan surface modification changed to a rough microstructure (white 
arrows, Figure 6.1 (g,h)). The irregular structure of the LbL-chitosan coating may be partly due to 
aldehyde fixation, which leads to chitosan aggregates via inter- and intra-chain cross-links of free 
amine groups [34]. These results demonstrated that the LbL-chitosan coating was effectively 
deposited throughout the PCL scaffold at both pore sizes.  
 
 
Figure  6.1: (a, b) Micro-computed tomography and (c, d) SEM images exhibiting the 
macrostructure of the scaffolds. SEM micrographs showing the surface topography of the 
samples of (e, f) pure and (g, h) chitosan modified PCL surface. The panels correspond to PCL1 
(a, c, e, g) and PCL2 (b, d, f, h). The pore surface topography of PCL demonstrates a change 
from smooth toward rough microstructures for both PCL1 and PCL2.  White arrows represent 
chitosan layer aggregates. Scale bars (c to h) are 5 to 100 microns, as indicated. 
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6.3.2 Cold seeding improves cell seeding distribution in PCL scaffolds   
Scaffolds with Hoechst-stained cell nuclei were analyzed at day 1 post seeding by top and 
transverse views, following classic, cold, and 2-step methods (Figure 6.2). The white contours in 
panels A-C represent “clean” areas on the scaffold surface in which the cells have freely 
penetrated through and left the top surface, and settled in the pores. Cold-seeded cells with 2% 
serum penetrated to the deeper pores (open arrowheads, Figure 6.2e), and escaped through the 
scaffold to the bottom of the culture well (Figure 6.3a) leading to 13.6 % deviation from the ideal 
33% cell distribution in each of the 3 layers (Figure 6.3b). Cells seeded at 37°C (1-step or 2-step 
seeding) collected mostly at the surface (white arrowheads, Figure 6.2(d, f)). The 2-step seeding 
procedure led to the lowest number of escaped cells (Figure 6.3a), and the highest % deviation 
from 33% cell distribution at different penetration depths (Figure 6.3b). These data showed that 
cold-seeding generates the most uniform cell distribution in the scaffold. 
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Figure  6.2: Fluorescent images of the Hoechst stained hBMSCs on the seeding area, where white 
contours represent the top view porous areas where the cells have freely penetrated through and 
completely left the top surface (a-c) or infiltrated the depth of the scaffold cross-section (d-f), as 
shown by confocal images of the Hoechst stained cells in the rectangular cross section of PCL2 
scaffolds. The panels represent classical seeding at 37°C (a, d), cold seeding at 4°C with 2% FBS 
(b, e) and 2-step seeding at 37°C (c, f). Cold seeding exhibits the most uniform cell distribution 
across the PCL scaffold. Scale bar = 1 mm 
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Figure  6.3: (a) AlamarBlue® metabolic assay as an indirect method to compare the number of 
cells that completely passed through the PCL2 scaffolds seeded with different seeding protocols: 
classical seeding at 37°C, cold seeding at 4°C with 2% FBS and 2-step seeding at 37°C. The cold 
seeding protocol with 2% FBS demonstrates the highest number of escaped beads which 
corresponds to the best cell penetration. The classical seeding protocol gave lower escape than 
cold-seeding and higher than the 2-step condition (P < 0.05); and (b) Average percentage of cell 
numbers counted at each penetration depth for each seeding protocol. α is the deviation from 
homogeneity of cell distribution at each penetration depth calculated. The homogeneity 
percentage for three penetration depth is 33%. The cold seeding protocol with 2% FBS displays 
the lowest deviation from homogeneity. 
 
6.3.3 Cell attachment, proliferation and matrix deposition 
hBMSCs cold-seeded and cultured 2 days in 3D scaffolds in proliferation medium had a rounded 
morphology with thin filopodia anchored to the PCL-only pore surfaces (Figure 6.4a), and a 
spread morphology on chitosan-coated pore surfaces (Figure 6.4b), for both 84 and 141 µm pore 
sizes.  
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Figure  6.4: ESEM micrographs of hBMSCs on (a) uncoated and (b) chitosan coated pores of PCL 
at day 2. Isolated hBMSCs (thick arrow) form rounded morphologies with filopodia (thin arrows) 
on the uncoated pores, whereas they fully spread on the chitosan coated pores of the scaffold. 
 
After 2 days in culture, hBMSC cell clusters were observed in larger PCL2 pores (Figure 6.5(i, 
m), with heavy deposition of ECM fibers and sheets along chitosan-coated pore surfaces (Figure 
6.5(a, e)). In the 84 micron PCL1 scaffolds, hBMSCs were more restricted to top edge pores 
(white rectangle, Figure 6.5e). Sparse cells with round morphologies were detected on 
unmodified PCL1 pore surfaces, with and without chitosan coating (Figure 6.5(a, b)). These data 
suggest that cells thrive and take root as colonies rather than isolated single cells, given the more 
elongated and spread features with ECM accumulation in highly colonized areas in the PCL2 
scaffolds (Figure 6.5(i, j)). Cells were found to rapidly secrete a fibrous matrix in unmodified 
PCL pores (Figure 6.5(b, c, j, k)), and to adopt a more fully elongated and packed morphology in 
flattened sheets on the LbL-chitosan coated PCL surfaces (Figure 6.5(f, g, n, o)). Some hBMSCs 
appear to be partly detached from the surface of LbL-chitosan modified which could be due to 
likely detachment of chitosan from the surface by pulling forces of the contractile apparatus of 
the hBMSC (open arrowhead, Figure 6.5g). At day 31, rubbled surfaces were observed that may 
represent mineralized matrix (Figure 6.5(h, p)). 
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Figure  6.5: ESEM images of the pore interspacial area for (a-d) PCL1, (e-h) chitosan surface 
modified PCL1, (i-l) PCL2, (m-p) chitosan surface modified PCL2. The panels represent PCL 
scaffolds cultured at day 2 (a, b, e, f, i, j, m, n), day 10 (c, g, k, o) and day 31 (d, h, l, p). White 
rectangle in panel E upper zone represents the fully colonized area. Thin arrows represent 
collagen fibers and ECM sheets, whereas thick white arrows illustrate hBMSCs. White arrow-
heads represent pores with dense ECM fibers. The open white arrowhead in panel G illustrates 
the likely detachment of the chitosan layer. Scale bar in panels (c, d), (b, f, g, j, k, n, o), (h, l, p), 
(a, i), and (e, m) = 5, 10, 20, 50 and 200 microns, respectively 
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According to H&E stained sections at culture day 10, hBMSCs colonized ECM filling the 
unmodified PCL pores (white arrowheads, Figure 6.6(a, e)), while in chitosan-coated pores, 
hBMSCs were detected both in pore ECM and on pore surfaces (black arrowheads, Figure 6.6(b, 
f)). At day 31, cells formed thick outer layers that showed ingrowth into the edge pores with less 
infiltration in the inner pores (dashed rectangle, Figure 6.6(c, g)). The surface modification by 
chitosan led to a homogeneous matrix deposition all across the scaffold thickness (Figure 6.6(d, 
h) versus (Figure 6.6(c, g)).  
 
 
Figure  6.6: Histological images of H&E stained extracellular matrix illustrating the rectangular 
cross section of (a-d) PCL1, (e-h) PCL2, at (a, b, e, f) day 10 and (c, d, g, h) day 31 in the (a, c, e, 
g) absence and (b, d, f, h) presence of chitosan coating. hBMSCs on the ECM in the pore 
interspace area and on the pore surface is represented by white and black arrow-heads. The black 
rectangle represents the depth of the constructs. At day 10, hBMSCs in unmodified scaffolds 
prefer to remain on the deposited matrix in the space between the pores, whereas they spread on 
the pore surface of chitosan coated scaffolds. At day 31, chitosan coated scaffolds exhibit a more 
uniform matrix deposition across the scaffold. Panels a, b, e, f: dry-mount sections to retain PCL 
scaffold (S). Panels c, d, g, h: toluene-extracted PCL scaffold (ES). White arrowheads: interpore 
cells. Black arrowheads: cells adhering to pore surfaces. Scale bar = 100 microns 
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6.3.4 Histological analysis of matrix mineralization 
At day 10, constructs showed no sign of calcium deposits (Figure 6.7(a, b, e, f)). Therefore, 
chitosan was insufficient to accelerate osteogenesis in the absence of dexamethasone. At day 31, 
punctate matrix calcification was detected in PCL-only scaffolds, mainly in the outer monolayers 
of the PCL1-only scaffolds (Figure 6.7c) and larger PCL2 edge pores containing MSC aggregates 
(white rectangles and arrows, Figure 6.7g).  These data show that mineralization in unmodified 
PCL scaffolds only occurs in areas where the scaffold is highly colonized. A similar outer layer 
of calcified matrix was detected in chitosan-coated scaffolds, along with a more uniform punctate 
calcification of inner pores (white rectangles and arrows, Figure 6.7(d, h)). Data in Fig 6.7(d, h) 
suggest that mineralization in LbL-chitosan scaffolds occurs by the hBMSCs depositing a 
collagenous matrix on the surface of the pores that is competent to calcify. Thus, chitosan guides 
the osteogenic process. Micro-CT images of LbL-chitosan modified PCL1 and PCL2 scaffolds 
(Figure 6.7(i, k)) show evidence of mineral deposition at the edges (thick white arrows). 
However, minerals could not be detected deep inside the scaffolds most probably due to the 
similar radio-opacity of PCL and minerals (see outer mineralized layer, thin white arrows, Figure 
6.7(i, k)).  
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Figure  6.7: Alizarin red stained (a-d, J) PCL1 and (e-h, L) PCL2 sections at (a, b, e, f) day 10 and 
(c, d, g, h, j, l) day 31 in the (a, c, e, g) absence and (b, d, f, h, j, l) presence of chitosan coating. 
White dashed rectangles represent the areas inside the PCL scaffolds where minerals are 
observed. Thick white arrows show the deposited calcium nodules; micro-CT images of chitosan 
surface modified (i) PCL1 and (k) PCL2 scaffolds. Thin and thick arrows respectively represent 
an outer skin of partly mineralized ECM, and likely minerals at the periphery of the scaffolds.  
Minerals are deposited in the highly colonized top and inner sections of uncoated PCL1 and 
PCL2 scaffolds, whereas they were deposited along the surfaces of the edge and inner pores in 
chitosan coated samples. Scale bar for panels (a-h, j, l) = 100 microns 
 
3-fold more tissue was detected in outer pores of uncoated samples at day 31, with the highest 
ECM in the outer pores of PCL2 samples (12% vs. 7% other conditions, p<0.05, Figure 6.8a). 
Around 2% to 4% ECM formed in deeper levels of the scaffolds (white bars, Figure 6.8a). More 
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mineralized tissue was observed in the edge (0.3% to 1.5%) compared to inner pores in uncoated-
PCL1 and PCL2 (0.02% to 0.7%, Figure 6.8b).  
 
Figure  6.8: (a) Extracellular matrix % on the edge and in the depth of the sections for PCL1 and 
PCL2 scaffolds in the presence or absence of chitosan coating according to quantitative 
histomorphometry. Although chitosan coating does not significantly affect the amount of ECM 
deposited, the formation of ECM becomes more uniform across the surface-modified scaffolds; 
(b) Mineral % on the edge and in the depth of the sections for PCL1 and PCL2 scaffolds in the 
presence or absence of chitosan coating. There is a significant increase in the mineral % on the 
edge and in the depth of PCL1 scaffolds by modifying the surface with chitosan. This effect was 
not significant for PCL2 discs. Statistical significance was observed for (*, §) and (#, $, @) 
conditions at p < 0.005 and p<0.05, respectively 
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Compared to the unmodified PCL1, LbL-chitosan coated PCL1 scaffolds showed 5-fold higher 
Ca2+ deposition in the edge pores, and 12-fold more in the inner pores (p<0.05, Figure 6.8b). 
Although a similar trend for higher % mineral deposition was observed for the chitosan-coated vs 
uncoated PCL2 samples, no statistical significance was found between the data, mainly due to 
sporadic calcification in some highly colonized uncoated PCL2 pores. 
In 2D monolayer control osteogenic cultures, chitosan enhanced alkaline phosphatase activity 
compared to tissue culture plastic (Figure 6.9(a, c)). However, chitosan was unable to guide the 
hBMSCs towards the terminal osteoblast differentiation, since the mineralization was suppressed 
by chitosan as shown in Figure 6.9(b, d).  
 
Figure  6.9: (a, c) Alkaline phosphatase and (b, d) alizarin red staining of the 2D cultured 
monolayer hBMSCs at day 31 in the (a, b) absence and (b, c) presence of chitosan coating on the 
wells. Although there is an increase in the ALP activity of the cells, chitosan suppresses the 
matrix mineralization 
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6.4  Discussion 
This study reports the novel effects of LbL-chitosan coating in promoting a more uniform 
mineralization in 84 micron PCL scaffold pores. The result was achieved in part by using an 
optimized cold cell-seeding protocol. In previous work, we observed that cell aggregation during 
static seeding prevents cells from infiltrating the interconnecting pores whereas 10 micron latex 
beads show good penetration for scaffolds with at least 80 micron pore diameter [10]. Cold 
seeding reduces metabolic activity and a lower 2% FBS potentially reduces PCL surface 
biofouling, allowing cells to behave more like individual inert beads.  
The rounded hBMSC morphology of isolated cells in unmodified PCL scaffolds in this study is 
in accordance with a previous observation of rounded morphologies of L929 mouse fibroblasts 
on electrospun PCL scaffolds [35]. It is well established that cell-biomaterial interactions can 
influence ECM and mineral deposition, hence biomaterial properties can influence hBMSCs to 
differentiate to osteoblasts [36]. In this study, we show that hBMSCs tend to migrate onto the 
freshly secreted collagen fibers in the space-filling area of the pores rather than remain on the 
hydrophobic PCL surface after 10 days of culture in CCM. Cell proliferation in these 
hydrophobic niches led to mineralization in some pores, without requiring cell attachment. By 
contrast, chitosan coated PCL surfaces drive the cells to form active attachments on the surface of 
the pores through fully elongated morphologies even in the smaller pore size scaffold. Cell 
adhesion to the chitosan coating can significantly promote mineralizing behavior and physical 
interfacing of the cells and scaffold.  
Pure or surface-modified 3D PCL scaffolds with or without the incorporation of bioactive agents 
such as Bone Morphogenetic Protein-2 (BMP2) and RGD have already been tested for in vitro 
osteogenesis [37-40]. These previous investigations most often examined either the cell response, 
or the scaffold morphology, and few studies carefully characterized or quantified the ability of 
hBMSCs to biomineralize in a 3D environment. Previous studies analyzed PCL scaffolds 
impregnated with osteoconductive materials such as hydroxyapatite to improve mechanical 
properties required for cortical bone repair [41], but there is still a lack of knowledge regarding 
the cell/PCL interaction and biomineralization in pure 3D PCL scaffolds seeded with hBMSCs. 
Low levels of mineralization have been generally associated with pure PCL scaffolds pre-seeded 
with various cell types including hBMSCs [41-43]. Our results clearly show that even the 
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hydrophobic PCL can stimulate a disorderly in vitro biomineralization process, in ~5% of the 
matrix area (i.e., 0.3% mineral for 7% tissue formed, Figure 6.8). Although the distribution of 
minerals at the outer and inner pores of the scaffolds is a determining factor for osseointegration 
of the scaffolds in vivo [44], to our knowledge, the investigation of pore size in vitro, in 3D PCL 
constructs has seen little activity. In this study, we showed that a change in the pore size could 
not independently induce biomineralization. This is in agreement with the results obtained by 
Akay et al. who showed that the pore size has minimal effect on in vitro bone ingrowth [45].     
Chitosan improved the formation of mineral deposits in the lower pore size, however the effect is 
less pronounced in PCL2 scaffolds (Figure 6.8b). BMSCs have previously been shown to exhibit 
higher levels of osteogenic differentiation of in 3D as opposed to 2D systems [46]. The weaker 
biomineralization of larger pore sizes could be related to suppressed mineralization of chitosan-
coated 2D surfaces (Figure 6.9). It was previously shown that hBMSCs are capable of ingesting 
chitosan particles in a 2D system, which interferes with biomineralization [47]. Therefore, it is 
possible that in our system, the less curved surfaces of PCL2 mimic a 2D suppressed osteogenic 
behavior, while the more highly curved pore surfaces of PCL1 scaffolds could potentially 
interfere with the ingestion of chitosan particles.  
The deposition of minerals across the chitosan-coated scaffolds is non-uniform and accounts for 
approximately 20% of the matrix area (i.e., 1.6% mineral for 7% tissue formed), and the low 
mineral signal in micro-CT images of Figure 6.7(i, k) is consistent with sparse mineral deposits. 
In a study by Abrahamsson et al, 3D PCL scaffolds with pore dimensions similar to and larger 
than those in our PCL2 scaffolds were used to demonstrate qualitatively that hBMSCs can 
deposit mineral [37], in agreement with our findings for PCL-only scaffolds. Chastain et al. 
investigated the osteogenic differentiation of hBMSCs on 2D and 3D PCL substrates and 
speculated that vitronectin, a serum protein, may be adsorbed to PCL surfaces and inhibit 
biomineralization [48], although quantitative mineralization assays were not done. The lack of 
mineral deposition in the deeper levels of unmodified PCL scaffolds in our study, brings us to 
speculate that the migration of hBMSCs onto the ECM fibers and sheets (Figure 6.6(a, e)) and the 
lack of a solid osteogenic ground for the cells to adhere to inhibits the mineralization process. 
This study is the first to report the effect of chitosan surface modification of porous 3D PCL 
scaffolds on the in vitro osteogenic behavior of osteoprogenitor cells. Yang et al. demonstrated 
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that chitosan incorporated inside PCL electrospun nanofibers improved the adhesion, 
proliferation and calcification of calvarial MC3T3-E1 preosteoblasts [49]. However, the 
influence of the pore size and chitosan on the mineralization of the stem cells was not 
independently investigated. Our study proved that a 3D PCL scaffold alone and chitosan-coated 
2D culture cannot actively promote the process of matrix mineralization; our results clearly 
demonstrate that the combinatory effect of chitosan and porous PCL structure specifically at the 
lower pore size can highly improve mineral deposition.  
The limitations regarding the sporadic deposition of minerals inside chitosan coated constructs 
emphasize that the in vitro static cultures in 3D PCL scaffolds are insufficient for achieving a 
biomechanically stable bone formation. Therefore, given the cost and limitations of perfusion 
bioreactors, it would be necessary to further develop an in vivo system in which vasculature can 
form and invade the 3D PCL scaffold, which may require at least 100 μm and potentially up to 
600 μm [50]. Therefore, although a better in vitro performance was observed for 84 μm scaffolds 
in the presence of chitosan, PCL scaffolds of 141 μm may show better performance in vivo. This 
hypothesis will be verified in a future work.  
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CHAPTER 7 GENERAL DISCUSSION 
This research study involved many unknown parameters starting from finding suitable materials 
for the fabrication of the scaffolds to the surface modification protocols, to the in vitro osteogenic 
assays. Therefore, developing the project from scratch and optimizing the experimental methods 
in order to achieve unbiased data were always accompanied by scientific and technical issues 
which had to be overcome in every single step. This chapter concentrates on the problems 
encountered during this thesis. According to the works done, three major categories are going to 
be discussed in this section: PCL scaffold fabrication and infiltration studies, surface 
modification of PCL scaffolds and finally osteogenic potential of the surface modified PCL 
scaffolds. 
7.1 PCL scaffold fabrication and infiltration studies 
The choice of PEO as the porogen phase was because of its water solubility as a factor that 
eliminates the issue of solvent toxicity. Due to the immiscibility of PCL and PEO, the use of PCL 
greatly facilitated the production of porous PCL scaffolds. However, we had first considered the 
production of PLA scaffolds. In that case, PEO could not be used as the porogen phase due to its 
partial miscibility with PLA. The morphology of non-annealed PLA-PEO samples as compared 
to PCL-PEO both at 50/50 vol% composition is demonstrated in Figure 7.1. Although sparse 
pores are observed on the surface of the partially miscible PLA/PEO blend after solvent 
extraction, the co-continuous morphology (pore interconnectivity) cannot be reached. 
 
Figure  7.1: SEM microstructure of a) 50PLA/50PEO vol% and b) 50PCL/50PEO vol%. Scale bar 
= 10 microns 
a b 
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This is also in accordance with the results obtained by (Nijenhuis et al., 1996). Selection of 
another porogen phase could potentially need another solvent which could not have been as 
biocompatible as water. Therefore, we decided to change the polymer of interest according to the 
works in the literature without compromising the biocompatibility of the system.  
However, the problems also existed even in the case of the PCL/PEO blend. The coarsening 
phenomenon achieved by the static annealing after the melt blending was carried out at 160°C 
which is 100°C higher than the melting temperatures of both PCL and PEO. The reason for the 
use of such high temperature is the fact the PCL/PEO blend appears to resist the coarsening 
phenomenon at lower temperatures and short annealing times (lower than 30min). SEM 
micrographs in Figure 7.2 demonstrates how the blend resists phase growth at 100°C and for 
annealing periods up to 30 min, which itself is considered to be a long time as compared to the 
reaction of other polymer blend systems to annealing. As a result, in order to achieve the required 
morphology for the production of scaffolds, the annealing times and temperature were 
respectively increased to 160°C and minimum 30 min, which led to the formation of pore sizes 
adequate for the bone tissue engineering application, as demonstrated in Figure 4.2.  
 
Figure  7.2: Resistance of co-continuous PCL/PEO blend to annealing at 100°C. (a) non-annealed; 
(b) t= 20 min; and c) t= 30 min 
 
  
Knowing that virtually all the PEO in the annealed samples is extracted according to the results in 
Table 4.2, the scaffolds produced by 45PCL/55PEO vol% blends possess 55% porosity. 
Although the porosity of the scaffolds could have increased by partial extraction of PCL, or the 
incorporation of a third component to the system, we decided to keep the porosity unchanged. 
a b c 
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This was because adding the porosity as another variable to the system would just overcomplicate 
this study. Although some studies report the neutral effect of porosity on in vitro osteogenesis, 
Takahashi et al. explained that lower porosities could in fact stimulate the osteogenesis due to 
cell aggregation (Itoh et al., 2004; Takahashi & Tabata, 2004). Our study only considered the 
effect of pore size at constant porosity. However, considering the effect of porosity and 
investigating more complicated morphologies could be a route to future works, which is 
discussed in the next section. 
In order to investigate the effect of pore size on the infiltration of scaffolds by beads, several 
attempts have been done which failed due to the fact that the bead suspension escaped from the 
edges of the discs onto the culture plate. This led to a false reading of the number of beads that 
were supposed to fully pass through the scaffolds, and also caused a lot of variations in the data. 
In order to settle this issue, the agarose gel setup was devised as mentioned in Chapter 4 in order 
to confine the edges of the discs and only allow for the longitudinal penetration of beads/cells by 
gravity. 
In order to verify how closely the beads could mimic hBMSCs for scaffold infiltration, the 
experiments had to be repeated with cells. However, unlike beads, the cells could not have been 
simply counted using a cell counter, since some cells adhered to the culture plate underneath the 
scaffolds during the infiltration time; the fact that increased the amount of experimental error and 
led to biased data. This issue was overcome by the hypothesis that the cells that fully penetrated 
the scaffolds and accumulated at the bottom of the pores would proliferate negligibly if 
trypsinized and resuspended into another culture plate after the infiltration assay. Consequently, 
fixing and staining the cell nuclei with the Hoechst dye could then be effectively performed, in 
order for us to be able to count the cells by image analysis.   
   
7.2 Surface modification of PCL scaffolds 
The deposition of a homogeneous chitosan layer on the PCL took a long time and energy, 
because of preliminary misleading results. The dip coating strategy was first employed to modify 
the surface of PCL. According to the pilot tests performed by (Guzmán-Morales et al., 2009) the 
concentration of 50 μg/mL was chosen for the chitosan solution. Fluorescent microscopy images 
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of the PCL scaffolds treated with chitosan having rhodamine isothiocyanate (RITC) as the 
fluorophore (DDA=98% and Mw=237,000) showed promising results when PCL glowed only 
after the chitosan dip-coating, which determined that there certainly was a change in the surface 
chemistry of PCL. However, fluorescent microscopy was the only technique which confirmed the 
existence of chitosan material on the surface and kept us still trying to detect the layer by other 
techniques such as atomic force microscopy and SEM. Figure 7.3 shows some of these 
inconsistent results.  
 
Figure  7.3: (a,b) Atomic force microscopy images (phase mode) of the interface between the PCL 
and a pore; and (c) SEM image of the same area showing an external layer with a considerable 
submicron thickness  
 
Failed surface experiments one after another added to the confusion whether there was a coating 
on the surface or rather aggregates of chitosan which led to the fluorescence of the construct. By 
increasing the concentration of chitosan, the XPS measurements finally detected signals related to 
chitosan. However, the peaks detected by the survey mode of the XPS were not consistent at 
PCL 
Chitosan 
(?) 
Pore
L 
a b 
c 
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various positions on the scaffolds, which brought us to asking the question which according to 
literature is normally neglected by the researchers: is the chitosan coating uniformly deposited in 
every studied position inside the scaffold or not? Since our scaffold is 3D, i.e. the third dimension 
is in the same order of magnitude as the other two), it becomes extremely important to verify if 
the chitosan exists at various positions at various depths inside the constructs. The local non-
homogeneity of the chitosan coating could lead to controversial cellular behavior and therefore 
lead to unreliable results. The idea of LbL deposition of polyelectrolytes on the PCL scaffolds 
was then put forward in order to solve the issue of data inconsistency related to the dip coating 
strategy, as explained in Chapter 5. 
7.3 Osteogenic potential of surface modified PCL scaffolds 
The topics discussed in this section are divided into two subsections: technical and scientific 
challenges. 
7.3.1 Technical challenges  
One of the technical problems that existed in our osteogenic assays was the fact that the cells 
failed to infiltrate the scaffolds of 41 μm pore average diameter. This scaffold was first selected 
to act as our small pore size sample (PCL1). However, such limitation in the scaffold infiltration 
led to an influential idea to improve the cell seeding strategy by modifying our cell seeding 
protocol. The results regarding the inefficient cell infiltration in the scaffolds of 40 μm pore size 
are separately included in Appendix 4 of this thesis and will not be discussed here.  
Also, when analyzing the H&E and VK stained sections using toluene as the commonly used 
clearing agent in histological staining, PCL scaffolds were accidentally eluted from the slides, 
whose effect was both positive and negative. Visualizing the scaffolds in microscopic evaluations 
is of great importance, as the boundaries between the scaffold material and pores are evident. 
However, although this could be appealing for illustrating the ECM, cells and minerals in the 
space-filling areas between the pores, a lot of information is masked in the shadow of the 
scaffolds at the surfaces of the pores. We have discussed in Chapter 6 that by modifying the 
surface with chitosan, the cells are driven toward the PCL surface rather than migrating onto the 
collagenous fibers and sheets in the space-filling areas of the pores. However, this information is 
lost when the PCL scaffold is present on the slide. Therefore, to solve this issue, we decided to 
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finally use toluene and extract PCL in order to include all data possible especially for 
histomorphometric measurements. The difference in the H&E, VK and alizarin red stained 
sections are elaborated in Appendix 4 of this thesis. 
 
7.3.2 Scientific challenges 
Since this last part of the thesis led to unexpected findings, the results produced in Chapter 6 are 
going to be discussed more in this section. Many researchers have previously studied the ability 
of various cell sources to biomineralize 3D scaffolds composed of different materials, including 
rodent, canine, and human primary MSCs, as well as iPS and osteoblast cell lines (Abrahamsson 
et al., 2010; Holy et al., 2000; Poh et al., 2013; Rai et al., 2004; Sun et al., 2012; Zou et al., 
2013). However, as mentioned in section 2.2.3.3, attempts for determining pore size requirements 
for both in vitro and in vivo assays are still ongoing, and contradictory results do exist in this 
matter. Our histomorphometric results in Chapter 6, confirmed the neutral effect of pore size on 
the amount of minerals deposited, as previously reported by (Akay et al., 2004).  
For unmodified PCL scaffolds, biomineralization occurred in highly colonized areas of PCL1 
(top edge) and PCL2 (top edge and nearly top areas) scaffolds. Quantitative evaluation of by 
histomorphometry, however, showed low amounts of deposited minerals inside the constructs, 
which is greatly enhanced specifically for PCL1 scaffolds by the addition of chitosan to the pore 
surface. No effect was observed for the PCL2 samples. Therefore, two points have to be 
addressed:  
1) Matrix mineralization across the scaffold thickness is not uniform for chitosan modified 
scaffolds, i.e. minerals are deposited sporadically, whereas areas with no minerals are observed. 
In Chapter 5, the homogeneity of the chitosan layer inside the scaffolds was ascertained. 
Therefore, hBMSCs were all supposedly in contact with roughly same surface components at all 
levels inside the structure. The reason for the occurrence of punctate minerals is therefore 
unclear. 
2) Chitosan seems to improve biomineralization in the lower pore size, but not in the bigger pore 
size sample. The 2D osteogenic assay supported the theory that chitosan could be potentially 
ingested by hBMSCs and therefore the osteogenesis is suppressed, which is also in agreement 
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with the results obtained by (Guzmán-Morales et al., 2009). By increasing the pore size (from 84 
μm to 141 μm), we are actually moving toward a more 2D system with more flat surfaces. As a 
result, hBMSCs seem to be able to dislodge and ingest chitosan particles from the surface of the 
pores, which can hold back the biomineralization process. However, in PCL1 scaffolds, chitosan 
actually promotes the deposition of minerals. We speculate that in the lower pore size, hBMSCs 
are somehow unable to internalize and consume chitosan particles present on the surface of the 
pores because of the higher curvature of the structure. Consequently, chitosan seems to enhance 
the process of biomineralization through mediation by cell-chitosan interactions rather than 
suppression by chitosan ingestion. It is reported that chitosan promotes bone formation through 
differentiation of h-BMSCs (Mathews et al., 2011). In the latter study, we believe that the cells 
were also unable to internalize chitosan and therefore a positive effect on the osteogenesis was 
observed. However, the arguments above are all speculations and therefore need to be backed up 
by future experiments, some of which are proposed in the next section.         
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CONCLUSION AND RECOMMENDATIONS 
To date, a comprehensive examination of bone tissue engineering scaffolds of significantly 
different pore sizes including scaffold infiltration as an essential factor for the quality of tissue 
ingrowth, has not been carried out. Highly controlled 3D scaffolds destined for tissue engineering 
applications were fabricated from the melt blending of PCL and PEO at the co-continuous 
composition followed by static annealing and selective extraction of PEO. The generated 
scaffolds demonstrate complete pore interconnectivity, sharp unimodal pore size distribution, 
together with precise control over the pore size varying over two orders of magnitude. While 
non-annealed structures exhibit a polymodal and irregular size dispersity, our results show that 
the static annealing of the blends can lead to a sharp unimodal pore size distribution. For the 
purpose of investigating the effect of pore size on the infiltration of scaffolds by hBMSCs, a 
novel in vitro approach using model 10-micron beads was employed. These results demonstrated 
that a threshold in the scaffold pore size exists beyond which the hBMSCs can follow the linear 
behavior of the beads for the infiltration of the 3D constructs. This was attributed to the cell 
aggregation of hBMSCs near the seeding area for smaller pore sizes, whereas beads provided a 
baseline for non-aggregated systems at all ranges of pore size. Therefore, the novel bead system 
can be used as a reference model for devising proper seeding protocols to overcome retention and 
cell distribution issues within the scaffolds. PCL scaffolds of 141 μm average pore size in this 
study show the best bead/cell retention and distribution inside the scaffolds. According to 
cytotoxicity assays, no significant difference in L929 cell viability exists while in contact with 
the scaffolds, as compared to the control monolayer cells and few necrotic cells were detected. 
Nevertheless, there was a slight difference in cell morphology on tissue culture wells with a more 
elongated and fibroblast-like phenotype, compared to that on the PCL scaffold where the cells 
appeared to remain spherical. The sphericity of cells on the PCL scaffolds originates from its 
hydrophobic nature which has to be overcome by surface modification techniques.  
In order to modify the surface of the PCL scaffolds, chitosan was selected as the bioactive agent 
that can bring hydrophilicity and cytocompatibility to the surface. For this purpose, Layer-by-
Layer self assembly of polyelectrolytes was used and compared with the classic dip-coating 
technique. Chitosan surface modification of virtually 3D porous PCL constructs by the LbL 
technique has been done for the first time in this study. Since there is an intrinsic force of 
attraction between the positively charged chitosan and the slightly negatively charged PCL, the 
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classic deep coating succeeds to deposit chitosan on the surface, yet fails to produce a 
homogeneous coating, which is confirmed by ToF-SIMS and XPS analysis. Gravimetric 
measurements demonstrate that three main regions exist according to the number of deposited 
layers: a surface preparation region, an onset for layer buildup region and a more well-defined 
layer region. These regions are confirmed by the XPS analysis examining the evolution of O/C, 
N/C and S/C ratios from 4 layers to 8 layers of assembled polyelectrolytes. These analyses were 
also performed at various depths of 3D constructs and demonstrate that a uniform local 
deposition of chitosan was observed. SEM imaging revealed that there is a microscopically rough 
assembly of layers ranging in total thickness from 550 to 700 nanometers. The hydrophilic 
surface of PCL after chitosan surface modification has the potential to be used in cell culture 
studies to evaluate the potential of the scaffolds for inducing hBMSC differentiation and 
osteoblasts mineralization. 
For the first time, a novel static cell seeding at 4°C in a medium containing 2% serum is 
presented to maximize the efficiency of scaffold infiltration and improve the homogeneity of cell 
distribution at different depths within the scaffolds. Conventional cell seeding at 37°C as well as 
a 2-step seeding protocol at 37°C were proved inefficient by AlamarBlue® assay and image 
analysis. hBMSCs were cold-seeded in PCL scaffolds with and without chitosan coating, cultured 
for 10 days in CCM and another 21 days in an osteogenic medium. At day 2, sparse rounded 
hBMSCs were observed with filopodia anchoring to the unmodified PCL, while they formed 
elongated morphologies on chitosan coated pore surfaces. ESEM and histological evaluations at 
day 10 demonstrated that the cells prefer to migrate onto the secreted ECM in the space-filling 
area of the unmodified pores, whereas they actively spread on the pore surface of LbL-chitosan 
scaffolds. The % matrix formed in the structures is always higher at the outer pores (near the 
edge), which is not particularly influenced by the pore size and chitosan surface modification. 
Mineral deposits were observed at highly colonized areas of the unmodified scaffolds (near the 
top edge), but accumulated sporadically at deeper levels inside the LbL-chitosan modified 
scaffolds. Histomorphometric measurements demonstrate that chitosan promotes 
biomineralization in the smaller pore size scaffolds, while not influencing that in the larger pore 
size structures. Increasing the pore size drives the microstructure toward more flat surfaces and 
close to a 2D system, where the ingestion of chitosan particles by the hBMSCs appears to 
suppress the osteogenesis. On the other hand, the cells seem to be unable to dislodge chitosan 
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particles at the smaller pore size potentially due to the higher curvature of the system. Hence, the 
biomineralization is enhanced through effective cell-chitosan interactions.  
We hope that our efforts in the production of highly structured and surface modified porous PCL 
scaffolds have been fruitful, and that we have come one step closer to a sustainable treatment for 
bone fracture nonunions. There is still a long way ahead, but we are hopeful that someday will 
come that no Canadian is forced to suffer from painful complications following a bone injury.   
 
The following recommendations for future work are worth considering: 
1. For the sake of simplicity and to earn the basic knowledge about the properties of our 
scaffolds, this research study was carried out with PCL constructs with 55% porosity as 
imposed by the volume percentage of the PEO porogen phase. However, it would be 
interesting to investigate also the effect of porosity on cellular functions. This could be 
easily done by the partial extraction of PCL after PEO removal. Or, by adding another 
biodegradable blend component to the PCL/PEO system. Thermoplastic starch could be a 
fit candidate for the purpose, as it is also water-soluble like PEO. Actually, the blend of 
PCL/TPS has already been reported to resist annealing according to (Li & Favis, 2010), 
while we showed that the blend of PCL/PEO reacted to annealing at 160°C. Therefore, 
there might be a possibility of forming a bimodal pore size distribution depending on the 
thermodynamics of the ternary blend of PCL/PEO/TPS. Here is the morphology of the 
non-annealed ternary blend 40PCL/40PEO/20TPS36 vol% (as a pilot study in this thesis) 
with a higher porosity after the extraction of PEO and TPS. Scale bar = 1 micron. 
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2. It would be also interesting to generate a microporous continuous network (<5 μm pore 
size) inside the matrix of the PCL scaffolds. These micropores could serve as pathways 
for the transfer of oxygen, nutrients and wastes, whereas the macropores can act as 
attachment sites for cells. This could be possible by developing an A/B/C–B–C ternary 
blend system in which one of the components has affinity to migrate into the PCL phase 
and form co-continuous structure while also reaching the interface, i.e. a co-continuous in 
co-continuous structure is formed. An example of this kind of morphology has been 
reported by (Wang et al., 2014)  
3. In this study, PDADMAC and PSS polyelectrolytes were used for the LbL surface 
modification of PCL. Although these two materials are not exactly biocompatible, they 
did not show negative impact on our osteogenic and other cell experiments. Despite this 
limitation, these polyelectrolytes have been already used in tissue engineering in vitro 
experiments (Kidambi et al., 2004; Pastorino et al., 2006; Ricotti et al., 2011). 
Nevertheless, in our study, the LbL modified PCL surface was completely covered with 
chitosan. However, in order to reduce the risks of exposure to bio-incompatible 
compounds, we therefore suggest using bio and cell-compatible polyelectrolyte pairs that 
can replace PDADMAC and PSS while not compromising the strong positive and 
negative charges needed. 
4. The elastic modulus of PCL has been reported in the literature to be in the range of 0.21-
0.44 GPa which is in accordance with that of the proximal trabecular bone (Linde & 
Hvid, 1989). Although PCL can mechanically support the ingrowth of trabecular bone, it 
will fail to assist the formation of cortical bone with a high elastic modulus of 11.5-17 
GPa (Cullinane & Einhorn, 2002). Therefore, it is essential to mechanically reinforce 
PCL by incorporating nano and microparticles in the PCL matrix or mixing PCL and PEO 
in a ternary blend with HA which is the inorganic part of the bone matrix.  
5. It would also be interesting to investigate the effect of chitosan concentration and 
molecular weight on the efficiency of LbL deposition as well as osteogenesis in the 3D 
PCL structure. We should note that high chitosan concentrations might lead to cell 
apoptosis during osteogenesis (Guzmán-Morales et al., 2009). Also, we might be able to 
find a critical molecular weight for chitosan which can reverse the role of chitosan in 
171 
 
osteogenesis, i.e. chitosan ingestion by hBMSCs and suppression of mineralization, as 
opposed to effective cell-chitosan interactions that can promote osteogenesis. Other 
positively charged bioactive agents such as positively charged liposomes which release 
growth factors can also be potentially deposited on the surface whose effects on 
osteogenesis can be studied.  
6. The evaluation of bone regeneration in vivo at higher pore sizes of PCL scaffolds (to 
permit vascularization) in the presence or absence of the chitosan coating could lead to 
valuable information about the efficiency of these scaffolds in potential clinical 
applications. It would be interesting to see whether the increase in the pore size in the 
presence of chitosan, would follow our in vitro results and lead to lower levels of bone 
formation in vivo, the formation of vasculature inside the bigger pores as suggested by 
(Kuboki et al., 2001) can yield high levels of new bone formation. 
7. In Chapter 6, we speculated that superior biomineralization in the smaller pore size of the 
LbL-chitosan modified PCL could be attributed to the higher curvature in these scaffolds. 
In order to prove this hypothesis, we can simplify the system to hollow cylindrical 
substrates (PCL or not) with different diameters: small representing high curvature; and 
large representing low curvature systems. The surface of these cylindrical substrates 
should be chitosan coated via the LbL technique (same procedure as in Chapter 5). 
hBMSCs can now be seeded on the external and/or internal surface of these tubes and 
cultured in proliferation and osteogenic medium for 10 and another 21 days, respectively. 
The hypothesis is that there will be more mineralization on the smaller diameter tube than 
the larger one.  
8. The cylindrical systems mentioned above can also be combined in concentric cylinders 
with different diameters (as depicted in the figure below, ϕ1<ϕ2) to mimic the ring 
structure of the osteon. In the presence of chitosan, concentric cell monolayers can be 
formed with a likely mineral concentration gradient from low on the outer layers to high 
on the inner layers close to the center.  
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9. A substitute for the cylindrical systems above which would perhaps be more feasible is 
the use of flat substrates yet with a jagged structure with shallow cavities between the 
surface stripes. The distance between the “bumpy” stripes determines the curvature of the 
system; the smaller the distance, the higher the curvature.  
 
At the end, I would like to wish the best of luck to the researcher(s) that follow me in this project 
in order to bring our product closer to clinical applications and hopefully benefit mankind.   
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APPENDIX 1 – BONE TISSUE ENGINEERING MATERIALS  
Extensive studies have investigated the nature of the materials that have the potential to be used 
as bone tissue engineering scaffolds. These studies have placed these materials into the following 
categories: metals, ceramics, natural polymers, synthetic polymers, and combinations of these 
materials to form composites (Glowacki & Mizuno, 2008; Gong et al., 2001; Hadjipanayi et al., 
2009; Hollinger & Battistone, 1986; Liu & Ma, 2004; Nienhuijs et al., 2006). Apart from all 
differences due to diversity of these materials, they should all have common specific 
characteristics for being used as bone grafts. They must be inherently biocompatible, 
biodegradable, and highly cell adhesive. Also, they all must have porous, mechanically stable and 
three dimensional structure. As long as biodegradability is concerned for bone tissue engineering 
applications, medium to long-term material stability is required for the newly formed tissue to 
withstand early functional loads and become self-supporting (Gogolewski, 2000; Roy et al., 
2003). The ease of manufacturing and processability of these substances are also determining 
parameters in selecting bone graft materials.  
 
Metals 
As a result of their superior mechanical properties, metals are number one implant materials used 
in orthopedics. However, their main drawback is their lack of biodegradation, which results in the 
necessity of performing a second surgery for their removal or accepting the toxicity risk due to 
the accumulation of metal ions in case they remain inside the patient’s body (Rubin & 
Yaremchuk, 1997). In literature, metals such as stainless steel, titanium and titanium alloys have 
been shown to exhibit good osteoconductive yet weak osteoinductive properties (Khan et al., 
2008; Zaffe, 2005).  The concept of porosity for the metal implants is often different from other 
types of grafts or scaffolds, as the bulk of the implant is only the solid metal but the outer surface 
is covered with porous titanium coatings whose pore size ranges from a nanometer scale to 
hundreds of microns depending on the fabrication technique (Harvey et al., 1999; Story et al., 
1998). The reason for such external porous coating is to overcome their inherent lack of tissue 
adherence (Hulbert et al., 1970). Plasma spraying of titanium was used to fabricate such coatings 
with 200-400 µm and 50-60% porosity in order to treat dog femoral defects (Pilliar, 1998). Apart 
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from solid metals with porous coatings on their surface, fully porous metal scaffolds do exist. For 
instance, fiber meshes made of titanium with 86% porosity and a 250 μm average pore size have 
been used for the in vitro culture of rat bone mesenchymal cells (van den Dolder et al., 2003). 
These mesh materials have also been successfully used as fixation grafts in hip arthroplasty as 
demonstrated in Figure A1.1 (Baad-Hansen et al., 2011). 
 
Figure A1.1: Cups made of titanium-aluminum-vanadium alloy core with a pure titanium fiber 
mesh on the surface (adapted from (Baad-Hansen et al., 2011) ) 
 
Ceramics 
Ceramics and ceramic composites used for osteogenesis are materials whose foundation lies upon 
the existence of hydroxyapatite, which is the inorganic calcium phosphate phase of the bone. As a 
result, ceramics are known for their impeccable osteoconductive properties in bone regeneration 
applications. Also, their stiffness fully complies with that of the real bone. However, the elastic 
moduli of the ceramic materials deviating from those of the bone and the fact that ceramics lack 
osteoinductivity could be considered as disadvantages for these bone grafts (Khan et al., 2008; 
Zaffe, 2005). There are mainly two types of ceramics: 
 
Crystalline ceramics 
As the name suggests, these ceramics have crystalline structure and are usually processed by 
sintering the ceramic powder at high temperatures to produce block and cylinder scaffolds which 
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have approximately 80% porosity and 400-600 µm pore size. These scaffolds have been used to 
induce ectopic bone formation in mice and effectively treat rat femoral defects (Damien et al., 
2003; Dong et al., 2001). As another example, natural coral, also a type of crystalline ceramic, 
molded into the form of a human mandibular condyle and pre-seeded with rabbit mesenchymal 
stem cells, induced ectopic bone formation in mice (Chen et al., 2002). Figure A1.2 demonstrates 
CaSiO3 ceramics and their osteogenic potential in healing rat femoral defects. The level of bone 
formation after 8 weeks is higher than TCP scaffolds (Wu et al., 2012). 
  
Figure A1.2: (a, b) SEM images of CaSiO3 scaffolds, (c) H&E images of explanted scaffolds 8-
weeks post-surgery: NB stands for new bone, and d) % bone formation by micro-CT analysis 
(adapted from (Wu et al., 2012)) 
 
Glass and glass-ceramics 
Amorphous glass and polycrystalline glass-ceramics are also members of the ceramics family. 
While crystallization is avoided in the fabrication of amorphous glass by rapid cooling, a so-
called “controlled crystallization” is performed to form amorphous and crystalline phases 
together in the ceramics. Glass scaffolds with a low porosity level of 5% and a wide range of pore 
sizes from 10-200 µm induced bone ingrowth in rabbit tibia defects (Tarvainen et al., 1986). 
a 
b 
c 
d 
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Bioglass, a trademark material with chemical compositions different from those of regular glass, 
was also used to fabricate scaffolds with interconnected porous networks to support human 
primary osteoblasts, as well as induce ectopic bone formation in thigh muscles of dogs (Xynos et 
al., 2000; Yuan et al., 2001). Also, glass-ceramics with pore sizes ranging from 10-300 µm with 
around 50% porosity have been proven effective in the restoration of femoral defects in rabbits 
(El-Ghannam, 2004). Wu et al. demonstrated that 3D mesoporous bioactive glass (MBG) can 
enhance ALP activity of mesenchymal stem cells in vitro 7 days post-seeding as shown in Figure 
A1.3 (Wu et al., 2011).   
 
Figure A1.3: ALP activity of MSCs seeded in the mesoporous bioactive glass scaffolds at Days 
1, 3 and 7. ALP activity is considerably higher than that of the control culture plate (Wu et al., 
2011) 
 
Natural polymers  
Biomaterials obtained from natural resources such as collagen and glycosaminoglycans mostly 
comprise of structural tissue materials and therefore are biocompatible, biodegradable and 
hydrophilic. Consequently, these materials can encourage bone tissue development by directing 
cell adhesion and other cellular functions at the site of injury (Lee & Mooney, 2001). However, 
rapid biodegradation of these natural polymers along with their poor mechanical properties are 
considered as a downside to their application in bone tissue engineering. In order to reduce their 
degradation rate and reinforce their mechanical properties, natural polymers are commonly 
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chemically modified by cross-linking or are blended with other materials, which on the other 
hand might compromise their biocompatibility and limit their use (van Luyn et al., 1992). In this 
section, common natural polymers are introduced. 
 
Collagen 
Collagen as the most abundant natural polymer accounts for approximately 30% of all body 
proteins and is the main component of mammalian connective tissue. It is found in every tissue 
that requires stability and flexibility at the same time. Among fourteen types of collagens that 
have been identified so far, the major constituent of orthopedic tissues are the fibrillar collagen 
(type I and type II) (Heinegard, 2001). Such fibrillar structure originating from its triple-helix 
structure leads to high tensile strengths (Lee et al., 2001a). Collagen is mostly used for soft 
orthopedic tissue regeneration. However, its mechanical properties can be easily enhanced for use 
in other applications by cross-linking chemically by aldehydes (glutaraldehyde and 
formaldehyde) and diimides (carbodiimide) or physically by UV irradiation or heat (Lee et al., 
2001b; Park et al., 2002). Tibia defects in rats have been treated by using collagen scaffolds with 
pore sizes ranging from 11-105 µm and 14-134 µm (Rocha et al., 2002). Furthermore, in vitro 
studies with bovine osteoblasts within anionic collagen scaffolds prepared by hydrolysis 
demonstrated increased alkaline phosphatase over three weeks (Moreira et al., 2004). 
 
Glycosaminoglycans 
Glycosaminoglycans (GAGs), which consist of repeating disaccharide units in linear 
arrangement, usually include an uronic acid component (glucuronic or iduronic acid) and an 
amino sugar (such as n-acetyl-d-glucosamine). The largest GAG is Hyaluronic acid (HA) or 
hyaluronan which is an anionic polysaccharide composed of repeating disaccharide units of N-
acetylglucosamine and glucuronic acid and can either be isolated from natural sources like 
rooster comb or be obtained from microbial fermentation routes. HA is also the major component 
of cartilage extracellular matrix from which it can be easily isolated (Pachence, 1997). Although 
HA is mostly used for chondrogenesis due to its ability to encourage chondrocyte proliferation 
and ECM production, HA based scaffolds with 80–90% porosity and pore sizes ranging from 
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100-600 μm were employed for the osteogenic differentiation of the murine pluripotent cell line 
C3H10T1/2 (Kim & Valentini, 2002). Also, Figure A1.4 demonstrates that bone grafts 
supplemented with HA have proved promising in healing tibia defects in rabbits (Aslan et al., 
2006). 
 
Figure A1.4: Bone healing scores in tibia defects (0 = empty cavity, 7 = bone only) (Aslan et al., 
2006) 
 
Synthetic polymers 
Chemically synthesized polymers are advantageous over natural biomaterials due to their 
versatility and ability to transform into scaffolds with various shapes, porosities, pore sizes, 
molecular weights, molecular weight distributions and degradation rates through numerous 
fabrication techniques. In this matter, the effect of fabrication parameters has been investigated 
on the scaffold properties generated from poly(a-hydroxy acid), (poly(D,L-lactide), and 
poly(lactide-co-glycolide) (Hu et al., 2002). Several synthetic polymers have been used for 
orthopedic grafts, including poly(α-hydroxy esters), poly(ε-caprolactone), poly(orthoesters), 
poly(anhydrides), PEG-based materials (including PEO), poly(amino acids), and fumarate-based 
materials. Some of these materials are discussed in this section. 
 
Poly(α-hydroxy esters) 
Due to the FDA approval for poly(glycolic acid) (PGA) and poly(lactic acid) (PLA) to be used as 
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drug delivery and suture materials, these polymers have been widely studied in tissue engineering 
applications. These two polymers and their copolymer are discussed in this subsection. 
 
Poly(glycolic acid) (PGA) 
Poly(glycolic acid) (PGA) is a linear aliphatic polyester which is by far the most studied 
synthetic polymer in tissue engineering. Depending on the synthesis procedure of PGA -being 
mainly by ring-opening polymerization- its crystallinity can reach 46-52%, which leads to a low 
level of solubility in organic solvents (except highly halogenated solvents) and a high melting 
point (224-226°C). PGA is highly hydrophilic which makes it collapse and lose its mechanical 
strength rapidly in the period of 2-4 weeks. This property of PGA makes it a suitable material for 
surgical sutures but not a mechanically stable one for load-bearing applications such as bone 
grafts (Frazza & Schmitt, 1971). Like other polyesters, PGA goes through a hydrolytic bulk 
degradation of ester linkages depending on its level of crystallinity (Athanasiou et al., 1998; 
Mikos et al., 1993). This polymer also has good processability features as it can be processed in 
extrusion and injection molding equipments. The VK staining images of PGA porous scaffolds 
seeded with umbilical cord mesenchymal stromal cells at 3 and 6 weeks post-seeding (Figure 
A1.5) clearly exhibits high levels of calcium mineral deposition within the scaffolds, and hence 
emphasizes on the osteogenic potential of this polymeric material. 
 
Figure A1.5: VK staining of PGA sections at (a) 3 and (b) 6 weeks post-seeding. Mineral 
deposition increased considerably with time (adapted from (Wang, Dormer, Bonewald, & 
Detamore, 2010)) 
a b 
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Poly(lactic acid) 
Poly(lactic acid) (PLA) is another aliphatic polyester in the poly(α-hydroxy ester) family which 
has similar characteristics to those of PGA. However, the hydrophilicity of PLA is less than that 
of PGA due to the existence of an extra methyl group in its backbone. This relative hydrophobic 
nature of PLA prolongs its degradation time and reinforces its mechanical properties as compared 
to PGA, and makes it a desirable material for orthopedic fixation devices (Athanasiou et al., 
1998; Daniels et al., 1990; Mikos et al., 1994). PLA goes through the same degradation 
mechanism as the PGA, except that lactic acid is the by-product of the hydrolytic degradation 
reaction of PLA. Also, in comparison to PGA, PLA is more soluble in organic solvents such as 
methylene chloride and chloroform.  
Since PLA is a chiral molecule, it is mainly consisted of two distinct stereoisomeric forms: 
PDLA and PLLA enantiomers. PDLLA is the racemic polymer obtained from the combination of 
these two enantiomers. Generally PLLA is more used compared to the other two stereoisomers. 
The main difference between these forms of PLA is their crystallinity. Both PDLA and PLLA are 
semi-crystalline polymers. However, the addition of more than 15% of PDLA to PLLA makes it 
amorphous (Vert et al., 1992). Normally PDLLA is used in drug delivery applications because of 
its amorphous nature that leads to a homogeneous dispersion of drug in the matrix. Moreover this 
amorphous nature of PDLLA leads to a drop in its melting point as well as mechanical properties 
such as tensile stress and modulus, yet an increase in the elongation at break. Also it degrades 
faster than the two PDLA and PLLA free forms (Mark, 2009). The melting point of PLA as a 
function of molecular weight ranges between 145-180°C (normally reported as 170°C) and its 
glass transition temperature ranges from 50-64°C (normally reported as 56°C) (Mark, 2009).  
In the case of bone tissue engineering, the proliferation and mineralized matrix formation by rat 
BMSCs have been reported to improve significantly on PLA scaffolds (Matsuzaka et al., 2000). 
Nonetheless, very few works have investigated only PLA as a bone implant in the recent years. 
  
Poly(lactide-co-glycolide) 
The principal goal for the copolymerization of PLA and PGA in order to synthesize Poly(lactide-
co-glycolic acid) (PLGA) is to either decrease the hydrophilicity of PGA or to increase the 
hydrophilicity of PLA in order for them to be used in wider ranges of applications. The properties 
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of the PLGA copolymer are completely different from those of the pure PLA and PGA 
homopolymers.  As opposed to PLA and PGA which are semi-crystalline polymers, PLGA is 
completely amorphous almost at all ranges of copolymer ratios, because of the disruption of the 
crystalline phases. As a result, hydrolytic degradation of PLGA occurs at a much faster rate than 
its constituting homopolymers (Athanasiou et al., 1998; Hollinger, 1983; Pachence, 1997). 
PLGA copolymer has been a much more investigated material in the literature for osteogenic 
purposes than PLA and PGA, as it does not have the low hydrophilicity issue of PLA and 
degrades much slower than PGA as an implant. For instance, 2D and 3D PLGA scaffolds 
impregnated with human bone morphogenetic protein-2 (hBMP-2) and seeded with rabbit 
BMSCs induced osteogenic differentiation and extracellular matrix production over a period of 
two months in vitro (Huang et al., 2004). Also, alveolar bone atrophies right after tooth extraction 
have been prevented by using PLGA dental implants with interconnected porous structures 
(Maspero et al., 2002). Furthermore, Penk et al. have studied the potential of PLGA scaffolds for 
bone regeneration in rat tibial head defects. Figure A1.6 shows that the scaffold (S) is completely 
invaded with lamellar bone (L) (Penk et al., 2013).  
 
Figure A1.6: Goldner-Masson stained image of a rat tibial head defect: PLGA scaffold (S) has 
been completely invaded by newly formed lamellar bone (adapted from (Penk et al., 2013)) 
 
Other synthetic polymers 
Apart from the discussed synthetic polymers and the biomaterials of interest elaborated in section 
2.2.4, other materials have been investigated for bone tissue engineering applications. These 
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materials include poly(anhydrides) (Anseth Kristi et al., 1997; Domb et al., 1991; Gunatillake & 
Adhikari, 2003), Poly(amino acids) (Abramson et al., 2002; Kim et al., 2011; Pachence, 
1997) and Fumarate-based polymers (Fisher et al., 2001; Fisher et al., 2002; Lewandrowski et al., 
2003; Timmer et al., 2003). The use of these synthetic polymers in bone tissue engineering has 
seen very little activity in the past recent year. 
 
Composites 
The main reason why composites were developed was to overcome likely drawbacks of the 
individual biomaterials, while benefiting from their advantages at the same time. For example, 
ceramics as explained above are excellent osteoconductive materials. However, their brittleness 
hinders their use as a single material to be used as bone implants. Therefore, by incorporating 
ceramics with other materials like synthetic polymers such as PCL, their osteoconductivity can 
still be used while PCL adds to their toughness. For instance, hydroxyapatite scaffolds were 
coated with a composite coating of hydroxyapatite/PCL which led to a higher compressive 
strength and elastic modulus (Kim et al., 2004). On the other hand, porous polymeric scaffolds 
often suffer from lower compressive strengths and moduli as compared to those of the human 
bone, which compromises the compatibility of the polymer implants with the surrounding tissue 
and increases the risk of scaffold debonding from the tissue under stress conditions. Park et al. 
also fabricated the PCL/HA scaffolds and demonstrated that incorporating hydroxyapatite 
powder to the molten PCL improves the ALP activity of human osteosarcoma MG63 cell lines at 
all culture periods, as illustrated in Figure A1.7 (Park et al., 2011). Stress shielding as explained 
in section 2.2.3.5 is another issue which could happen in the case of bone implants, and whose 
risks could be highly reduces by the use of blends and composites.  
Hydroxyapatite ceramic materials have also been processed with two natural biomaterials 
chitosan and gelatin to make a composite material which supported the proliferation and 
mineralization of rat calvarial osteoblasts in vitro (Zhao et al., 2002). In another study collagen 
scaffolds have been coated with hydroxyapatite to enhance the osseointegration of the implant, 
which supported the attachment and proliferation of rabbit periosteal cells (Lickorish et al., 
2004). Also, adding fillers or coatings like hydroxyapatite or TCP could also improve the 
mechanical properties of natural and synthetic polymers and render them closer to those of the 
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natural bone. Some of these composites include Poly(L-lactide-co-D,L-lactide)/TCP, 
Poly(propylene fumarate)/TCP and Hydroxyapatite/TCP/chitosan (Roy et al., 2003; Wolfe et al., 
2002; Zhang & Zhang, 2002). 
 
Figure A1.7 : ALP activity of MG63 cells on the scaffolds. Asterisks denote signiﬁcant 
differences (*p<0.05, **p<0.01, ***p<0.001) (Park et al., 2011) 
  
  210 
 
APPENDIX 2 – SCAFFOLD FABRICATION TECHNIQUES  
Sintering 
Sintering is the most common method to produce ceramic scaffolds. There are many variations in 
the process of sintering; however, the basics are the same for all of them. Sintering is defined as 
the condensation of ceramic powder at high temperatures (below their melting point) into a solid 
ceramic bulk. In this method, after the formation of slurry from the ceramic powder and putting it 
in the mold, compression is applied to form a “green body” which is the unsintered ceramic. 
Then the temperature is risen to 1100-1300 °C depending on the powder used. After sintering, 
pressure is applied isotactically. By applying certain modifications in the process, microporous or 
macroporous structures can be obtained. By using the standard sintering process, random pores 
with 5 µm diameter are obtained. However, for achieving a pore size of 100-500 µm, the most 
common approach is to use appropriately sized naphthalene particles with the ceramics powder 
before the formation of the green body. Therefore, during the sintering process, naphthalene 
particles are sublimated and macropores are generated. Another method is by using hydrogen 
peroxide to make the slurry which produces oxygen bubbles during sintering and makes the 
macropores (Rengachary et al., 1998). 
 
Solvent casting and particulate leaching 
Solvent casting and particulate leaching is the most commonly used approach for the production 
of porous polymeric tissue engineering scaffolds. In this approach, water soluble salts such as 
sodium chloride, sodium citrate and occasionally sugars and lipids are mixed with a polymer 
solution and cast into a mold of the desired scaffold shape. The evaporation or lyophilization of 
the solvent together with the extraction of the porogen phase by immersion in water (in the case 
of salts) leads to the solidification of the polymer and the formation of a porous network. This 
method was used to fabricate PLGA scaffolds in order to engineer trabecular bone as explained 
by (Thomson et al., 1995).   
The porosity produced via this technique can reach up to 98% and the pore size can be 100-600 
µm depending on the size of the porogen particles (Kim & Valentini, 2002; Nazarov et al., 2004). 
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Type, amount and size of the porogen particles are key parameters in controlling the porosity and 
pore size criteria which limit the control over the porous structure in this process. The main 
disadvantages of this approach include the residual solvent and porogen material in the system 
and the limitation in the thickness of the scaffolds produced. As a matter of fact, all the scaffolds 
produced by the solvent casting and porogen leaching technique are limited to a thickness range 
of 0.5-2 mm (Liao et al., 2002). In addition, achieving complete pore interconnectivity is very 
limited in this technique, which makes it unfavourable for uniform cell seeding and tissue 
ingrowth. 
 
Gas foaming 
The major problem of the solvent casting/particulate leaching method is the residual solvent that 
can be a threat for in vivo applications. Gas foaming is a technique that does not use solvents for 
the generation of porosity and therefore the effect of solvent is completely eliminated. This 
method was first introduced by Mooney et al. for tissue engineering applications (Mooney et al., 
1996). In this approach, CO2 gas is used to create polymer foams. Compression-molded polymer 
disks are exposed to high pressure CO2 in order to saturate the gas in the discs. CO2 is then 
released from the system by a pressure drop, which causes a thermodynamic instability. This 
instability is then compensated by the nucleation and growth of gas bubbles in the discs which 
make the pores in the polymer matrix. The porosity and pore size highly depend on the amount of 
gas and the pressure drop rate. The gas foaming method generates relatively high pore sizes 
ranging from 100-800 µm in diameter, and porosities as high as 97% (Kim et al., 2012; Nazarov 
et al., 2004; Trantolo et al., 2003). However, because of the gas bubbles in the polymer discs, gas 
foaming alone leads to the formation of a closed-pore and non-interconnected porous structure. 
As a matter of fact, only 10-30% of the pores generated by this technique are interconnected 
(Harris et al., 1998; Mooney et al., 1996). Therefore, this method is often combined with other 
techniques such as solvent casting and particulate leaching (Harris et al., 1998). Recently, the gas 
foaming fabrication technique has been used for the production of porous calcium phosphate 
scaffolds with pore sizes ranging from 300-800 µm and porosities up to 85% for in vitro (mouse 
BMSCs) and in vivo (rat jawbone and tibia) bone regeneration (Kim et al., 2012).  
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Thermally-induced phase separation (TIPS) 
Phase separation in general is based on the demixing phenomenon of a polymer solution into 
polymer rich and solvent rich phases. Such demixing usually occurs either by exposure to another 
immiscible solvent or in the case of thermally-induced phase separation (TIPS), thermal 
manipulation (change in temperature). In section 2.2.4.3, this method was introduced as the most 
common approach for the production of three-dimensional chitosan scaffolds. In this technique, 
the polymer is dissolved in its specific solvent at high temperature. The temperature is then 
dropped rapidly usually by freezing and falling from a single homogeneous phase region into a 
biphasic region according to the phase diagram of a binary fluid (Figure A2.1), which leads to 
phase separation. Then, the solvent phase is subsequently removed by sublimation (Freeze-
drying) which leaves a porous polymer scaffold (Nam & Park, 1999)  
 
Figure A2.1: Phase diagram of a binary fluid (Raudino et al., 2011) 
 
One advantage of this technique over solvent casting-particulate leaching is better mechanical 
properties of the produced scaffolds. It was proved that PLA scaffolds produced by this technique 
with the same porosity as those produced by solvent-casting particulate leaching demonstrated 20 
times higher modulus (Ma et al., 2001). Nevertheless, there is an important drawback to this 
technique, which is the limitation for the generation of large pore sizes; this method is commonly 
used for the production of pore sizes of 10-100 µm which might not be ideal for seeding bone 
forming cells as discussed in section 2.2.3.3.2. As a result, a combination of this technique with 
other methods must be used to push the pore size into an acceptable window (Wei & Ma, 2004; 
Yang et al., 2008). The TIPS method does not always involve freezing as the agent for phase 
separation, as sometimes heating might as well lead to phase segregation (Shen et al., 2010). This 
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technique has been proposed for use in bone tissue engineering, yet its in vivo application started 
in the recent past, when nanohydroxyapatite/collagen (nHAC), and PLLA-composite scaffolds 
produced by this method have been used for rabbit femoral condyle repair (Niu et al., 2011).  
 
Freeze-drying 
Freeze-drying is a rapid method for the fabrication of bone tissue engineering scaffolds with a 
relatively high degree of control over the porosity and pore size. The procedure consists of 
mixing an organic solution containing a dissolved polymer with water until a homogeneous 
emulsion is achieved. The emulsion is then poured into a metal mold of a pre-defined shape and 
is exposed to a rapid cooling by liquid nitrogen to freeze-in the liquid structure. Freeze-drying 
removes the water and solvent from the emulsion which leads to the formation of a scaffold with 
highly interconnected pores, porosity of more than 90% and the average pore size ranging from 
20-500 µm (Whang et al., 1995; Zhao et al., 2002). One main disadvantage of this method is the 
formation of a closed-pore structure which again has to be overcome by its combination with 
other techniques. The applications of this approach for the formation of porous 3D structures for 
osteogenic purposes are numerous. Hydroxyapatite/chitosan-gelatin, Collagen/hydroxyapatite 
and hydroxyapatite/chitosan composite scaffolds with pore sizes of 30-500 µm have been 
fabricated to examine the in vitro attachment and proliferation behavior of rat osteoblasts, rabbit 
periosteal cells and mice osteoblastic cell line (MC-3T3-E1) (Lickorish et al., 2004; Zhang et al., 
2012; Zhao et al., 2002).  
 
Melt molding/particulate leaching 
Melt molding technique is a simple method which can combine the porogen leaching principle 
and polymer processing for the fabrication of scaffolds in diverse geometries. In this approach, 
porogen and polymer particles are mixed and put in a mold and heated above the polymer glass 
transition temperature (for amorphous polymers) or polymer melting temperature (for semi-
crystalline polymers). The mixture is then removed from the mold, quenched and soaked in a 
proper solvent to leach the porogen out of the mixture and yield a three-dimensional porous 
structure. The controlling parameters and basics of solvent casting and particulate leaching in this 
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appendix also apply for melt molding. This method was used by Thomson et al. to fabricate 
scaffolds out of melt molding of PLGA with gelatin microparticles as porogen (Thomson et al., 
1995). PLGA/poly(vinyl alcohol) (PVA) scaffolds with 90% porosity and 200-300 µm pore size 
have also been fabricated by this approach in order to evaluate their degradation behavior in vivo 
by using a rat model (Oh et al., 2006). Nanocomposite scaffolds made of PLGA and surface 
modified hydroxyapatite with 90% porosity and 100-300 µm pore size are another products of 
this method which exhibited rapid healings of rabbit radius defects (Cui et al., 2009).  
 
Electrospinning 
Electrostatic fiber spinning or electrospinning is a modern technique for the fabrication of nano 
and micro-scale porous structures. The principle of electrospinning is the electrostatic spraying of 
polymer fibers on a conductive target substrate by use of an electric field that controls the quality 
of the final product (Boland et al., 2001). A schematic of the vertical setup of the electrospinning 
apparatus is illustrated in Figure A2.2.  
In this technique, a polymer solution or melt is injected with an electric potential which produces 
a charge imbalance between the injector and the target substrate. For polymer solutions, the most 
important factor is determining the critical entanglement concentration above which fibers can be 
formed. Should the charge imbalance overcome the surface tension of the polymer solution or 
melt (critical voltage), an electrically charged polymer jet is formed. During the fiber deposition 
or after, the solvent evaporates and porous structures are produced. 
Biocompatible polymers like PCL, PGA and PLGA can be electrospun to form nanofiber 
scaffolds with porosities higher than 90%. Fiber thickness, average pore diameter and other 
scaffold properties can be controlled by parameters like polymer concentration in the solution, 
ejection rate, type of the solvent, applied voltage, capillary diameter, the collecting surface 
material and the distance between the capillary and the collecting surface. The fiber diameter can 
range from hundreds of nanometers up to several microns (Li et al., 2002b).  
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Figure A2.2: Schematic of an electrospinning set up (Bhardwaj & Kundu, 2010) 
 
Famous work by Yoshimoto et al. discusses the electrospinning process for PCL by using 
chloroform as the solvent and 10-15 kV as the voltage (Yoshimoto et al., 2003). The scaffolds 
produced by the same study were seeded with rat BMSCs, and their in vitro osteogenic behavior 
was studied at week 4 post-seeding. It was shown that cell multilayers were formed, and minerals 
and collagen type I were detected on the scaffolds in this period. Two main interrelated 
drawbacks observed in this approach are the limited mechanical properties of the scaffolds 
produced and the decrease of porosity with the increase of the fiber thickness. Also, creating 
various shapes using the electrospun fibers has always been an issue and has limited the use of 
this technique in bone tissue engineering.  
 
Rapid-prototyping techniques 
Developed by the advanced industrial technology and computer science, rapid-prototyping 
techniques are now able to fabricate a complex product based on a computer-aided design model. 
These techniques include 3D printing (3DP), selective laser sintering (SLS) and fusion deposition 
modeling (FDM) (Yang et al., 2002). The aforementioned methods are known for their precision 
and control over the fabricated porous structure. However, the most important inconvenience of 
rapid-prototyping methods is their inability to design and fabricate scaffolds of fine 
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microstructures due to their resolution limitations. Therefore, the porosities of the produced 
scaffolds are mainly low and their mechanical properties are evidently compromised. An example 
for the application of 3D printed structures in bone tissue engineering, is the use of PGA/PLA 
scaffolds pre-seeded with dog BMSCs for healing craniomaxillofacial bone injuries (Xu et al., 
2010a). In addition, PCL and PCL-TCP composite scaffolds fabricated by fused-deposition 
modeling aimed to repair and regenerate osteochondral defects in articular joints by pre-seeded 
rabbit BMSCs (Swieszkowski et al., 2007).   
  
  217 
 
APPENDIX 3 – XPS ANALYSIS OF MULTILAYER FILMS  
Since XPS establishes the main surface characterization technique for the analysis of various 
layers in the LbL technique as explained in Chapter 5, this appendix is concentrated on the 
fundamentals of XPS and experimental conditions of the performed tests.  
  
XPS fundamentals 
X-ray photoelectron spectroscopy is a surface characterization technique which is based on 
Einstein’s photoelectric effect discovery, and was developed by Siegbahn et al. at the University 
of Uppsala, Sweden (Siegbahn, 1967).  XPS is a technique to obtain surface information about 
composition and chemical state. The technique is based on the irradiation of X-ray photons with a 
constant wavelength on a sample material and therefore causing electrons to be ejected from their 
original state. The kinetic energies of the ejected photoelectrons are measured which permits the 
detection of various elements. In the case of our study, the relative concentration of the elements 
is determined by ratios of these photoelectron intensities. According to Equation 16, the detected 
kinetic energies of the electrons are actually the energies remaining from the initial photon 
energy (hν) after consuming the binding energy of the specific excited electron (B.E) to reach the 
valence band and finally reach the detector (φspectrometer): 
                                
Where K.E is the kinetic energy of the photoelectron,    is the X-ray photon energy, B.E is the 
binding energy associated with the excited electron in a particular orbital and φspectrometer is the 
spectrometer (concentric hemispherical analyzer) work function. Since the binding energy of the 
excited core electron in its orbital is specific to a unique element, the detected kinetic energy 
could be used as a fingerprint for the identification of elements and compounds. Also, since the 
excited photoelectrons have low kinetic energies, XPS experiments must be performed in an 
ultra-high vacuum (UHV) chamber of 10
-9–10-10 Torr. Figure A3.1 illustrates the penetration 
depth of the X-ray beams and the detection depth by the XPS apparatus. It is clear that although a 
large area is bombarded with X-ray beams and they can penetrate approximately 1 micron deep 
inside the substrate, a small area of 1 mm
2
 is analyzed whose sampling depth is less than ~10nm. 
Nevertheless, electrons of deeper layers can still escape out of the sample but due to their 
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collisions with other electrons and atoms, they would only be translated as background noise in 
the final spectra.  
 
Figure A3.1: Penetration depth of X-ray and detection depth by XPS (adapted from (Shu)) 
 
A typical XPS spectrum plots the photoemission intensity as a function of the binding energy as 
shown in Figure A3.2. It is clear that any specific atom is exhibited at a specific binding energy 
which is a function of the state of their electronegativity and surrounding bonded atoms and 
hence corresponding to that unique atom (Dementjev et al., 2000). 
 
Figure A3.2: Typical XPS spectrum (Wagner & Muilenberg, 1979) 
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Experimental conditions and analysis 
The details of the XPS characterization settings for the detection of N 1s (nitrogen) specific to the 
chitosan molecule, and/or other atoms in the case of LbL coatings are presented in Table A3.1. 
 
Table A3.1: Experimental Conditions of the XPS analysis 
Apparatus ESCALAB 3 MKII de VG 
Source Mg Kα 
Power 216W (12kV, 18mA) 
Analyzed Surface 2mmx3mm 
Analyzed Depth 50-100 Ǻ 
Survey Scans 
Energy Step Size 1.0 eV 
Pass Energy 100 eV 
High Resolution Scans 
Energy Step Size 0.05 eV 
Pass Energy 20 eV 
Background Subtractions 
Shirley Method (Shirley, 
1972) 
Sensitivity factor table 
Wagner (Wagner & 
Muilenberg, 1979) 
Charge correction with respect to C1s at 285.0eV 
 
The relative atomic percentage is calculated according to Equation 17: 
                                  
      
          
         
Where A1 represents the peak area for element 1 and SF1 is the sensitivity factor for that 
element. SF values are taken from Table A3.2. 
  220 
 
Table A3.2: Atomic sensitivity factors (ASFs) (Wagner & Muilenberg, 1979) 
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APPENDIX 4 – SUPPLEMENTARY HISTOLOGICAL DATA  
Effect of toluene 
The use of toluene as the clearing agent in our histological data had an obvious influence on the 
results obtained. PCL is soluble in toluene and therefore is eluted from the slides in its presence 
in the final steps of the staining protocols. Figure A4.1 shows how the extraction of PCL using 
toluene reveals the information that were previously missing or being masked in the shadow of 
the scaffolds. Additionally, there seems to be an interaction between the hematoxylin and eosin 
stain as well as Toluidine Blue (in the VK assay) with PCL, as the scaffold picks up some of the 
stain color and becomes purple at some areas. 
 
Figure A4.1: Effect of toluene on the information obtained by H&E and VK staining 
 
Thus, it is clear that for histomorphometric measurements in Chapter 6, the scaffolds had to be 
extracted for us to obtain reasonable results which are not affected by the scaffolds on the slides. 
  222 
 
Effect of pore size and seeding at 37 °C 
In Chapter 4, we determined a minimum pore size requirement for having the optimal cell 
escape/retention in PCL scaffolds. However, for our osteogenic assay two distinct pore sizes 
needed to be investigated: PCL1 with pore size < 100 μm and PCL2 with pore size> 100 μm. In 
this pilot study (osteogenic assay 1), PCL1 scaffolds with 41 μm and PCL2 with 141 μm 
(unchanged) average pore diameter were selected. Following a classic seeding at 37°C, 5 day 
culture period in CCM, the osteogenic assay of BMSCs was carried out for three weeks, after 
which the samples were harvested, cryosectioned and stained for histology and other experiments 
like those discussed in Chapter 6.  
H&E staining images shown in Figure A4.2 demonstrates the effect of pore size on the formation 
of matrix inside the toluene extracted scaffolds after 21 days of osteogenic assay in the presence 
or absence of chitosan coating. 
 
Figure A4.2: Effect of pore size on the infiltration and tissue formation within PCL scaffolds. 
Red squares represent areas where ECM is missing 
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It is clear that PCL1 scaffolds with 41 μm pore size pre-seeded at 37°C do not allow proper 
scaffold infiltration, and therefore the cell penetration is hindered near the structure edges. 
However, the addition of chitosan appears to be improving the cell penetration and ECM 
deposition. PCL2 scaffolds, on the other hand, are fully infiltrated by cells and hence show high 
levels of ECM formation. This is in accordance with our infiltration results in Chapter 4. 
Therefore, due to infiltration limitations imposed by such small pore size, we decided to increase 
the pore size of PCL1 samples to a higher value of 84 μm as well as reduce the seeding 
temperature down to 4°C (to decrease the metabolic activity of the cells) for the osteogenic assay 
used in Chapter 6.  
 
Effect of chitosan surface modification 
Furthermore, it is evident that the chitosan surface treatment in this pilot study also leads to the 
formation of more matrix on the surface of the pores after 21 days of culture, as shown in Figure 
A4.3. These observations are also in agreement with our results in Chapter 6.  
 
Figure A4.3: Effect of chitosan surface treatment on the deposition of ECM 
 
Efficiency of VK (toluidine blue) staining 
Having selected a higher pore size for PCL1 for our osteogenic assay, BMSCs were cultured 
inside the scaffolds for 10 days in a proliferation medium (CCM), after which the osteogenic 
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assay was performed for three weeks. VK staining involves the reaction of silver ions with 
phosphates to produce silver phosphate which is reduced to silver through photochemical 
degradation by the UV light and can later be visualized as dark brown-black silver deposits. 
Figure A4.4 describes the efficiency of the VK (Tol Blue) staining.  
 
Figure A4.4: Efficiency of VK (Tol Blue) as compared to AR staining 
 
Our results at Day2 demonstrate that the chitosan layer deposited on the PCL1 surface are visibly 
affected by the Toluidine Blue (Tol Blue) counterstain used in the VK staining. It is yet unclear 
whether the Tol Blue is reacting with chitosan or the LbL polyelectrolytes underneath. Also, 
surprisingly, some dark deposits (represented by white arrows) are observed inside chitosan 
coated scaffolds at Day2 which could not be due to any minerals, knowing that the osteogenesis 
assay started at Day10. Furthermore, such artifacts due to the VK staining does not match the 
mineral deposits observed in the AR stained sections (depicted by red squares); VK staining led 
to unreliable results. It should be also noted that another study has shown that VK staining might 
be insufficient to confirm biomineralization in vitro (Bonewald et al., 2003).  
In order to check whether the patches of minerals detected by the AR staining correspond to the 
pores with highly colonized cells, we performed a side-by-side analysis of AR and H&E (non-
eluted PCL) staining images (5x) at Day31 for uncoated (Figure A4.5) and chitosan coated 
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(Figure A4.6) PCL scaffolds. According to Figure A4.5, the occurrence of mineral deposits 
overlaps with highly colonized areas on the top and on the edges of the scaffolds. Figure A4.6 
shows that the minerals in the LbL-chitosan coated scaffolds are deposited mostly on the surface 
and some in the interspace between the pores, where cells also exist but are not necessarily dense.  
 
Figure A4.5: Side-by-side H&E and AR 5x images of PCL-only scaffolds at Day31 
 
Figure A4.6: Side-by-side H&E and AR 5x images of PCL-chitosan scaffolds at Day31 
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APPENDIX 5 – MICRO-COMPUTED TOMOGRAPHY 
Micro-CT was initially selected as a method for confirming biomineralization inside PCL 
scaffolds at Day31. To achieve this goal, binary image thresholding has been done in order to be 
able to distinguish between the PCL scaffold and mineral deposits. Table A5.1 summarizes the 
preliminary selected thresholds for different samples. 
Table A5.1 : Thresholds for detection of scaffolds and/or minerals in CT-Analyser (CTAn) 
Sample Threshold 
Cell-seeded scaffolds : Scaffold + Mineral 70-255 
Cell-seeded scaffolds : Mineral only 160-255 
Non-seeded PCL1 Failed  
Non-seeded PCL2 40-110 
 
However, the thresholds above led to positive signals which were located inside the bulk of PCL 
rather than on the pore surface, as illustrated in u-CT images generated by the CTAn software 
(Figure A5.1). In this figure, green, black and pink sections respectively represent the scaffold, 
pores and positive mineral signals. We speculate that these positive signals originate from the 
segments inside the PCL bulk which are probably under tension and whose radio-opacity is 
comparable to that of the minerals. These false-positive signals are much less observed for PCL2 
samples. Real mineral signals are probably those detected at the edges of the pores. 
  227 
 
 
Figure A5.1: Real and false-positive signals for minerals at Day 31 (scaffolds cross-section) 
 
Considering the successful formation of minerals in the form of a “skin” at the perimeter of the 
scaffolds (Figure 6.7(i, k)) using the same thresholds mentioned above), we conclude that the 
extent of mineralization is not sufficient for the mineral particles to be quantified separately from 
PCL.  
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APPENDIX 6 – ENERGY-DISPERSIVE X-RAY SPECTROSCOPY 
Energy-dispersive X-ray spectroscopy (EDS or EDX) is an analytical surface characterization 
technique which is based on the principle that each element has its unique atomic structure which 
is represented by the X-ray peaks emitted off that specific atom at the surface of a substrate. In 
order to obtain elemental surface information, therefore, the emission of characteristic X-rays 
should be stimulated. This can be done by bombarding the surface with X-ray, protons and 
electron beams. Electron beam excitation is used in scanning electron microscopes (SEM). This 
electron bombardment ejects an electron from the inner shells of an atom at its ground state, 
creating an “electron hole” which is filled by another high energy electron from an outer shell 
hence releasing an X-ray beam. Like in the case of XPS, the level of this energy along with the 
number of ejected X-rays is measured using a detector called energy-dispersive spectrometer. 
The detected energy is attributed to the difference in the energies of the two shells and is specific 
to a unique atomic structure from which the X-rays were emitted. 
As a pilot study, we used the EDX functionality of the ESEM apparatus (ESEM, Quanta 200 
FEG, FEI Company, Czech Republic) to detect mineral deposits inside the pores of the PCL 
scaffolds. Figure A6.1 illustrates the EDX analysis of the regions of interest (white rectangles) in 
the chitosan-coated PCL scaffolds after the osteogenic assay (Day31). The negative control 
corresponding to the bulk of PCL does not show a calcium peak, whereas the area between the 
pores exhibits up to 4.3% calcium. The samples used for this study, unfortunately, were gold-
coated for the sake of ESEM visualization, and therefore a considerable gold peak is present 
which overlaps with that of the phosphate. Future works could potentially look into EDX analysis 
in further detail with PCL samples without chitosan coating and before gold-sputtering in order to 
reveal more information including the phosphate peak.   
In conclusion, the EDX analysis also proves the occurrence of biomineralization inside chitosan 
coated PCL scaffolds, which is in agreement with our AR calcium staining results. 
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Figure A6.1: EDX analysis of chitosan-coated PCL scaffolds at Day31 points to successful 
biomineralization 
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